<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>generics</title>
		<link>https://biospectrumasia.com/rssfeed/pharma/generics</link>
		<atom:link href="https://biospectrumasia.com/rssfeed/pharma/generics" rel="self" type="application/rss+xml" />
		<description>generics</description>
					<item>
			<title>Accro and Fosun advance oral TYK2/JAK1 inhibitor AC-201 into China Phase II/III vitiligo trial</title>
			<atom:link href="https://biospectrumasia.com/news/33/28344/accro-and-fosun-advance-oral-tyk2-jak1-inhibitor-ac-201-into-china-phase-ii-iii-vitiligo-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/28344/accro-and-fosun-advance-oral-tyk2-jak1-inhibitor-ac-201-into-china-phase-ii-iii-vitiligo-trial.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28344.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/28344/accro-and-fosun-advance-oral-tyk2-jak1-inhibitor-ac-201-into-china-phase-ii-iii-vitiligo-trial.html</guid>
		</item>	
				<item>
			<title>Formosa Pharma files European trial application for Kadcyla biosimilar TSY-110</title>
			<atom:link href="https://biospectrumasia.com/news/33/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28288.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html</guid>
		</item>	
				<item>
			<title>Strides receives USFDA EIR for Bengaluru manufacturing facility</title>
			<atom:link href="https://biospectrumasia.com/news/33/28230/strides-receives-usfda-eir-for-bengaluru-manufacturing-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/28230/strides-receives-usfda-eir-for-bengaluru-manufacturing-facility.html</link>
			<pubDate>Thu, 20 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1787209166_img_strides_pharma-28230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/28230/strides-receives-usfda-eir-for-bengaluru-manufacturing-facility.html</guid>
		</item>	
				<item>
			<title>Orasis submits Australia application for presbyopia eye drop</title>
			<atom:link href="https://biospectrumasia.com/news/33/28040/orasis-submits-australia-application-for-presbyopia-eye-drop.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/28040/orasis-submits-australia-application-for-presbyopia-eye-drop.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-28040.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/28040/orasis-submits-australia-application-for-presbyopia-eye-drop.html</guid>
		</item>	
				<item>
			<title>Hansa Biopharma Reports Positive European Post-Authorisation Data for Idefirix</title>
			<atom:link href="https://biospectrumasia.com/news/33/27763/hansa-biopharma-reports-positive-european-post-authorisation-data-for-idefirix.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27763/hansa-biopharma-reports-positive-european-post-authorisation-data-for-idefirix.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-27763.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27763/hansa-biopharma-reports-positive-european-post-authorisation-data-for-idefirix.html</guid>
		</item>	
				<item>
			<title>FDA Approves TREMFYA Label Expansion for Structural Joint Damage in Psoriatic Arthritis</title>
			<atom:link href="https://biospectrumasia.com/news/33/27756/fda-approves-tremfya-label-expansion-for-structural-joint-damage-in-psoriatic-arthritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27756/fda-approves-tremfya-label-expansion-for-structural-joint-damage-in-psoriatic-arthritis.html</link>
			<pubDate>Fri, 05 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tremfya-27756.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27756/fda-approves-tremfya-label-expansion-for-structural-joint-damage-in-psoriatic-arthritis.html</guid>
		</item>	
				<item>
			<title>China’s API Industry Signals Strategic Global Shift At API China 2026 Overseas Pharmaceutical Market Forum</title>
			<atom:link href="https://biospectrumasia.com/news/33/27643/chinas-api-industry-signals-strategic-global-shift-at-api-china-2026-overseas-pharmaceutical-market-forum.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27643/chinas-api-industry-signals-strategic-global-shift-at-api-china-2026-overseas-pharmaceutical-market-forum.html</link>
			<pubDate>Thu, 14 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d3c3ce94_3216_4519_a00e_220e9bd159df-27643.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27643/chinas-api-industry-signals-strategic-global-shift-at-api-china-2026-overseas-pharmaceutical-market-forum.html</guid>
		</item>	
				<item>
			<title>South Korea’s Biopharma Expansion Signals Next Decade Of Global Innovation Growth At API China 2026</title>
			<atom:link href="https://biospectrumasia.com/news/33/27644/south-koreas-biopharma-expansion-signals-next-decade-of-global-innovation-growth-at-api-china-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27644/south-koreas-biopharma-expansion-signals-next-decade-of-global-innovation-growth-at-api-china-2026.html</link>
			<pubDate>Thu, 14 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d4b0f482_f208_48c5_8c87_cbf56e30d9a1-27644.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27644/south-koreas-biopharma-expansion-signals-next-decade-of-global-innovation-growth-at-api-china-2026.html</guid>
		</item>	
				<item>
			<title>Middle East Pharma Markets Emerge As Strategic Growth Corridor At API China 2026</title>
			<atom:link href="https://biospectrumasia.com/news/33/27645/middle-east-pharma-markets-emerge-as-strategic-growth-corridor-at-api-china-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27645/middle-east-pharma-markets-emerge-as-strategic-growth-corridor-at-api-china-2026.html</link>
			<pubDate>Thu, 14 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mage_may_14_2026_09_40_04_am-27645.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27645/middle-east-pharma-markets-emerge-as-strategic-growth-corridor-at-api-china-2026.html</guid>
		</item>	
				<item>
			<title>China Opens One Of The World’s Largest Pharmaceutical Industry Platforms As API China 2026 And Co Located Mega Exhibitions Begin</title>
			<atom:link href="https://biospectrumasia.com/news/33/27628/china-opens-one-of-the-worlds-largest-pharmaceutical-industry-platforms-as-api-china-2026-and-co-located-mega-exhibitions-begin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27628/china-opens-one-of-the-worlds-largest-pharmaceutical-industry-platforms-as-api-china-2026-and-co-located-mega-exhibitions-begin.html</link>
			<pubDate>Wed, 13 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_20260513_wa0008-27628.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27628/china-opens-one-of-the-worlds-largest-pharmaceutical-industry-platforms-as-api-china-2026-and-co-located-mega-exhibitions-begin.html</guid>
		</item>	
				<item>
			<title>China’s Pharma Industry Accelerates Intelligent Manufacturing Push At Opening Session Of 2026 Pharmaceutical Innovation And Compliance Development Forum</title>
			<atom:link href="https://biospectrumasia.com/news/33/27630/chinas-pharma-industry-accelerates-intelligent-manufacturing-push-at-opening-session-of-2026-pharmaceutical-innovation-and-compliance-development-forum.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27630/chinas-pharma-industry-accelerates-intelligent-manufacturing-push-at-opening-session-of-2026-pharmaceutical-innovation-and-compliance-development-forum.html</link>
			<pubDate>Wed, 13 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ecab3c30_8872_4cc5_a6b3_0b1759b5ee04-27630.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27630/chinas-pharma-industry-accelerates-intelligent-manufacturing-push-at-opening-session-of-2026-pharmaceutical-innovation-and-compliance-development-forum.html</guid>
		</item>	
				<item>
			<title>Smart Pharmaceutical Factories Take Centre Stage At API China 2026</title>
			<atom:link href="https://biospectrumasia.com/news/33/27632/smart-pharmaceutical-factories-take-centre-stage-at-api-china-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27632/smart-pharmaceutical-factories-take-centre-stage-at-api-china-2026.html</link>
			<pubDate>Wed, 13 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bb9e1cad_9dc7_455d_a5b5_b82b0bff8bca-27632.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27632/smart-pharmaceutical-factories-take-centre-stage-at-api-china-2026.html</guid>
		</item>	
				<item>
			<title>Heath Coats Highlights Evolving FDA Inspection Expectations At Charles River APAC Biomanufacturing Leadership Summit</title>
			<atom:link href="https://biospectrumasia.com/news/33/27315/heath-coats-highlights-evolving-fda-inspection-expectations-at-charles-river-apac-biomanufacturing-leadership-summit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27315/heath-coats-highlights-evolving-fda-inspection-expectations-at-charles-river-apac-biomanufacturing-leadership-summit.html</link>
			<pubDate>Tue, 10 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heathcoat_1_-27315.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27315/heath-coats-highlights-evolving-fda-inspection-expectations-at-charles-river-apac-biomanufacturing-leadership-summit.html</guid>
		</item>	
				<item>
			<title>OneSource-Hikma partnership secures approval to commercialise generic version of OzempicÂ® in Saudi Arabia</title>
			<atom:link href="https://biospectrumasia.com/news/33/27194/onesource-hikma-partnership-secures-approval-to-commercialise-generic-version-of-ozempic-in-saudi-arabia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/27194/onesource-hikma-partnership-secures-approval-to-commercialise-generic-version-of-ozempic-in-saudi-arabia.html</link>
			<pubDate>Wed, 11 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_2_2026_20147_www_bing_com-27194.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/27194/onesource-hikma-partnership-secures-approval-to-commercialise-generic-version-of-ozempic-in-saudi-arabia.html</guid>
		</item>	
				<item>
			<title>India&#039;s Morepen secures approval of anti-allergy API Loratadine for export to China</title>
			<atom:link href="https://biospectrumasia.com/news/33/25817/indias-morepen-secures-approval-of-anti-allergy-api-loratadine-for-export-to-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/25817/indias-morepen-secures-approval-of-anti-allergy-api-loratadine-for-export-to-china.html</link>
			<pubDate>Tue, 01 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_5_-25817.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/25817/indias-morepen-secures-approval-of-anti-allergy-api-loratadine-for-export-to-china.html</guid>
		</item>	
				<item>
			<title>Mitigating Patent Cliff Fallout</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/25658/mitigating-patent-cliff-fallout.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/25658/mitigating-patent-cliff-fallout.html</link>
			<pubDate>Sat, 01 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_3_2025_141313_-25658.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/25658/mitigating-patent-cliff-fallout.html</guid>
		</item>	
				<item>
			<title>Collaboration vs Competition: Patent Cliffs</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/25659/collaboration-vs-competition-patent-cliffs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/25659/collaboration-vs-competition-patent-cliffs.html</link>
			<pubDate>Sat, 01 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alice_zeng-25659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/25659/collaboration-vs-competition-patent-cliffs.html</guid>
		</item>	
				<item>
			<title>Eisai grants exclusive development and distribution rights for Tasurgratinib in Greater China to SciClone Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/33/25654/eisai-grants-exclusive-development-and-distribution-rights-for-tasurgratinib-in-greater-china-to-sciclone-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/25654/eisai-grants-exclusive-development-and-distribution-rights-for-tasurgratinib-in-greater-china-to-sciclone-pharma.html</link>
			<pubDate>Fri, 28 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cv-25654.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/25654/eisai-grants-exclusive-development-and-distribution-rights-for-tasurgratinib-in-greater-china-to-sciclone-pharma.html</guid>
		</item>	
				<item>
			<title>Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder</title>
			<atom:link href="https://biospectrumasia.com/news/33/25035/andelyn-biosciences-chosen-by-hubble-therapeutics-to-manufacture-gene-therapy-for-rare-childhood-blindness-disorder.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/25035/andelyn-biosciences-chosen-by-hubble-therapeutics-to-manufacture-gene-therapy-for-rare-childhood-blindness-disorder.html</link>
			<pubDate>Fri, 11 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-25035.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/25035/andelyn-biosciences-chosen-by-hubble-therapeutics-to-manufacture-gene-therapy-for-rare-childhood-blindness-disorder.html</guid>
		</item>	
				<item>
			<title>Hyphens Pharma launches treatment for Atopic dermatitis (Eczema) expanding it&#039;s CeradanÂ® series</title>
			<atom:link href="https://biospectrumasia.com/news/33/24913/hyphens-pharma-launches-treatment-for-atopic-dermatitis-eczema-expanding-its-ceradan-series.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/24913/hyphens-pharma-launches-treatment-for-atopic-dermatitis-eczema-expanding-its-ceradan-series.html</link>
			<pubDate>Thu, 19 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image002-24913.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/24913/hyphens-pharma-launches-treatment-for-atopic-dermatitis-eczema-expanding-its-ceradan-series.html</guid>
		</item>	
				<item>
			<title>Addressing Supply Chain Vulnerabilities in the Global Pharmaceutical Industry</title>
			<atom:link href="https://biospectrumasia.com/news/33/24755/addressing-supply-chain-vulnerabilities-in-the-global-pharmaceutical-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/24755/addressing-supply-chain-vulnerabilities-in-the-global-pharmaceutical-industry.html</link>
			<pubDate>Thu, 22 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-24755.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/24755/addressing-supply-chain-vulnerabilities-in-the-global-pharmaceutical-industry.html</guid>
		</item>	
				<item>
			<title>Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market</title>
			<atom:link href="https://biospectrumasia.com/news/33/24668/chinese-generic-drug-for-breast-pancreatic-and-lung-cancer-approved-in-eu-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/24668/chinese-generic-drug-for-breast-pancreatic-and-lung-cancer-approved-in-eu-market.html</link>
			<pubDate>Wed, 31 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/closeup_image_medicine_pills_144627_3793-24668.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/24668/chinese-generic-drug-for-breast-pancreatic-and-lung-cancer-approved-in-eu-market.html</guid>
		</item>	
				<item>
			<title>China Life Science Conference and China Life Science Expo (CILSE) Set to Drive Innovation and Collaboration in Guangzhou</title>
			<atom:link href="https://biospectrumasia.com/news/33/23888/china-life-science-conference-and-china-life-science-expo-cilse-set-to-drive-innovation-and-collaboration-in-guangzhou.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/23888/china-life-science-conference-and-china-life-science-expo-cilse-set-to-drive-innovation-and-collaboration-in-guangzhou.html</link>
			<pubDate>Thu, 07 Mar 2024 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/23888/china-life-science-conference-and-china-life-science-expo-cilse-set-to-drive-innovation-and-collaboration-in-guangzhou.html</guid>
		</item>	
				<item>
			<title>Asia Pacific Forum on Precision Cancer Treatment at Taiwan Healthcare+ Expo 2023,  Wraps Up with Robust Discussions and Deep Insights</title>
			<atom:link href="https://biospectrumasia.com/news/33/23417/asia-pacific-forum-on-precision-cancer-treatment-at-taiwan-healthcare-expo-2023-wraps-up-with-robust-discussions-and-deep-insights.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/23417/asia-pacific-forum-on-precision-cancer-treatment-at-taiwan-healthcare-expo-2023-wraps-up-with-robust-discussions-and-deep-insights.html</link>
			<pubDate>Fri, 01 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/f7e09200_2cd3_4824_8032_6d2ece8ec92a-23417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/23417/asia-pacific-forum-on-precision-cancer-treatment-at-taiwan-healthcare-expo-2023-wraps-up-with-robust-discussions-and-deep-insights.html</guid>
		</item>	
				<item>
			<title>j</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/22802/j.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/22802/j.html</link>
			<pubDate>Wed, 26 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1690437881788-22802.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/22802/j.html</guid>
		</item>	
				<item>
			<title>â€œGeneric manufacturers will likely face increasing challenges such as pricing pressures driven by &#039;un-branding&#039; effortsâ€ </title>
			<atom:link href="https://biospectrumasia.com/opinion/33/22672/generic-manufacturers-will-likely-face-increasing-challenges-such-as-pricing-pressures-driven-by-un-branding-efforts-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/22672/generic-manufacturers-will-likely-face-increasing-challenges-such-as-pricing-pressures-driven-by-un-branding-efforts-.html</link>
			<pubDate>Tue, 04 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bio-22672.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/22672/generic-manufacturers-will-likely-face-increasing-challenges-such-as-pricing-pressures-driven-by-un-branding-efforts-.html</guid>
		</item>	
				<item>
			<title>Generic manufacturers from India &amp; Indonesia bring affordable drug for cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/news/33/22626/generic-manufacturers-from-india-indonesia-bring-affordable-drug-for-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/22626/generic-manufacturers-from-india-indonesia-bring-affordable-drug-for-cancer-treatment.html</link>
			<pubDate>Fri, 23 Jun 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22626.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/22626/generic-manufacturers-from-india-indonesia-bring-affordable-drug-for-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M</title>
			<atom:link href="https://biospectrumasia.com/news/33/22023/australia-based-mayne-pharma-sells-us-generic-prescription-product-portfolio-for-90-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/22023/australia-based-mayne-pharma-sells-us-generic-prescription-product-portfolio-for-90-m.html</link>
			<pubDate>Tue, 28 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-22023.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/22023/australia-based-mayne-pharma-sells-us-generic-prescription-product-portfolio-for-90-m.html</guid>
		</item>	
				<item>
			<title>Indian pharma firm Venus Remedies gets marketing approval for cancer drugs in Uzbekistan, Palestine</title>
			<atom:link href="https://biospectrumasia.com/news/33/21999/indian-pharma-firm-venus-remedies-gets-marketing-approval-for-cancer-drugs-in-uzbekistan-palestine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/21999/indian-pharma-firm-venus-remedies-gets-marketing-approval-for-cancer-drugs-in-uzbekistan-palestine.html</link>
			<pubDate>Thu, 23 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-21999.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/21999/indian-pharma-firm-venus-remedies-gets-marketing-approval-for-cancer-drugs-in-uzbekistan-palestine.html</guid>
		</item>	
				<item>
			<title>ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist</title>
			<atom:link href="https://biospectrumasia.com/news/33/21134/archimed-invests-in-plasmidfactory-a-german-gene-and-cell-therapy-specialist.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/21134/archimed-invests-in-plasmidfactory-a-german-gene-and-cell-therapy-specialist.html</link>
			<pubDate>Wed, 28 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/33-21134.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/21134/archimed-invests-in-plasmidfactory-a-german-gene-and-cell-therapy-specialist.html</guid>
		</item>	
				<item>
			<title>Portfolio Management and Pipeline Optimization for Generics (15th Edition) conference to unravel global generic pharma market opportunities</title>
			<atom:link href="https://biospectrumasia.com/news/33/20850/portfolio-management-and-pipeline-optimization-for-generics-15th-edition-conference-to-unravel-global-generic-pharma-market-opportunities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/20850/portfolio-management-and-pipeline-optimization-for-generics-15th-edition-conference-to-unravel-global-generic-pharma-market-opportunities.html</link>
			<pubDate>Mon, 08 Aug 2022 08:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chc1113_linkedin_-20850.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/20850/portfolio-management-and-pipeline-optimization-for-generics-15th-edition-conference-to-unravel-global-generic-pharma-market-opportunities.html</guid>
		</item>	
				<item>
			<title>35 manufacturers sign agreements to produce generic versions of Pfizer&#039;s oral COVID-19 drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/19889/35-manufacturers-sign-agreements-to-produce-generic-versions-of-pfizers-oral-covid-19-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/19889/35-manufacturers-sign-agreements-to-produce-generic-versions-of-pfizers-oral-covid-19-drug.html</link>
			<pubDate>Fri, 18 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19889.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/19889/35-manufacturers-sign-agreements-to-produce-generic-versions-of-pfizers-oral-covid-19-drug.html</guid>
		</item>	
				<item>
			<title>Taiwan approves new first-line treatment for advanced renal cell carcinoma</title>
			<atom:link href="https://biospectrumasia.com/news/33/19646/taiwan-approves-new-first-line-treatment-for-advanced-renal-cell-carcinoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/19646/taiwan-approves-new-first-line-treatment-for-advanced-renal-cell-carcinoma.html</link>
			<pubDate>Mon, 31 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aprove-19646.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/19646/taiwan-approves-new-first-line-treatment-for-advanced-renal-cell-carcinoma.html</guid>
		</item>	
				<item>
			<title>Eisai to market Gilead&#039;s rheumatoid arthritis drug in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/33/19516/eisai-to-market-gileads-rheumatoid-arthritis-drug-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/19516/eisai-to-market-gileads-rheumatoid-arthritis-drug-in-asia.html</link>
			<pubDate>Thu, 23 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19516.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/19516/eisai-to-market-gileads-rheumatoid-arthritis-drug-in-asia.html</guid>
		</item>	
				<item>
			<title>Biocon partners with Tabuk Pharma to commercialise speciality generic medicines in Middle East</title>
			<atom:link href="https://biospectrumasia.com/news/33/19457/biocon-partners-with-tabuk-pharma-to-commercialise-speciality-generic-medicines-in-middle-east.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/19457/biocon-partners-with-tabuk-pharma-to-commercialise-speciality-generic-medicines-in-middle-east.html</link>
			<pubDate>Wed, 08 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-19457.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/19457/biocon-partners-with-tabuk-pharma-to-commercialise-speciality-generic-medicines-in-middle-east.html</guid>
		</item>	
				<item>
			<title>C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/33/19329/c2-pharma-completes-multiple-local-regulatory-filings-and-expands-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/19329/c2-pharma-completes-multiple-local-regulatory-filings-and-expands-portfolio.html</link>
			<pubDate>Wed, 10 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-19329.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/19329/c2-pharma-completes-multiple-local-regulatory-filings-and-expands-portfolio.html</guid>
		</item>	
				<item>
			<title>Biopharma leads to develop self-replicating and conventional mRNA therapeutics and vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/33/18634/biopharma-leads-to-develop-self-replicating-and-conventional-mrna-therapeutics-and-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/18634/biopharma-leads-to-develop-self-replicating-and-conventional-mrna-therapeutics-and-vaccines.html</link>
			<pubDate>Tue, 20 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene_therapy_dna_3d_chemical_molecule_structure_low_poly_polygonal_triangle_point_line_115739_274-18634.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/18634/biopharma-leads-to-develop-self-replicating-and-conventional-mrna-therapeutics-and-vaccines.html</guid>
		</item>	
				<item>
			<title>Patient access to gene therapies for cancer set to increase in next decade: GlobalData</title>
			<atom:link href="https://biospectrumasia.com/news/33/18446/patient-access-to-gene-therapies-for-cancer-set-to-increase-in-next-decade-globaldata.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/18446/patient-access-to-gene-therapies-for-cancer-set-to-increase-in-next-decade-globaldata.html</link>
			<pubDate>Fri, 25 Jun 2021 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-18446.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/18446/patient-access-to-gene-therapies-for-cancer-set-to-increase-in-next-decade-globaldata.html</guid>
		</item>	
				<item>
			<title>Bayer leads Metagenomi complete $65M series A financing round</title>
			<atom:link href="https://biospectrumasia.com/news/33/17124/bayer-leads-metagenomi-complete-65m-series-a-financing-round.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/17124/bayer-leads-metagenomi-complete-65m-series-a-financing-round.html</link>
			<pubDate>Mon, 16 Nov 2020 13:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene_therapy-17124.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/17124/bayer-leads-metagenomi-complete-65m-series-a-financing-round.html</guid>
		</item>	
				<item>
			<title>Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes</title>
			<atom:link href="https://biospectrumasia.com/news/33/15979/cells-for-cells-and-austrianova-announce-publication-on-novel-method-to-produce-stem-cell-exosomes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15979/cells-for-cells-and-austrianova-announce-publication-on-novel-method-to-produce-stem-cell-exosomes.html</link>
			<pubDate>Thu, 21 May 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem_cell_derived_from_exosome_1-15979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15979/cells-for-cells-and-austrianova-announce-publication-on-novel-method-to-produce-stem-cell-exosomes.html</guid>
		</item>	
				<item>
			<title>Indian Pharma market to raise from US$34.3bn in 2020 to more than US$45bn by 2025</title>
			<atom:link href="https://biospectrumasia.com/news/33/15498/indian-pharma-market-to-raise-from-us34-3bn-in-2020-to-more-than-us45bn-by-2025.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15498/indian-pharma-market-to-raise-from-us34-3bn-in-2020-to-more-than-us45bn-by-2025.html</link>
			<pubDate>Mon, 24 Feb 2020 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/global_business_report-15498.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15498/indian-pharma-market-to-raise-from-us34-3bn-in-2020-to-more-than-us45bn-by-2025.html</guid>
		</item>	
				<item>
			<title>Towa to acquire Esteve&#039;s generic division for 320M euros</title>
			<atom:link href="https://biospectrumasia.com/news/33/15125/towa-to-acquire-esteves-generic-division-for-320m-euros.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15125/towa-to-acquire-esteves-generic-division-for-320m-euros.html</link>
			<pubDate>Tue, 24 Dec 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15125.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15125/towa-to-acquire-esteves-generic-division-for-320m-euros.html</guid>
		</item>	
				<item>
			<title>FDA approves first generics of Gilenya</title>
			<atom:link href="https://biospectrumasia.com/news/33/15071/fda-approves-first-generics-of-gilenya.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15071/fda-approves-first-generics-of-gilenya.html</link>
			<pubDate>Mon, 16 Dec 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15071.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15071/fda-approves-first-generics-of-gilenya.html</guid>
		</item>	
				<item>
			<title>Panacea Biotec launches diabetes drug in India</title>
			<atom:link href="https://biospectrumasia.com/news/33/15053/panacea-biotec-launches-diabetes-drug-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15053/panacea-biotec-launches-diabetes-drug-in-india.html</link>
			<pubDate>Wed, 11 Dec 2019 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes_2-15053.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15053/panacea-biotec-launches-diabetes-drug-in-india.html</guid>
		</item>	
				<item>
			<title>HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/15032/hec-pharm-biocon-sun-pharma-get-fda-approval-for-ms-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15032/hec-pharm-biocon-sun-pharma-get-fda-approval-for-ms-drug.html</link>
			<pubDate>Fri, 06 Dec 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/multiple_sclerosis-15032.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15032/hec-pharm-biocon-sun-pharma-get-fda-approval-for-ms-drug.html</guid>
		</item>	
				<item>
			<title>Eris Lifesciences acquires trademark Zomelis from Novartis for India market</title>
			<atom:link href="https://biospectrumasia.com/news/33/15020/eris-lifesciences-acquires-trademark-zomelis-from-novartis-for-india-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/15020/eris-lifesciences-acquires-trademark-zomelis-from-novartis-for-india-market.html</link>
			<pubDate>Wed, 04 Dec 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/15020/eris-lifesciences-acquires-trademark-zomelis-from-novartis-for-india-market.html</guid>
		</item>	
				<item>
			<title>EMA and FDA accept marketing applications for Chugai&#039;s Satralizumab </title>
			<atom:link href="https://biospectrumasia.com/news/33/14790/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14790/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-.html</link>
			<pubDate>Thu, 31 Oct 2019 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/elevation_of_eye_g_962777986_860x485-14790.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14790/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s confirms recall of all Ranitidine products</title>
			<atom:link href="https://biospectrumasia.com/news/33/14751/dr-reddys-confirms-recall-of-all-ranitidine-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14751/dr-reddys-confirms-recall-of-all-ranitidine-products.html</link>
			<pubDate>Thu, 24 Oct 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14751.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14751/dr-reddys-confirms-recall-of-all-ranitidine-products.html</guid>
		</item>	
				<item>
			<title>Eisai, Nichi-Iko explore generic pharma biz in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/14602/eisai-nichi-iko-explore-generic-pharma-biz-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14602/eisai-nichi-iko-explore-generic-pharma-biz-in-china.html</link>
			<pubDate>Tue, 01 Oct 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14602.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14602/eisai-nichi-iko-explore-generic-pharma-biz-in-china.html</guid>
		</item>	
				<item>
			<title>Glenmark receives approval from Russia to market Montlezir </title>
			<atom:link href="https://biospectrumasia.com/news/33/14597/glenmark-receives-approval-from-russia-to-market-montlezir-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14597/glenmark-receives-approval-from-russia-to-market-montlezir-.html</link>
			<pubDate>Mon, 30 Sep 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicines_nirbhaya_1_647_080916110045-14597.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14597/glenmark-receives-approval-from-russia-to-market-montlezir-.html</guid>
		</item>	
				<item>
			<title>Glenmark receives Orphan Drug Designation for GBR 1342</title>
			<atom:link href="https://biospectrumasia.com/news/33/14502/glenmark-receives-orphan-drug-designation-for-gbr-1342.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14502/glenmark-receives-orphan-drug-designation-for-gbr-1342.html</link>
			<pubDate>Tue, 17 Sep 2019 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_126848-14502.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14502/glenmark-receives-orphan-drug-designation-for-gbr-1342.html</guid>
		</item>	
				<item>
			<title>Lupin launches antidepressant drug </title>
			<atom:link href="https://biospectrumasia.com/news/33/14320/lupin-launches-antidepressant-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14320/lupin-launches-antidepressant-drug-.html</link>
			<pubDate>Fri, 23 Aug 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets_2-14320.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14320/lupin-launches-antidepressant-drug-.html</guid>
		</item>	
				<item>
			<title>Teva launches Epinephrine Injection in the US</title>
			<atom:link href="https://biospectrumasia.com/news/33/14286/teva-launches-epinephrine-injection-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/14286/teva-launches-epinephrine-injection-in-the-us.html</link>
			<pubDate>Wed, 21 Aug 2019 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14286.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/14286/teva-launches-epinephrine-injection-in-the-us.html</guid>
		</item>	
				<item>
			<title>Sandoz launches oncology generic gefitinib in 13 EU countries</title>
			<atom:link href="https://biospectrumasia.com/news/33/13962/sandoz-launches-oncology-generic-gefitinib-in-13-eu-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13962/sandoz-launches-oncology-generic-gefitinib-in-13-eu-countries.html</link>
			<pubDate>Wed, 10 Jul 2019 16:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2-13962.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13962/sandoz-launches-oncology-generic-gefitinib-in-13-eu-countries.html</guid>
		</item>	
				<item>
			<title>Sun Pharma and CMS enter into a License Agreement for Tildrakizumab in Greater China</title>
			<atom:link href="https://biospectrumasia.com/news/33/13843/sun-pharma-and-cms-enter-into-a-license-agreement-for-tildrakizumab-in-greater-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13843/sun-pharma-and-cms-enter-into-a-license-agreement-for-tildrakizumab-in-greater-china.html</link>
			<pubDate>Thu, 27 Jun 2019 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/a_number_of_medicines_of_all_shapes_and_size_laid_out_on_a_table_2560x1707-13843.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13843/sun-pharma-and-cms-enter-into-a-license-agreement-for-tildrakizumab-in-greater-china.html</guid>
		</item>	
				<item>
			<title>Teva announces launch of a generic version of TracleerÂ® in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/13768/teva-announces-launch-of-a-generic-version-of-tracleer-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13768/teva-announces-launch-of-a-generic-version-of-tracleer-in-us.html</link>
			<pubDate>Thu, 20 Jun 2019 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_126848_1_-13768.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13768/teva-announces-launch-of-a-generic-version-of-tracleer-in-us.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PMDA completes inspection of Lupin&#039;s Mandideep facility (Unit-2)</title>
			<atom:link href="https://biospectrumasia.com/news/33/13630/japans-pmda-completes-inspection-of-lupins-mandideep-facility-unit-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13630/japans-pmda-completes-inspection-of-lupins-mandideep-facility-unit-2.html</link>
			<pubDate>Wed, 05 Jun 2019 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/inspection-13630.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13630/japans-pmda-completes-inspection-of-lupins-mandideep-facility-unit-2.html</guid>
		</item>	
				<item>
			<title>GSK announces approval of Shingrix in China </title>
			<atom:link href="https://biospectrumasia.com/news/33/13547/gsk-announces-approval-of-shingrix-in-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13547/gsk-announces-approval-of-shingrix-in-china-.html</link>
			<pubDate>Mon, 27 May 2019 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-13547.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13547/gsk-announces-approval-of-shingrix-in-china-.html</guid>
		</item>	
				<item>
			<title>FDA approves SORILUX(R) for Adolescent Plaque Psoriasis</title>
			<atom:link href="https://biospectrumasia.com/news/33/13521/fda-approves-soriluxr-for-adolescent-plaque-psoriasis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13521/fda-approves-soriluxr-for-adolescent-plaque-psoriasis.html</link>
			<pubDate>Thu, 23 May 2019 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-13521.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13521/fda-approves-soriluxr-for-adolescent-plaque-psoriasis.html</guid>
		</item>	
				<item>
			<title>Sandoz receives regulatory approval from NMPA for Rosuvastatin</title>
			<atom:link href="https://biospectrumasia.com/news/33/13424/sandoz-receives-regulatory-approval-from-nmpa-for-rosuvastatin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13424/sandoz-receives-regulatory-approval-from-nmpa-for-rosuvastatin.html</link>
			<pubDate>Thu, 09 May 2019 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-13424.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13424/sandoz-receives-regulatory-approval-from-nmpa-for-rosuvastatin.html</guid>
		</item>	
				<item>
			<title>Alembic set to sell its drugs into Chinese market</title>
			<atom:link href="https://biospectrumasia.com/news/33/13407/alembic-set-to-sell-its-drugs-into-chinese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13407/alembic-set-to-sell-its-drugs-into-chinese-market.html</link>
			<pubDate>Wed, 08 May 2019 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collboration_3-13407.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13407/alembic-set-to-sell-its-drugs-into-chinese-market.html</guid>
		</item>	
				<item>
			<title>CStone, Numab enter into an exclusive licensing agreement for ND021 </title>
			<atom:link href="https://biospectrumasia.com/news/33/13366/cstone-numab-enter-into-an-exclusive-licensing-agreement-for-nd021-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13366/cstone-numab-enter-into-an-exclusive-licensing-agreement-for-nd021-.html</link>
			<pubDate>Thu, 02 May 2019 16:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-13366.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13366/cstone-numab-enter-into-an-exclusive-licensing-agreement-for-nd021-.html</guid>
		</item>	
				<item>
			<title>EirGenix inks commercialization agreement with Sandoz</title>
			<atom:link href="https://biospectrumasia.com/news/33/13348/eirgenix-inks-commercialization-agreement-with-sandoz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13348/eirgenix-inks-commercialization-agreement-with-sandoz.html</link>
			<pubDate>Tue, 30 Apr 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13348.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13348/eirgenix-inks-commercialization-agreement-with-sandoz.html</guid>
		</item>	
				<item>
			<title>Teva launches generic AndroGel</title>
			<atom:link href="https://biospectrumasia.com/news/33/13277/teva-launches-generic-androgel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13277/teva-launches-generic-androgel.html</link>
			<pubDate>Mon, 22 Apr 2019 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13277.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13277/teva-launches-generic-androgel.html</guid>
		</item>	
				<item>
			<title>Teva announces launch of generic version of EXJADEÂ® </title>
			<atom:link href="https://biospectrumasia.com/news/33/13099/teva-announces-launch-of-generic-version-of-exjade-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13099/teva-announces-launch-of-generic-version-of-exjade-.html</link>
			<pubDate>Mon, 25 Mar 2019 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chloramphenicol_suspension_500x500-13099.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13099/teva-announces-launch-of-generic-version-of-exjade-.html</guid>
		</item>	
				<item>
			<title>FDA accepts NDA for Lemborexant to treat Insomnia</title>
			<atom:link href="https://biospectrumasia.com/news/33/13000/fda-accepts-nda-for-lemborexant-to-treat-insomnia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/13000/fda-accepts-nda-for-lemborexant-to-treat-insomnia.html</link>
			<pubDate>Tue, 12 Mar 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sleep_wake_disorder-13000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/13000/fda-accepts-nda-for-lemborexant-to-treat-insomnia.html</guid>
		</item>	
				<item>
			<title>Vitruvias, Sinotherapeutics launch approved version of Propafenone ER in the U.S.</title>
			<atom:link href="https://biospectrumasia.com/news/33/12988/vitruvias-sinotherapeutics-launch-approved-version-of-propafenone-er-in-the-u-s-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12988/vitruvias-sinotherapeutics-launch-approved-version-of-propafenone-er-in-the-u-s-.html</link>
			<pubDate>Mon, 11 Mar 2019 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/waste_medicines_image_2_mar14_1024x685-12988.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12988/vitruvias-sinotherapeutics-launch-approved-version-of-propafenone-er-in-the-u-s-.html</guid>
		</item>	
				<item>
			<title>CHMP backs Sanofi&#039;s Dupixen in asthma </title>
			<atom:link href="https://biospectrumasia.com/news/33/12971/chmp-backs-sanofis-dupixen-in-asthma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12971/chmp-backs-sanofis-dupixen-in-asthma-.html</link>
			<pubDate>Fri, 08 Mar 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/asthma-12971.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12971/chmp-backs-sanofis-dupixen-in-asthma-.html</guid>
		</item>	
				<item>
			<title>Lupin receives FDA approval for generic version Vidaza</title>
			<atom:link href="https://biospectrumasia.com/news/33/12915/lupin-receives-fda-approval-for-generic-version-vidaza.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12915/lupin-receives-fda-approval-for-generic-version-vidaza.html</link>
			<pubDate>Fri, 01 Mar 2019 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12915.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12915/lupin-receives-fda-approval-for-generic-version-vidaza.html</guid>
		</item>	
				<item>
			<title>Novartis receives FDA approval for Egaten</title>
			<atom:link href="https://biospectrumasia.com/news/33/12849/novartis-receives-fda-approval-for-egaten.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12849/novartis-receives-fda-approval-for-egaten.html</link>
			<pubDate>Wed, 20 Feb 2019 14:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_29149_960_720-12849.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12849/novartis-receives-fda-approval-for-egaten.html</guid>
		</item>	
				<item>
			<title>Lupin launches Tadalafil Tablets </title>
			<atom:link href="https://biospectrumasia.com/news/33/12794/lupin-launches-tadalafil-tablets-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12794/lupin-launches-tadalafil-tablets-.html</link>
			<pubDate>Wed, 13 Feb 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_tablets-12794.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12794/lupin-launches-tadalafil-tablets-.html</guid>
		</item>	
				<item>
			<title>Lupin receives FDA approval for Fluoxetine Tablets </title>
			<atom:link href="https://biospectrumasia.com/news/33/12793/lupin-receives-fda-approval-for-fluoxetine-tablets-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12793/lupin-receives-fda-approval-for-fluoxetine-tablets-.html</link>
			<pubDate>Wed, 13 Feb 2019 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12793.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12793/lupin-receives-fda-approval-for-fluoxetine-tablets-.html</guid>
		</item>	
				<item>
			<title>Lupin announces launch of NaMuscla</title>
			<atom:link href="https://biospectrumasia.com/news/33/12708/lupin-announces-launch-of-namuscla.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12708/lupin-announces-launch-of-namuscla.html</link>
			<pubDate>Mon, 04 Feb 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12708.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12708/lupin-announces-launch-of-namuscla.html</guid>
		</item>	
				<item>
			<title>Mylan&#039;s generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/33/12703/mylans-generic-version-of-advair-diskus-for-asthma-copd-patients-gets-fda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12703/mylans-generic-version-of-advair-diskus-for-asthma-copd-patients-gets-fda-approval.html</link>
			<pubDate>Fri, 01 Feb 2019 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12703.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12703/mylans-generic-version-of-advair-diskus-for-asthma-copd-patients-gets-fda-approval.html</guid>
		</item>	
				<item>
			<title>Cipla receives approval for Pfizer&#039;s Depo-Provera</title>
			<atom:link href="https://biospectrumasia.com/news/33/12640/cipla-receives-approval-for-pfizers-depo-provera.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12640/cipla-receives-approval-for-pfizers-depo-provera.html</link>
			<pubDate>Mon, 28 Jan 2019 09:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12640/cipla-receives-approval-for-pfizers-depo-provera.html</guid>
		</item>	
				<item>
			<title>Glenmark receives tentative ANDA approval for Topiramate</title>
			<atom:link href="https://biospectrumasia.com/news/33/12614/glenmark-receives-tentative-anda-approval-for-topiramate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12614/glenmark-receives-tentative-anda-approval-for-topiramate.html</link>
			<pubDate>Thu, 24 Jan 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approval_requires-12614.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12614/glenmark-receives-tentative-anda-approval-for-topiramate.html</guid>
		</item>	
				<item>
			<title>Lupin receives FDA approval for Levothyroxine Sodium Tablets</title>
			<atom:link href="https://biospectrumasia.com/news/33/12586/lupin-receives-fda-approval-for-levothyroxine-sodium-tablets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12586/lupin-receives-fda-approval-for-levothyroxine-sodium-tablets.html</link>
			<pubDate>Tue, 22 Jan 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12586.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12586/lupin-receives-fda-approval-for-levothyroxine-sodium-tablets.html</guid>
		</item>	
				<item>
			<title>J&amp;J completes acquisition of Ci:z Holdings </title>
			<atom:link href="https://biospectrumasia.com/news/33/12566/jj-completes-acquisition-of-ciz-holdings-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12566/jj-completes-acquisition-of-ciz-holdings-.html</link>
			<pubDate>Fri, 18 Jan 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/584_main-12566.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12566/jj-completes-acquisition-of-ciz-holdings-.html</guid>
		</item>	
				<item>
			<title>Aurobindo Pharma&#039;s subsidiary to acquire products from Spectrum Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/33/12564/aurobindo-pharmas-subsidiary-to-acquire-products-from-spectrum-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12564/aurobindo-pharmas-subsidiary-to-acquire-products-from-spectrum-pharma.html</link>
			<pubDate>Fri, 18 Jan 2019 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-12564.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12564/aurobindo-pharmas-subsidiary-to-acquire-products-from-spectrum-pharma.html</guid>
		</item>	
				<item>
			<title>Lupin&#039;s NaMuscla receives EC Approval </title>
			<atom:link href="https://biospectrumasia.com/news/33/12472/lupins-namuscla-receives-ec-approval-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12472/lupins-namuscla-receives-ec-approval-.html</link>
			<pubDate>Tue, 08 Jan 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approval_requires-12472.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12472/lupins-namuscla-receives-ec-approval-.html</guid>
		</item>	
				<item>
			<title>Hetero Labs limited acquires Tarbis Farma </title>
			<atom:link href="https://biospectrumasia.com/news/33/12419/hetero-labs-limited-acquires-tarbis-farma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12419/hetero-labs-limited-acquires-tarbis-farma-.html</link>
			<pubDate>Wed, 02 Jan 2019 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acqusition-12419.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12419/hetero-labs-limited-acquires-tarbis-farma-.html</guid>
		</item>	
				<item>
			<title>JHL Biotech declares Phase III Study of JHL1101 </title>
			<atom:link href="https://biospectrumasia.com/news/33/12391/jhl-biotech-declares-phase-iii-study-of-jhl1101-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12391/jhl-biotech-declares-phase-iii-study-of-jhl1101-.html</link>
			<pubDate>Fri, 28 Dec 2018 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibodies-12391.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12391/jhl-biotech-declares-phase-iii-study-of-jhl1101-.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s lab announces the launch of Sevelamer Carbonate in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/12386/dr-reddys-lab-announces-the-launch-of-sevelamer-carbonate-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12386/dr-reddys-lab-announces-the-launch-of-sevelamer-carbonate-in-us.html</link>
			<pubDate>Fri, 28 Dec 2018 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thumbnail_fotolia_131224316_subscription_monthly_m-12386.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12386/dr-reddys-lab-announces-the-launch-of-sevelamer-carbonate-in-us.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches Aspirin and Extended-Release Dipyridamole Capsules in USA</title>
			<atom:link href="https://biospectrumasia.com/news/33/12377/dr-reddys-launches-aspirin-and-extended-release-dipyridamole-capsules-in-usa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12377/dr-reddys-launches-aspirin-and-extended-release-dipyridamole-capsules-in-usa.html</link>
			<pubDate>Thu, 27 Dec 2018 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/waste_medicines_image_2_mar14_1024x685-12377.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12377/dr-reddys-launches-aspirin-and-extended-release-dipyridamole-capsules-in-usa.html</guid>
		</item>	
				<item>
			<title>The Changing API Industry</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/12303/the-changing-api-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/12303/the-changing-api-industry.html</link>
			<pubDate>Mon, 17 Dec 2018 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cq5dam_web_banner_start_banner_12-12303.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/12303/the-changing-api-industry.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s announces the launch of Omeprazole Delayed-Release Tablets </title>
			<atom:link href="https://biospectrumasia.com/news/33/12263/dr-reddys-announces-the-launch-of-omeprazole-delayed-release-tablets-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12263/dr-reddys-announces-the-launch-of-omeprazole-delayed-release-tablets-.html</link>
			<pubDate>Tue, 11 Dec 2018 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/waste_medicines_image_2_mar14_1024x685-12263.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12263/dr-reddys-announces-the-launch-of-omeprazole-delayed-release-tablets-.html</guid>
		</item>	
				<item>
			<title>Inflazome completes $46M series B financing to develop NLRP3 inhibitors</title>
			<atom:link href="https://biospectrumasia.com/news/33/12124/inflazome-completes-46m-series-b-financing-to-develop-nlrp3-inhibitors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12124/inflazome-completes-46m-series-b-financing-to-develop-nlrp3-inhibitors.html</link>
			<pubDate>Wed, 21 Nov 2018 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fund-12124.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12124/inflazome-completes-46m-series-b-financing-to-develop-nlrp3-inhibitors.html</guid>
		</item>	
				<item>
			<title>Amgen&#039;s Repatha shows durable treatment effect in long-term study</title>
			<atom:link href="https://biospectrumasia.com/news/33/12062/amgens-repatha-shows-durable-treatment-effect-in-long-term-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/12062/amgens-repatha-shows-durable-treatment-effect-in-long-term-study.html</link>
			<pubDate>Tue, 13 Nov 2018 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-12062.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/12062/amgens-repatha-shows-durable-treatment-effect-in-long-term-study.html</guid>
		</item>	
				<item>
			<title>Accera closes new investment led by Wilmar</title>
			<atom:link href="https://biospectrumasia.com/news/33/11821/accera-closes-new-investment-led-by-wilmar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/11821/accera-closes-new-investment-led-by-wilmar.html</link>
			<pubDate>Thu, 04 Oct 2018 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11821.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/11821/accera-closes-new-investment-led-by-wilmar.html</guid>
		</item>	
				<item>
			<title>FDA approves first generic version of EpiPen</title>
			<atom:link href="https://biospectrumasia.com/news/33/11522/fda-approves-first-generic-version-of-epipen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/11522/fda-approves-first-generic-version-of-epipen.html</link>
			<pubDate>Fri, 17 Aug 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11522.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/11522/fda-approves-first-generic-version-of-epipen.html</guid>
		</item>	
				<item>
			<title>Bayer to stop Essure sales at year-end</title>
			<atom:link href="https://biospectrumasia.com/news/33/11351/bayer-to-stop-essure-sales-at-year-end.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/11351/bayer-to-stop-essure-sales-at-year-end.html</link>
			<pubDate>Mon, 23 Jul 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1201709115_133b3927a3_b-11351.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/11351/bayer-to-stop-essure-sales-at-year-end.html</guid>
		</item>	
				<item>
			<title>Aurobindo to acquire Apotex&#039;s biz in European countries</title>
			<atom:link href="https://biospectrumasia.com/news/33/11288/aurobindo-to-acquire-apotexs-biz-in-european-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/11288/aurobindo-to-acquire-apotexs-biz-in-european-countries.html</link>
			<pubDate>Mon, 16 Jul 2018 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-11288.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/11288/aurobindo-to-acquire-apotexs-biz-in-european-countries.html</guid>
		</item>	
				<item>
			<title>Jeil Pharma unveils new research centre</title>
			<atom:link href="https://biospectrumasia.com/news/33/10886/jeil-pharma-unveils-new-research-centre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10886/jeil-pharma-unveils-new-research-centre.html</link>
			<pubDate>Wed, 16 May 2018 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10886.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10886/jeil-pharma-unveils-new-research-centre.html</guid>
		</item>	
				<item>
			<title>GB Sciences completes tech transfer of neuropathic pain formula </title>
			<atom:link href="https://biospectrumasia.com/news/33/10615/gb-sciences-completes-tech-transfer-of-neuropathic-pain-formula-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10615/gb-sciences-completes-tech-transfer-of-neuropathic-pain-formula-.html</link>
			<pubDate>Wed, 04 Apr 2018 22:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chemiluminiscence_with_the_scientist-10615.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10615/gb-sciences-completes-tech-transfer-of-neuropathic-pain-formula-.html</guid>
		</item>	
				<item>
			<title> Propanc Biopharma Completes Reproduction run for its pancreatic drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/10487/-propanc-biopharma-completes-reproduction-run-for-its-pancreatic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10487/-propanc-biopharma-completes-reproduction-run-for-its-pancreatic-drug.html</link>
			<pubDate>Thu, 15 Mar 2018 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pancreas-10487.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10487/-propanc-biopharma-completes-reproduction-run-for-its-pancreatic-drug.html</guid>
		</item>	
				<item>
			<title>Lupin launches generic Namenda XR capsules in the US</title>
			<atom:link href="https://biospectrumasia.com/news/33/10372/lupin-launches-generic-namenda-xr-capsules-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10372/lupin-launches-generic-namenda-xr-capsules-in-the-us.html</link>
			<pubDate>Wed, 21 Feb 2018 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/520309_lupin777-10372.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10372/lupin-launches-generic-namenda-xr-capsules-in-the-us.html</guid>
		</item>	
				<item>
			<title>GSK receives European approval for expanded indication for Influenza Vaccine </title>
			<atom:link href="https://biospectrumasia.com/news/33/10353/gsk-receives-european-approval-for-expanded-indication-for-influenza-vaccine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10353/gsk-receives-european-approval-for-expanded-indication-for-influenza-vaccine-.html</link>
			<pubDate>Fri, 16 Feb 2018 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shots_for_all_vaccines_keep_airmen_healthy_150323_f_it851_010-10353.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10353/gsk-receives-european-approval-for-expanded-indication-for-influenza-vaccine-.html</guid>
		</item>	
				<item>
			<title>Lupin launches generic Clobex Lotion in the US</title>
			<atom:link href="https://biospectrumasia.com/news/33/10270/lupin-launches-generic-clobex-lotion-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10270/lupin-launches-generic-clobex-lotion-in-the-us.html</link>
			<pubDate>Tue, 06 Feb 2018 16:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/520309_lupin777-10270.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10270/lupin-launches-generic-clobex-lotion-in-the-us.html</guid>
		</item>	
				<item>
			<title>Admedus launches ADAPT technology in India</title>
			<atom:link href="https://biospectrumasia.com/news/33/10268/admedus-launches-adapt-technology-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10268/admedus-launches-adapt-technology-in-india.html</link>
			<pubDate>Tue, 06 Feb 2018 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/inda_launch_website_e1517285337726-10268.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10268/admedus-launches-adapt-technology-in-india.html</guid>
		</item>	
				<item>
			<title>Cardinal Health closes China distribution business, divests it to Shanghai Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/33/10244/cardinal-health-closes-china-distribution-business-divests-it-to-shanghai-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10244/cardinal-health-closes-china-distribution-business-divests-it-to-shanghai-pharma.html</link>
			<pubDate>Fri, 02 Feb 2018 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10244.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10244/cardinal-health-closes-china-distribution-business-divests-it-to-shanghai-pharma.html</guid>
		</item>	
				<item>
			<title>Telehealth programme by CGH and Philips empowers heart failure patients </title>
			<atom:link href="https://biospectrumasia.com/news/33/10213/telehealth-programme-by-cgh-and-philips-empowers-heart-failure-patients-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10213/telehealth-programme-by-cgh-and-philips-empowers-heart-failure-patients-.html</link>
			<pubDate>Thu, 25 Jan 2018 23:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_03-10213.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10213/telehealth-programme-by-cgh-and-philips-empowers-heart-failure-patients-.html</guid>
		</item>	
				<item>
			<title>Synthetic virus to tackle antimicrobial resistance</title>
			<atom:link href="https://biospectrumasia.com/news/33/10203/synthetic-virus-to-tackle-antimicrobial-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10203/synthetic-virus-to-tackle-antimicrobial-resistance.html</link>
			<pubDate>Wed, 24 Jan 2018 22:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellular_virus_wallpaper-10203.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10203/synthetic-virus-to-tackle-antimicrobial-resistance.html</guid>
		</item>	
				<item>
			<title>Single blood test screens for eight cancer types</title>
			<atom:link href="https://biospectrumasia.com/news/33/10174/single-blood-test-screens-for-eight-cancer-types.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10174/single-blood-test-screens-for-eight-cancer-types.html</link>
			<pubDate>Fri, 19 Jan 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-10174.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10174/single-blood-test-screens-for-eight-cancer-types.html</guid>
		</item>	
				<item>
			<title>Genomics reveals key macrophages&#039; involvement in systemic sclerosis</title>
			<atom:link href="https://biospectrumasia.com/news/33/10172/genomics-reveals-key-macrophages-involvement-in-systemic-sclerosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10172/genomics-reveals-key-macrophages-involvement-in-systemic-sclerosis.html</link>
			<pubDate>Thu, 18 Jan 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-10172.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10172/genomics-reveals-key-macrophages-involvement-in-systemic-sclerosis.html</guid>
		</item>	
				<item>
			<title>FDA approves Boston Scientific&#039;s spectra wavewriter spinal cord stimulator system</title>
			<atom:link href="https://biospectrumasia.com/news/33/10158/fda-approves-boston-scientifics-spectra-wavewriter-spinal-cord-stimulator-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10158/fda-approves-boston-scientifics-spectra-wavewriter-spinal-cord-stimulator-system.html</link>
			<pubDate>Tue, 16 Jan 2018 23:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2000px_boston_scientific_logo_svg-10158.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10158/fda-approves-boston-scientifics-spectra-wavewriter-spinal-cord-stimulator-system.html</guid>
		</item>	
				<item>
			<title>Adapsyn Bioscience announces research collaboration with Pfizer Inc.</title>
			<atom:link href="https://biospectrumasia.com/news/33/10130/adapsyn-bioscience-announces-research-collaboration-with-pfizer-inc-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10130/adapsyn-bioscience-announces-research-collaboration-with-pfizer-inc-.html</link>
			<pubDate>Thu, 11 Jan 2018 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-10130.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10130/adapsyn-bioscience-announces-research-collaboration-with-pfizer-inc-.html</guid>
		</item>	
				<item>
			<title>Sangamo and Pfizer announce collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/33/10101/sangamo-and-pfizer-announce-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10101/sangamo-and-pfizer-announce-collaboration.html</link>
			<pubDate>Thu, 04 Jan 2018 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-10101.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10101/sangamo-and-pfizer-announce-collaboration.html</guid>
		</item>	
				<item>
			<title>Zomedica Pharmaceuticals enters into license and supply agreement with Celsee</title>
			<atom:link href="https://biospectrumasia.com/news/33/10056/zomedica-pharmaceuticals-enters-into-license-and-supply-agreement-with-celsee.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10056/zomedica-pharmaceuticals-enters-into-license-and-supply-agreement-with-celsee.html</link>
			<pubDate>Tue, 26 Dec 2017 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/document_428335_960_720-10056.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10056/zomedica-pharmaceuticals-enters-into-license-and-supply-agreement-with-celsee.html</guid>
		</item>	
				<item>
			<title>Array BioPharma collaborates with Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/33/10018/array-biopharma-collaborates-with-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/10018/array-biopharma-collaborates-with-pfizer.html</link>
			<pubDate>Wed, 20 Dec 2017 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/connect_20333_1920-10018.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/10018/array-biopharma-collaborates-with-pfizer.html</guid>
		</item>	
				<item>
			<title>Sanofi and Regeneron announce positive results for PD-1 antibody </title>
			<atom:link href="https://biospectrumasia.com/news/33/9982/sanofi-and-regeneron-announce-positive-results-for-pd-1-antibody-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9982/sanofi-and-regeneron-announce-positive-results-for-pd-1-antibody-.html</link>
			<pubDate>Thu, 14 Dec 2017 16:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibodies_attacking_a_virus1_1280x640-9982.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9982/sanofi-and-regeneron-announce-positive-results-for-pd-1-antibody-.html</guid>
		</item>	
				<item>
			<title>Sanofi presents R&amp;D strategy and innovative pipeline </title>
			<atom:link href="https://biospectrumasia.com/news/33/9981/sanofi-presents-rd-strategy-and-innovative-pipeline-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9981/sanofi-presents-rd-strategy-and-innovative-pipeline-.html</link>
			<pubDate>Thu, 14 Dec 2017 16:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sanofi_2_crop-9981.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9981/sanofi-presents-rd-strategy-and-innovative-pipeline-.html</guid>
		</item>	
				<item>
			<title>Representation disparity in ages below and above 75 years </title>
			<atom:link href="https://biospectrumasia.com/news/33/9967/representation-disparity-in-ages-below-and-above-75-years-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9967/representation-disparity-in-ages-below-and-above-75-years-.html</link>
			<pubDate>Tue, 12 Dec 2017 22:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9967.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9967/representation-disparity-in-ages-below-and-above-75-years-.html</guid>
		</item>	
				<item>
			<title>Juno Therapeutics signs three license agreements</title>
			<atom:link href="https://biospectrumasia.com/news/33/9957/juno-therapeutics-signs-three-license-agreements.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9957/juno-therapeutics-signs-three-license-agreements.html</link>
			<pubDate>Mon, 11 Dec 2017 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/document_428335_960_720-9957.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9957/juno-therapeutics-signs-three-license-agreements.html</guid>
		</item>	
				<item>
			<title>FDA approves Amgen&#039;s Repatha (evolocumab)</title>
			<atom:link href="https://biospectrumasia.com/news/33/9941/fda-approves-amgens-repatha-evolocumab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9941/fda-approves-amgens-repatha-evolocumab.html</link>
			<pubDate>Thu, 07 Dec 2017 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approved-9941.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9941/fda-approves-amgens-repatha-evolocumab.html</guid>
		</item>	
				<item>
			<title>Mr. Jeong Woo Choo has been appointed as the President and CEO of SK Biopharmaceuticals and SK Life Science </title>
			<atom:link href="https://biospectrumasia.com/news/33/9911/mr-jeong-woo-choo-has-been-appointed-as-the-president-and-ceo-of-sk-biopharmaceuticals-and-sk-life-science-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9911/mr-jeong-woo-choo-has-been-appointed-as-the-president-and-ceo-of-sk-biopharmaceuticals-and-sk-life-science-.html</link>
			<pubDate>Fri, 01 Dec 2017 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9911/mr-jeong-woo-choo-has-been-appointed-as-the-president-and-ceo-of-sk-biopharmaceuticals-and-sk-life-science-.html</guid>
		</item>	
				<item>
			<title>Janssen supports first-of-its-kind Asia Pacific Prostate Cancer- Patient Coalition to improve patient outcomes across the region</title>
			<atom:link href="https://biospectrumasia.com/news/33/9894/janssen-supports-first-of-its-kind-asia-pacific-prostate-cancer-patient-coalition-to-improve-patient-outcomes-across-the-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9894/janssen-supports-first-of-its-kind-asia-pacific-prostate-cancer-patient-coalition-to-improve-patient-outcomes-across-the-region.html</link>
			<pubDate>Thu, 30 Nov 2017 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2307899_960_720-9894.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9894/janssen-supports-first-of-its-kind-asia-pacific-prostate-cancer-patient-coalition-to-improve-patient-outcomes-across-the-region.html</guid>
		</item>	
				<item>
			<title>Biohaven receives agreement from FDA on initial pediatric study plan </title>
			<atom:link href="https://biospectrumasia.com/news/33/9881/biohaven-receives-agreement-from-fda-on-initial-pediatric-study-plan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9881/biohaven-receives-agreement-from-fda-on-initial-pediatric-study-plan-.html</link>
			<pubDate>Tue, 28 Nov 2017 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/migraine-9881.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9881/biohaven-receives-agreement-from-fda-on-initial-pediatric-study-plan-.html</guid>
		</item>	
				<item>
			<title>Biogen and Alkermes announce license and collaboration agreement </title>
			<atom:link href="https://biospectrumasia.com/news/33/9879/biogen-and-alkermes-announce-license-and-collaboration-agreement-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9879/biogen-and-alkermes-announce-license-and-collaboration-agreement-.html</link>
			<pubDate>Tue, 28 Nov 2017 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal-9879.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9879/biogen-and-alkermes-announce-license-and-collaboration-agreement-.html</guid>
		</item>	
				<item>
			<title>Juluca by ViiV healthcare approved in US by USFDA</title>
			<atom:link href="https://biospectrumasia.com/news/33/9864/juluca-by-viiv-healthcare-approved-in-us-by-usfda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9864/juluca-by-viiv-healthcare-approved-in-us-by-usfda.html</link>
			<pubDate>Mon, 27 Nov 2017 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_151676_1280-9864.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9864/juluca-by-viiv-healthcare-approved-in-us-by-usfda.html</guid>
		</item>	
				<item>
			<title>GSK submits landmark IMPACT data to USFDA for the use of Trelegy Ellipta</title>
			<atom:link href="https://biospectrumasia.com/news/33/9863/gsk-submits-landmark-impact-data-to-usfda-for-the-use-of-trelegy-ellipta.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9863/gsk-submits-landmark-impact-data-to-usfda-for-the-use-of-trelegy-ellipta.html</link>
			<pubDate>Mon, 27 Nov 2017 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/inhaler-9863.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9863/gsk-submits-landmark-impact-data-to-usfda-for-the-use-of-trelegy-ellipta.html</guid>
		</item>	
				<item>
			<title>Puma biotech and Specialised Therapeutics signs agreement to commercialize NERLYNXÂ®</title>
			<atom:link href="https://biospectrumasia.com/news/33/9851/puma-biotech-and-specialised-therapeutics-signs-agreement-to-commercialize-nerlynx.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9851/puma-biotech-and-specialised-therapeutics-signs-agreement-to-commercialize-nerlynx.html</link>
			<pubDate>Fri, 24 Nov 2017 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/document_428335_960_720-9851.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9851/puma-biotech-and-specialised-therapeutics-signs-agreement-to-commercialize-nerlynx.html</guid>
		</item>	
				<item>
			<title>Step Pharma completes â‚¬14.5 million Series A financing </title>
			<atom:link href="https://biospectrumasia.com/news/33/9847/step-pharma-completes-14-5-million-series-a-financing-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9847/step-pharma-completes-14-5-million-series-a-financing-.html</link>
			<pubDate>Thu, 23 Nov 2017 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding-9847.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9847/step-pharma-completes-14-5-million-series-a-financing-.html</guid>
		</item>	
				<item>
			<title>FDA approves RxSight&#039;s light adjustable lens</title>
			<atom:link href="https://biospectrumasia.com/news/33/9842/fda-approves-rxsights-light-adjustable-lens.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9842/fda-approves-rxsights-light-adjustable-lens.html</link>
			<pubDate>Thu, 23 Nov 2017 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9842.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9842/fda-approves-rxsights-light-adjustable-lens.html</guid>
		</item>	
				<item>
			<title>PeptiDream announces collaboration with Bayer</title>
			<atom:link href="https://biospectrumasia.com/news/33/9819/peptidream-announces-collaboration-with-bayer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9819/peptidream-announces-collaboration-with-bayer.html</link>
			<pubDate>Tue, 21 Nov 2017 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/document_428335_960_720-9819.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9819/peptidream-announces-collaboration-with-bayer.html</guid>
		</item>	
				<item>
			<title>Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen</title>
			<atom:link href="https://biospectrumasia.com/news/33/9809/ionis-pharmaceuticals-licenses-second-antisense-gi-drug-to-janssen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9809/ionis-pharmaceuticals-licenses-second-antisense-gi-drug-to-janssen.html</link>
			<pubDate>Fri, 17 Nov 2017 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_384846_960_720-9809.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9809/ionis-pharmaceuticals-licenses-second-antisense-gi-drug-to-janssen.html</guid>
		</item>	
				<item>
			<title>Cue Biopharma announces research collaboration with Merck</title>
			<atom:link href="https://biospectrumasia.com/news/33/9808/cue-biopharma-announces-research-collaboration-with-merck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9808/cue-biopharma-announces-research-collaboration-with-merck.html</link>
			<pubDate>Fri, 17 Nov 2017 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/document_428335_960_720-9808.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9808/cue-biopharma-announces-research-collaboration-with-merck.html</guid>
		</item>	
				<item>
			<title>Generic Acticlate tablets launched by Lupin in USA </title>
			<atom:link href="https://biospectrumasia.com/news/33/9727/generic-acticlate-tablets-launched-by-lupin-in-usa-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9727/generic-acticlate-tablets-launched-by-lupin-in-usa-.html</link>
			<pubDate>Mon, 06 Nov 2017 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_2607338_960_720-9727.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9727/generic-acticlate-tablets-launched-by-lupin-in-usa-.html</guid>
		</item>	
				<item>
			<title>Lupin net profit falls 31% in Q2 to Rs 455 </title>
			<atom:link href="https://biospectrumasia.com/news/33/9692/lupin-net-profit-falls-31-in-q2-to-rs-455-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9692/lupin-net-profit-falls-31-in-q2-to-rs-455-.html</link>
			<pubDate>Tue, 31 Oct 2017 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/coins_1726618_960_720-9692.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9692/lupin-net-profit-falls-31-in-q2-to-rs-455-.html</guid>
		</item>	
				<item>
			<title>Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets</title>
			<atom:link href="https://biospectrumasia.com/news/33/9665/lupin-receives-fda-approval-for-generic-lodosyn-tablets-and-kapvay-extended-release-tablets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9665/lupin-receives-fda-approval-for-generic-lodosyn-tablets-and-kapvay-extended-release-tablets.html</link>
			<pubDate>Fri, 27 Oct 2017 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_2607338_960_720-9665.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9665/lupin-receives-fda-approval-for-generic-lodosyn-tablets-and-kapvay-extended-release-tablets.html</guid>
		</item>	
				<item>
			<title>Lupin receives FDA approval for generic Axiron topical solution</title>
			<atom:link href="https://biospectrumasia.com/news/33/9666/lupin-receives-fda-approval-for-generic-axiron-topical-solution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9666/lupin-receives-fda-approval-for-generic-axiron-topical-solution.html</link>
			<pubDate>Fri, 27 Oct 2017 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_1049259_960_720-9666.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9666/lupin-receives-fda-approval-for-generic-axiron-topical-solution.html</guid>
		</item>	
				<item>
			<title>US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/33/9624/us-fda-approves-bydureon-bcise-by-astrazeneca-for-type-2-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9624/us-fda-approves-bydureon-bcise-by-astrazeneca-for-type-2-diabetes.html</link>
			<pubDate>Mon, 23 Oct 2017 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes1-9624.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9624/us-fda-approves-bydureon-bcise-by-astrazeneca-for-type-2-diabetes.html</guid>
		</item>	
				<item>
			<title>US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/33/9623/us-fda-approves-bydureon-bcise-by-astrazeneca-for-type-2-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9623/us-fda-approves-bydureon-bcise-by-astrazeneca-for-type-2-diabetes.html</link>
			<pubDate>Mon, 23 Oct 2017 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9623/us-fda-approves-bydureon-bcise-by-astrazeneca-for-type-2-diabetes.html</guid>
		</item>	
				<item>
			<title>NCD: A major public health challenge for Asia-Pacific</title>
			<atom:link href="https://biospectrumasia.com/news/33/9580/ncd-a-major-public-health-challenge-for-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9580/ncd-a-major-public-health-challenge-for-asia-pacific.html</link>
			<pubDate>Wed, 11 Oct 2017 23:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/noncommunicable_diseases_world_map_deaths_per_million_persons_who2012_svg-9580.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9580/ncd-a-major-public-health-challenge-for-asia-pacific.html</guid>
		</item>	
				<item>
			<title>Lupin receives FDA approval for generic Corgard Tablets</title>
			<atom:link href="https://biospectrumasia.com/news/33/9570/lupin-receives-fda-approval-for-generic-corgard-tablets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9570/lupin-receives-fda-approval-for-generic-corgard-tablets.html</link>
			<pubDate>Tue, 10 Oct 2017 16:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_530373_960_720-9570.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9570/lupin-receives-fda-approval-for-generic-corgard-tablets.html</guid>
		</item>	
				<item>
			<title>&quot;Biomarkers can play a key role in improving diagnosis and disease management of heart failure. &quot;</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/9568/biomarkers-can-play-a-key-role-in-improving-diagnosis-and-disease-management-of-heart-failure-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/9568/biomarkers-can-play-a-key-role-in-improving-diagnosis-and-disease-management-of-heart-failure-.html</link>
			<pubDate>Tue, 10 Oct 2017 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prof_bayes_genis-9568.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/9568/biomarkers-can-play-a-key-role-in-improving-diagnosis-and-disease-management-of-heart-failure-.html</guid>
		</item>	
				<item>
			<title>Arthritis: Act before it gets Late</title>
			<atom:link href="https://biospectrumasia.com/news/33/9461/arthritis-act-before-it-gets-late.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9461/arthritis-act-before-it-gets-late.html</link>
			<pubDate>Wed, 13 Sep 2017 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arthritis-9461.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9461/arthritis-act-before-it-gets-late.html</guid>
		</item>	
				<item>
			<title>Michigan third most preferred destination in Midwest for life science investment</title>
			<atom:link href="https://biospectrumasia.com/news/33/9450/michigan-third-most-preferred-destination-in-midwest-for-life-science-investment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9450/michigan-third-most-preferred-destination-in-midwest-for-life-science-investment.html</link>
			<pubDate>Mon, 11 Sep 2017 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/139401482-9450.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9450/michigan-third-most-preferred-destination-in-midwest-for-life-science-investment.html</guid>
		</item>	
				<item>
			<title>Eli Lilly to invest more in new medicines and drive growth</title>
			<atom:link href="https://biospectrumasia.com/news/33/9444/eli-lilly-to-invest-more-in-new-medicines-and-drive-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9444/eli-lilly-to-invest-more-in-new-medicines-and-drive-growth.html</link>
			<pubDate>Fri, 08 Sep 2017 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_1582472_960_720-9444.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9444/eli-lilly-to-invest-more-in-new-medicines-and-drive-growth.html</guid>
		</item>	
				<item>
			<title>Lupin launches generic Benicar tablets in the US</title>
			<atom:link href="https://biospectrumasia.com/news/33/9417/lupin-launches-generic-benicar-tablets-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9417/lupin-launches-generic-benicar-tablets-in-the-us.html</link>
			<pubDate>Mon, 04 Sep 2017 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_2607338_960_720-9417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9417/lupin-launches-generic-benicar-tablets-in-the-us.html</guid>
		</item>	
				<item>
			<title>U.S. FDA approves chemo group&#039;s benznidazole to treat children with Chagas disease</title>
			<atom:link href="https://biospectrumasia.com/news/33/9403/u-s-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9403/u-s-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease.html</link>
			<pubDate>Fri, 01 Sep 2017 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/triatoma_infestans-9403.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9403/u-s-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease.html</guid>
		</item>	
				<item>
			<title>Battlefield Acupuncture (BFA): New pain management process for the military </title>
			<atom:link href="https://biospectrumasia.com/news/33/9379/battlefield-acupuncture-bfa-new-pain-management-process-for-the-military-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9379/battlefield-acupuncture-bfa-new-pain-management-process-for-the-military-.html</link>
			<pubDate>Sun, 27 Aug 2017 23:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1270px_blausen_0328_earanatomy-9379.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9379/battlefield-acupuncture-bfa-new-pain-management-process-for-the-military-.html</guid>
		</item>	
				<item>
			<title>Victoza indicated to reduce the risk of three major adverse cardiovascular events</title>
			<atom:link href="https://biospectrumasia.com/news/33/9377/victoza-indicated-to-reduce-the-risk-of-three-major-adverse-cardiovascular-events.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9377/victoza-indicated-to-reduce-the-risk-of-three-major-adverse-cardiovascular-events.html</link>
			<pubDate>Sat, 26 Aug 2017 01:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9377.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9377/victoza-indicated-to-reduce-the-risk-of-three-major-adverse-cardiovascular-events.html</guid>
		</item>	
				<item>
			<title>Generic Seroquel XR tablets launched by Lupin in USA</title>
			<atom:link href="https://biospectrumasia.com/news/33/9370/generic-seroquel-xr-tablets-launched-by-lupin-in-usa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9370/generic-seroquel-xr-tablets-launched-by-lupin-in-usa.html</link>
			<pubDate>Thu, 24 Aug 2017 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_2607338_960_720-9370.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9370/generic-seroquel-xr-tablets-launched-by-lupin-in-usa.html</guid>
		</item>	
				<item>
			<title>US FDA grants Lion TCR two orphan drug designations of T cell therapy against Hepatocellular Carcinoma </title>
			<atom:link href="https://biospectrumasia.com/news/33/9350/us-fda-grants-lion-tcr-two-orphan-drug-designations-of-t-cell-therapy-against-hepatocellular-carcinoma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9350/us-fda-grants-lion-tcr-two-orphan-drug-designations-of-t-cell-therapy-against-hepatocellular-carcinoma-.html</link>
			<pubDate>Mon, 21 Aug 2017 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-9350.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9350/us-fda-grants-lion-tcr-two-orphan-drug-designations-of-t-cell-therapy-against-hepatocellular-carcinoma-.html</guid>
		</item>	
				<item>
			<title>FDA provides new tools for tests to detect Zika virus infection </title>
			<atom:link href="https://biospectrumasia.com/news/33/9342/fda-provides-new-tools-for-tests-to-detect-zika-virus-infection-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9342/fda-provides-new-tools-for-tests-to-detect-zika-virus-infection-.html</link>
			<pubDate>Fri, 18 Aug 2017 13:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/zika1-9342.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9342/fda-provides-new-tools-for-tests-to-detect-zika-virus-infection-.html</guid>
		</item>	
				<item>
			<title>Bruker announces US FDA clearance of expanded 3rd claim for MALDI Biotyper</title>
			<atom:link href="https://biospectrumasia.com/news/33/9275/bruker-announces-us-fda-clearance-of-expanded-3rd-claim-for-maldi-biotyper.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9275/bruker-announces-us-fda-clearance-of-expanded-3rd-claim-for-maldi-biotyper.html</link>
			<pubDate>Tue, 01 Aug 2017 19:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/microbes-9275.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9275/bruker-announces-us-fda-clearance-of-expanded-3rd-claim-for-maldi-biotyper.html</guid>
		</item>	
				<item>
			<title>LEO Pharma gets EC nod for its first and only biologic Kyntheum that targets the IL-17 receptor</title>
			<atom:link href="https://biospectrumasia.com/news/33/9243/leo-pharma-gets-ec-nod-for-its-first-and-only-biologic-kyntheum-that-targets-the-il-17-receptor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9243/leo-pharma-gets-ec-nod-for-its-first-and-only-biologic-kyntheum-that-targets-the-il-17-receptor.html</link>
			<pubDate>Wed, 26 Jul 2017 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/leo_pharma_uksm-9243.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9243/leo-pharma-gets-ec-nod-for-its-first-and-only-biologic-kyntheum-that-targets-the-il-17-receptor.html</guid>
		</item>	
				<item>
			<title>Merck wins tentative U.S. FDA approval for Lusduna</title>
			<atom:link href="https://biospectrumasia.com/news/33/9241/merck-wins-tentative-u-s-fda-approval-for-lusduna.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9241/merck-wins-tentative-u-s-fda-approval-for-lusduna.html</link>
			<pubDate>Wed, 26 Jul 2017 14:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe_1884784_960_720_1_-9241.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9241/merck-wins-tentative-u-s-fda-approval-for-lusduna.html</guid>
		</item>	
				<item>
			<title>Study suggests positive airway pressure therapy could reduce COPD patient hospitalizationsÂ </title>
			<atom:link href="https://biospectrumasia.com/news/33/9168/study-suggests-positive-airway-pressure-therapy-could-reduce-copd-patient-hospitalizations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9168/study-suggests-positive-airway-pressure-therapy-could-reduce-copd-patient-hospitalizations.html</link>
			<pubDate>Tue, 11 Jul 2017 14:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9168.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9168/study-suggests-positive-airway-pressure-therapy-could-reduce-copd-patient-hospitalizations.html</guid>
		</item>	
				<item>
			<title>Japanese regulators grant additional approval for the sale of Ipsen&#039;s rare cancer drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/33/9135/japanese-regulators-grant-additional-approval-for-the-sale-of-ipsens-rare-cancer-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9135/japanese-regulators-grant-additional-approval-for-the-sale-of-ipsens-rare-cancer-drug-in-japan.html</link>
			<pubDate>Tue, 04 Jul 2017 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915423__340-9135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9135/japanese-regulators-grant-additional-approval-for-the-sale-of-ipsens-rare-cancer-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiwan Pharma Association opens new office in Malaysia</title>
			<atom:link href="https://biospectrumasia.com/news/33/9030/taiwan-pharma-association-opens-new-office-in-malaysia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/9030/taiwan-pharma-association-opens-new-office-in-malaysia.html</link>
			<pubDate>Fri, 09 Jun 2017 13:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new_office-9030.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/9030/taiwan-pharma-association-opens-new-office-in-malaysia.html</guid>
		</item>	
				<item>
			<title>New CoolPal Vertos Advance launched by Pelican BioThermal</title>
			<atom:link href="https://biospectrumasia.com/news/33/55/new-coolpal-vertos-advance-launched-by-pelican-biothermal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/55/new-coolpal-vertos-advance-launched-by-pelican-biothermal.html</link>
			<pubDate>Thu, 19 Jan 2017 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pelican_biothermal_logo_262x174-55.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/55/new-coolpal-vertos-advance-launched-by-pelican-biothermal.html</guid>
		</item>	
				<item>
			<title>CEPI board meeting with a focus on identifying disease priorities and future strategy</title>
			<atom:link href="https://biospectrumasia.com/news/33/48/cepi-board-meeting-with-a-focus-on-identifying-disease-priorities-and-future-strategy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/48/cepi-board-meeting-with-a-focus-on-identifying-disease-priorities-and-future-strategy.html</link>
			<pubDate>Mon, 19 Dec 2016 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/meeting1_274x186-48.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/48/cepi-board-meeting-with-a-focus-on-identifying-disease-priorities-and-future-strategy.html</guid>
		</item>	
				<item>
			<title>Mediven gets Frost &amp; Sullivan Entrepreneurial Company of the Year award</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/44/mediven-gets-frost-sullivan-entrepreneurial-company-of-the-year-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/44/mediven-gets-frost-sullivan-entrepreneurial-company-of-the-year-award.html</link>
			<pubDate>Wed, 15 Jun 2016 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/proteus_otsuka_agreement_140x85-44.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/44/mediven-gets-frost-sullivan-entrepreneurial-company-of-the-year-award.html</guid>
		</item>	
				<item>
			<title>Mediven gets Frost &amp; Sullivan Entrepreneurial Company of the Year award</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/45/mediven-gets-frost-sullivan-entrepreneurial-company-of-the-year-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/45/mediven-gets-frost-sullivan-entrepreneurial-company-of-the-year-award.html</link>
			<pubDate>Wed, 08 Jun 2016 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_top_20_survey_230x143-45.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/45/mediven-gets-frost-sullivan-entrepreneurial-company-of-the-year-award.html</guid>
		</item>	
				<item>
			<title>ULURU inks pact with Japanese medical firm</title>
			<atom:link href="https://biospectrumasia.com/news/33/1061/uluru-inks-pact-with-japanese-medical-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1061/uluru-inks-pact-with-japanese-medical-firm.html</link>
			<pubDate>Mon, 06 Jun 2016 12:28:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wound-care.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1061/uluru-inks-pact-with-japanese-medical-firm.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics</title>
			<atom:link href="https://biospectrumasia.com/news/33/7506/australias-starpharma-develops-zika-proof-condoms-for-athletes-ahead-of-rio-olympics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7506/australias-starpharma-develops-zika-proof-condoms-for-athletes-ahead-of-rio-olympics.html</link>
			<pubDate>Tue, 17 May 2016 12:06:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/starpharma-dual-protect-box-angled-2.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7506/australias-starpharma-develops-zika-proof-condoms-for-athletes-ahead-of-rio-olympics.html</guid>
		</item>	
				<item>
			<title>Gilead&#039;s cancer drug under FDA scrutiny</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/8289/gileads-cancer-drug-under-fda-scrutiny.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/8289/gileads-cancer-drug-under-fda-scrutiny.html</link>
			<pubDate>Tue, 15 Mar 2016 14:50:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/8289/gileads-cancer-drug-under-fda-scrutiny.html</guid>
		</item>	
				<item>
			<title>Celgene settles litigation with India&#039;s Natco</title>
			<atom:link href="https://biospectrumasia.com/news/33/7502/celgene-settles-litigation-with-indias-natco.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7502/celgene-settles-litigation-with-indias-natco.html</link>
			<pubDate>Mon, 28 Dec 2015 12:06:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7502/celgene-settles-litigation-with-indias-natco.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to commercialize AstraZeneca&#039;s nasal influenza vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/33/7303/daiichi-sankyo-to-commercialize-astrazenecas-nasal-influenza-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7303/daiichi-sankyo-to-commercialize-astrazenecas-nasal-influenza-vaccine-in-japan.html</link>
			<pubDate>Wed, 02 Sep 2015 12:14:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mystic-pharma-gets-us-patent-for-intranasal-cartridge-devices-technology.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7303/daiichi-sankyo-to-commercialize-astrazenecas-nasal-influenza-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>Glenmark&#039;s new generic gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/33/7237/glenmarks-new-generic-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7237/glenmarks-new-generic-gets-fda-nod.html</link>
			<pubDate>Fri, 21 Aug 2015 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7237/glenmarks-new-generic-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>ANI pharma, IDT Australia to commercialize US generic drugs</title>
			<atom:link href="https://biospectrumasia.com/news/33/7220/ani-pharma-idt-australia-to-commercialize-us-generic-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7220/ani-pharma-idt-australia-to-commercialize-us-generic-drugs.html</link>
			<pubDate>Tue, 18 Aug 2015 15:06:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7220/ani-pharma-idt-australia-to-commercialize-us-generic-drugs.html</guid>
		</item>	
				<item>
			<title>TWi Pharma launches generic version of appetite loss drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/7678/twi-pharma-launches-generic-version-of-appetite-loss-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7678/twi-pharma-launches-generic-version-of-appetite-loss-drug.html</link>
			<pubDate>Wed, 29 Jul 2015 14:08:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/b1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7678/twi-pharma-launches-generic-version-of-appetite-loss-drug.html</guid>
		</item>	
				<item>
			<title>ANI pharma acquires 22 generic drug from Teva</title>
			<atom:link href="https://biospectrumasia.com/news/33/6154/ani-pharma-acquires-22-generic-drug-from-teva.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6154/ani-pharma-acquires-22-generic-drug-from-teva.html</link>
			<pubDate>Thu, 16 Jul 2015 14:10:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/p.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6154/ani-pharma-acquires-22-generic-drug-from-teva.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo collaborates with Maruishi Pharmaceutical</title>
			<atom:link href="https://biospectrumasia.com/news/33/7586/daiichi-sankyo-collaborates-with-maruishi-pharmaceutical.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7586/daiichi-sankyo-collaborates-with-maruishi-pharmaceutical.html</link>
			<pubDate>Tue, 23 Jun 2015 11:51:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/person.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7586/daiichi-sankyo-collaborates-with-maruishi-pharmaceutical.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo&#039;s subsidiary launches four new generic drugs </title>
			<atom:link href="https://biospectrumasia.com/news/33/7812/daiichi-sankyos-subsidiary-launches-four-new-generic-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7812/daiichi-sankyos-subsidiary-launches-four-new-generic-drugs-.html</link>
			<pubDate>Thu, 18 Jun 2015 12:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7812/daiichi-sankyos-subsidiary-launches-four-new-generic-drugs-.html</guid>
		</item>	
				<item>
			<title>Orexigen, Takeda file lawsuit against Actavis for patent infringement</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/4357/orexigen-takeda-file-lawsuit-against-actavis-for-patent-infringement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/4357/orexigen-takeda-file-lawsuit-against-actavis-for-patent-infringement.html</link>
			<pubDate>Mon, 08 Jun 2015 14:46:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100227380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/4357/orexigen-takeda-file-lawsuit-against-actavis-for-patent-infringement.html</guid>
		</item>	
				<item>
			<title>Aurobindo Pharma files ANDA for HIV generic drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/4451/aurobindo-pharma-files-anda-for-hiv-generic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4451/aurobindo-pharma-files-anda-for-hiv-generic-drug.html</link>
			<pubDate>Wed, 27 May 2015 15:13:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4451/aurobindo-pharma-files-anda-for-hiv-generic-drug.html</guid>
		</item>	
				<item>
			<title>Activists challenge Gilead to give up Hep C drug patent</title>
			<atom:link href="https://biospectrumasia.com/news/33/7595/activists-challenge-gilead-to-give-up-hep-c-drug-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7595/activists-challenge-gilead-to-give-up-hep-c-drug-patent.html</link>
			<pubDate>Thu, 21 May 2015 12:04:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7595/activists-challenge-gilead-to-give-up-hep-c-drug-patent.html</guid>
		</item>	
				<item>
			<title>Teva launches generic of Abilify, antipsychotic drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/6801/teva-launches-generic-of-abilify-antipsychotic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6801/teva-launches-generic-of-abilify-antipsychotic-drug.html</link>
			<pubDate>Thu, 30 Apr 2015 12:53:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/140528-medex-amazonmain.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6801/teva-launches-generic-of-abilify-antipsychotic-drug.html</guid>
		</item>	
				<item>
			<title>Perrigo rejects Mylan&#039;s acquisition bid</title>
			<atom:link href="https://biospectrumasia.com/news/33/4577/perrigo-rejects-mylans-acquisition-bid.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4577/perrigo-rejects-mylans-acquisition-bid.html</link>
			<pubDate>Tue, 28 Apr 2015 14:29:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100144925.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4577/perrigo-rejects-mylans-acquisition-bid.html</guid>
		</item>	
				<item>
			<title>Teva&#039;s Potential $40 bn Mylan acquisition could transform generics space&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7069/tevas-potential-40-bn-mylan-acquisition-could-transform-generics-space.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7069/tevas-potential-40-bn-mylan-acquisition-could-transform-generics-space.html</link>
			<pubDate>Mon, 27 Apr 2015 12:40:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10058597.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7069/tevas-potential-40-bn-mylan-acquisition-could-transform-generics-space.html</guid>
		</item>	
				<item>
			<title>Asian generic companies focus more on market expansion</title>
			<atom:link href="https://biospectrumasia.com/news/33/6300/asian-generic-companies-focus-more-on-market-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6300/asian-generic-companies-focus-more-on-market-expansion.html</link>
			<pubDate>Sat, 25 Apr 2015 07:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6300/asian-generic-companies-focus-more-on-market-expansion.html</guid>
		</item>	
				<item>
			<title>Teva proposes to buy Mylan for $40.1 billion</title>
			<atom:link href="https://biospectrumasia.com/news/33/7089/teva-proposes-to-buy-mylan-for-40-1-billion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7089/teva-proposes-to-buy-mylan-for-40-1-billion.html</link>
			<pubDate>Wed, 22 Apr 2015 13:12:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100254809.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7089/teva-proposes-to-buy-mylan-for-40-1-billion.html</guid>
		</item>	
				<item>
			<title>Sandoz gets FDA nod for MS generic drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/6711/sandoz-gets-fda-nod-for-ms-generic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6711/sandoz-gets-fda-nod-for-ms-generic-drug.html</link>
			<pubDate>Fri, 17 Apr 2015 11:55:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/140528-medex-amazonmain.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6711/sandoz-gets-fda-nod-for-ms-generic-drug.html</guid>
		</item>	
				<item>
			<title>Aussie&#039;s IDT to manufacture 23 generic drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/6003/aussies-idt-to-manufacture-23-generic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6003/aussies-idt-to-manufacture-23-generic-drug.html</link>
			<pubDate>Tue, 14 Apr 2015 15:06:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100144925.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6003/aussies-idt-to-manufacture-23-generic-drug.html</guid>
		</item>	
				<item>
			<title>Brickell Biotech-Kaken Pharma to co-develop dermatology drug </title>
			<atom:link href="https://biospectrumasia.com/news/33/7219/brickell-biotech-kaken-pharma-to-co-develop-dermatology-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7219/brickell-biotech-kaken-pharma-to-co-develop-dermatology-drug-.html</link>
			<pubDate>Sun, 05 Apr 2015 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7219/brickell-biotech-kaken-pharma-to-co-develop-dermatology-drug-.html</guid>
		</item>	
				<item>
			<title>US rheumatoid arthritis market to reach $9.3 bn by 2020&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7169/us-rheumatoid-arthritis-market-to-reach-9-3-bn-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7169/us-rheumatoid-arthritis-market-to-reach-9-3-bn-by-2020.html</link>
			<pubDate>Thu, 02 Apr 2015 12:05:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100220917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7169/us-rheumatoid-arthritis-market-to-reach-9-3-bn-by-2020.html</guid>
		</item>	
				<item>
			<title>Amneal pharma to acquire Actavis Australia&#039;s generic business</title>
			<atom:link href="https://biospectrumasia.com/news/33/7221/amneal-pharma-to-acquire-actavis-australias-generic-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7221/amneal-pharma-to-acquire-actavis-australias-generic-business.html</link>
			<pubDate>Thu, 02 Apr 2015 11:38:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7221/amneal-pharma-to-acquire-actavis-australias-generic-business.html</guid>
		</item>	
				<item>
			<title>TWi appoints new CEO to boost US market</title>
			<atom:link href="https://biospectrumasia.com/news/33/5754/twi-appoints-new-ceo-to-boost-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5754/twi-appoints-new-ceo-to-boost-us-market.html</link>
			<pubDate>Mon, 09 Mar 2015 14:45:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100260345.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5754/twi-appoints-new-ceo-to-boost-us-market.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s TWi to independently hit the US market</title>
			<atom:link href="https://biospectrumasia.com/news/33/6274/taiwans-twi-to-independently-hit-the-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6274/taiwans-twi-to-independently-hit-the-us-market.html</link>
			<pubDate>Thu, 26 Feb 2015 12:38:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100211120.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6274/taiwans-twi-to-independently-hit-the-us-market.html</guid>
		</item>	
				<item>
			<title>Prasco Lab to market generics version of Colcrys in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/6043/prasco-lab-to-market-generics-version-of-colcrys-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6043/prasco-lab-to-market-generics-version-of-colcrys-in-us.html</link>
			<pubDate>Tue, 13 Jan 2015 13:06:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regu4.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6043/prasco-lab-to-market-generics-version-of-colcrys-in-us.html</guid>
		</item>	
				<item>
			<title>Canada quarantines APIs by India firm</title>
			<atom:link href="https://biospectrumasia.com/news/33/5393/canada-quarantines-apis-by-india-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5393/canada-quarantines-apis-by-india-firm.html</link>
			<pubDate>Wed, 07 Jan 2015 12:21:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regu4.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5393/canada-quarantines-apis-by-india-firm.html</guid>
		</item>	
				<item>
			<title>Cipla divests its stake from a Chinese firm</title>
			<atom:link href="https://biospectrumasia.com/news/33/5552/cipla-divests-its-stake-from-a-chinese-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5552/cipla-divests-its-stake-from-a-chinese-firm.html</link>
			<pubDate>Thu, 11 Dec 2014 14:17:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10073915.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5552/cipla-divests-its-stake-from-a-chinese-firm.html</guid>
		</item>	
				<item>
			<title>Aurobindo recalls epilepsy drug lot in US </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6556/aurobindo-recalls-epilepsy-drug-lot-in-us-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6556/aurobindo-recalls-epilepsy-drug-lot-in-us-.html</link>
			<pubDate>Tue, 25 Nov 2014 14:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6556/aurobindo-recalls-epilepsy-drug-lot-in-us-.html</guid>
		</item>	
				<item>
			<title>Ã¢â‚¬Å“Chinese generics market has no strategy for international playersÃ¢â‚¬Â</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/6410/chinese-generics-market-has-no-strategy-for-international-players.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/6410/chinese-generics-market-has-no-strategy-for-international-players.html</link>
			<pubDate>Mon, 17 Nov 2014 09:52:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/paul-m-bisaro-actavis-updated.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/6410/chinese-generics-market-has-no-strategy-for-international-players.html</guid>
		</item>	
				<item>
			<title>The US coaxing India to relax patent laws: MSF</title>
			<atom:link href="https://biospectrumasia.com/news/33/2369/the-us-coaxing-india-to-relax-patent-laws-msf.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2369/the-us-coaxing-india-to-relax-patent-laws-msf.html</link>
			<pubDate>Mon, 20 Oct 2014 17:35:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100260924.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2369/the-us-coaxing-india-to-relax-patent-laws-msf.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo seeks approval for TB drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/33/5888/daiichi-sankyo-seeks-approval-for-tb-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5888/daiichi-sankyo-seeks-approval-for-tb-drug-in-japan.html</link>
			<pubDate>Mon, 06 Oct 2014 17:38:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-257344-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5888/daiichi-sankyo-seeks-approval-for-tb-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Do India&#039;s bad quality drugs end up in Africa?</title>
			<atom:link href="https://biospectrumasia.com/news/33/7424/do-indias-bad-quality-drugs-end-up-in-africa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7424/do-indias-bad-quality-drugs-end-up-in-africa.html</link>
			<pubDate>Thu, 18 Sep 2014 17:05:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10073376.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7424/do-indias-bad-quality-drugs-end-up-in-africa.html</guid>
		</item>	
				<item>
			<title>Suzhou Amerigen launches Mecobalamin in China </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6162/suzhou-amerigen-launches-mecobalamin-in-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6162/suzhou-amerigen-launches-mecobalamin-in-china-.html</link>
			<pubDate>Thu, 21 Aug 2014 11:42:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057492.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6162/suzhou-amerigen-launches-mecobalamin-in-china-.html</guid>
		</item>	
				<item>
			<title>Sun Pharma registers Rs 1391 crores profit in Q1</title>
			<atom:link href="https://biospectrumasia.com/news/33/5934/sun-pharma-registers-rs-1391-crores-profit-in-q1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5934/sun-pharma-registers-rs-1391-crores-profit-in-q1.html</link>
			<pubDate>Mon, 18 Aug 2014 09:38:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/frost-sullivan-predicts-that-growth-in-clinical-testing-volumes-will-prompt-laboratories-to-employ-advanced-autoimmune-disease-diagnostic-tests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5934/sun-pharma-registers-rs-1391-crores-profit-in-q1.html</guid>
		</item>	
				<item>
			<title>FAPA: Indian pharma to fatten in biosimilars era</title>
			<atom:link href="https://biospectrumasia.com/news/33/5657/fapa-indian-pharma-to-fatten-in-biosimilars-era.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5657/fapa-indian-pharma-to-fatten-in-biosimilars-era.html</link>
			<pubDate>Thu, 14 Aug 2014 14:36:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10048343.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5657/fapa-indian-pharma-to-fatten-in-biosimilars-era.html</guid>
		</item>	
				<item>
			<title>Celltrion files an FDA application for biosimilar</title>
			<atom:link href="https://biospectrumasia.com/news/33/5655/celltrion-files-an-fda-application-for-biosimilar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5655/celltrion-files-an-fda-application-for-biosimilar.html</link>
			<pubDate>Thu, 14 Aug 2014 13:46:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234931.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5655/celltrion-files-an-fda-application-for-biosimilar.html</guid>
		</item>	
				<item>
			<title>Lupin, LG to launch an anti-diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/5503/lupin-lg-to-launch-an-anti-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5503/lupin-lg-to-launch-an-anti-diabetes-drug.html</link>
			<pubDate>Tue, 12 Aug 2014 11:24:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10082836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5503/lupin-lg-to-launch-an-anti-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>GSK to appoint RBS exec as new chairman</title>
			<atom:link href="https://biospectrumasia.com/news/33/5474/gsk-to-appoint-rbs-exec-as-new-chairman.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5474/gsk-to-appoint-rbs-exec-as-new-chairman.html</link>
			<pubDate>Mon, 11 Aug 2014 16:54:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5474/gsk-to-appoint-rbs-exec-as-new-chairman.html</guid>
		</item>	
				<item>
			<title>Alvogen acquires Korea&#039;s Dream Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/33/5424/alvogen-acquires-koreas-dream-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5424/alvogen-acquires-koreas-dream-pharma.html</link>
			<pubDate>Fri, 08 Aug 2014 10:18:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/office-227169-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5424/alvogen-acquires-koreas-dream-pharma.html</guid>
		</item>	
				<item>
			<title>Aurobindo aims for $2 bn revenues by FY15</title>
			<atom:link href="https://biospectrumasia.com/news/33/5452/aurobindo-aims-for-2-bn-revenues-by-fy15.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5452/aurobindo-aims-for-2-bn-revenues-by-fy15.html</link>
			<pubDate>Tue, 05 Aug 2014 13:36:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057221.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5452/aurobindo-aims-for-2-bn-revenues-by-fy15.html</guid>
		</item>	
				<item>
			<title>Merck aims to expand its China business</title>
			<atom:link href="https://biospectrumasia.com/news/33/5001/merck-aims-to-expand-its-china-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5001/merck-aims-to-expand-its-china-business.html</link>
			<pubDate>Tue, 05 Aug 2014 11:04:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100258930.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5001/merck-aims-to-expand-its-china-business.html</guid>
		</item>	
				<item>
			<title>India, China to produce generic of Gilead&#039;s TAF</title>
			<atom:link href="https://biospectrumasia.com/news/33/5312/india-china-to-produce-generic-of-gileads-taf.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5312/india-china-to-produce-generic-of-gileads-taf.html</link>
			<pubDate>Mon, 04 Aug 2014 17:13:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/g.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5312/india-china-to-produce-generic-of-gileads-taf.html</guid>
		</item>	
				<item>
			<title>FDA flags GMP issues at Impax&#039;s Taiwan facility</title>
			<atom:link href="https://biospectrumasia.com/news/33/4564/fda-flags-gmp-issues-at-impaxs-taiwan-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4564/fda-flags-gmp-issues-at-impaxs-taiwan-facility.html</link>
			<pubDate>Thu, 31 Jul 2014 13:10:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100160848.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4564/fda-flags-gmp-issues-at-impaxs-taiwan-facility.html</guid>
		</item>	
				<item>
			<title>Gilead allows sublicense of HIV drug to generic firms</title>
			<atom:link href="https://biospectrumasia.com/news/33/4661/gilead-allows-sublicense-of-hiv-drug-to-generic-firms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4661/gilead-allows-sublicense-of-hiv-drug-to-generic-firms.html</link>
			<pubDate>Fri, 25 Jul 2014 12:52:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10070281.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4661/gilead-allows-sublicense-of-hiv-drug-to-generic-firms.html</guid>
		</item>	
				<item>
			<title>Pfizer to acquire Innopharma at $360 mn</title>
			<atom:link href="https://biospectrumasia.com/news/33/3973/pfizer-to-acquire-innopharma-at-360-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3973/pfizer-to-acquire-innopharma-at-360-mn.html</link>
			<pubDate>Fri, 18 Jul 2014 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-257344-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3973/pfizer-to-acquire-innopharma-at-360-mn.html</guid>
		</item>	
				<item>
			<title>Abbott to sell branded generics business to Mylan</title>
			<atom:link href="https://biospectrumasia.com/news/33/1176/abbott-to-sell-branded-generics-business-to-mylan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1176/abbott-to-sell-branded-generics-business-to-mylan.html</link>
			<pubDate>Tue, 15 Jul 2014 16:36:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100117651.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1176/abbott-to-sell-branded-generics-business-to-mylan.html</guid>
		</item>	
				<item>
			<title>Tiyanyin pharma all set for GMP inspection </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/116/tiyanyin-pharma-all-set-for-gmp-inspection-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/116/tiyanyin-pharma-all-set-for-gmp-inspection-.html</link>
			<pubDate>Tue, 15 Jul 2014 13:36:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259374.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/116/tiyanyin-pharma-all-set-for-gmp-inspection-.html</guid>
		</item>	
				<item>
			<title>Mylan launches generic hypertension drug in US</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/1191/mylan-launches-generic-hypertension-drug-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/1191/mylan-launches-generic-hypertension-drug-in-us.html</link>
			<pubDate>Thu, 10 Jul 2014 11:40:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-brasil-farmaceutica-and-ranbaxy-farmaceutica-use-hybrid-business-model-to-promote-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/1191/mylan-launches-generic-hypertension-drug-in-us.html</guid>
		</item>	
				<item>
			<title>Beximco pharma receives TFDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/33/4276/beximco-pharma-receives-tfda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4276/beximco-pharma-receives-tfda-approval.html</link>
			<pubDate>Fri, 04 Jul 2014 11:21:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4276/beximco-pharma-receives-tfda-approval.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Meiji Seika Pharma buys Medreich</title>
			<atom:link href="https://biospectrumasia.com/news/33/1666/japans-meiji-seika-pharma-buys-medreich.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1666/japans-meiji-seika-pharma-buys-medreich.html</link>
			<pubDate>Fri, 27 Jun 2014 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1666/japans-meiji-seika-pharma-buys-medreich.html</guid>
		</item>	
				<item>
			<title>FDA warns Tianjin Zhongan for cGMP lapses</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/4335/fda-warns-tianjin-zhongan-for-cgmp-lapses.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/4335/fda-warns-tianjin-zhongan-for-cgmp-lapses.html</link>
			<pubDate>Thu, 26 Jun 2014 15:16:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100264712.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/4335/fda-warns-tianjin-zhongan-for-cgmp-lapses.html</guid>
		</item>	
				<item>
			<title>Mayne Pharma appoints a new vice president</title>
			<atom:link href="https://biospectrumasia.com/news/33/4190/mayne-pharma-appoints-a-new-vice-president.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4190/mayne-pharma-appoints-a-new-vice-president.html</link>
			<pubDate>Wed, 18 Jun 2014 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10023965.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4190/mayne-pharma-appoints-a-new-vice-president.html</guid>
		</item>	
				<item>
			<title>Bayer appoints a new President </title>
			<atom:link href="https://biospectrumasia.com/news/33/2704/bayer-appoints-a-new-president-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2704/bayer-appoints-a-new-president-.html</link>
			<pubDate>Wed, 11 Jun 2014 12:17:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2704/bayer-appoints-a-new-president-.html</guid>
		</item>	
				<item>
			<title>Bayer&#039;s CEO to step down by 2016</title>
			<atom:link href="https://biospectrumasia.com/news/33/2316/bayers-ceo-to-step-down-by-2016.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2316/bayers-ceo-to-step-down-by-2016.html</link>
			<pubDate>Thu, 05 Jun 2014 15:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/untitled.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2316/bayers-ceo-to-step-down-by-2016.html</guid>
		</item>	
				<item>
			<title>Teva to acquire migraine drug firm at $825 mn</title>
			<atom:link href="https://biospectrumasia.com/news/33/4216/teva-to-acquire-migraine-drug-firm-at-825-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4216/teva-to-acquire-migraine-drug-firm-at-825-mn.html</link>
			<pubDate>Wed, 04 Jun 2014 13:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100230594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4216/teva-to-acquire-migraine-drug-firm-at-825-mn.html</guid>
		</item>	
				<item>
			<title>Teva restructures organization model</title>
			<atom:link href="https://biospectrumasia.com/news/33/2740/teva-restructures-organization-model.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2740/teva-restructures-organization-model.html</link>
			<pubDate>Tue, 03 Jun 2014 14:38:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/terminate-employee-using-progressive-discipline-200x200.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2740/teva-restructures-organization-model.html</guid>
		</item>	
				<item>
			<title>China cracks the whip on big pharma</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/1620/china-cracks-the-whip-on-big-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/1620/china-cracks-the-whip-on-big-pharma.html</link>
			<pubDate>Mon, 02 Jun 2014 17:36:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/srinivas-rao1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/1620/china-cracks-the-whip-on-big-pharma.html</guid>
		</item>	
				<item>
			<title>Shasun to focus on global regulatory markets</title>
			<atom:link href="https://biospectrumasia.com/news/33/1273/shasun-to-focus-on-global-regulatory-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1273/shasun-to-focus-on-global-regulatory-markets.html</link>
			<pubDate>Mon, 02 Jun 2014 14:50:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10015810.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1273/shasun-to-focus-on-global-regulatory-markets.html</guid>
		</item>	
				<item>
			<title>Sun Pharma settles Gleevec compound litigation</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/2320/sun-pharma-settles-gleevec-compound-litigation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/2320/sun-pharma-settles-gleevec-compound-litigation.html</link>
			<pubDate>Tue, 20 May 2014 12:46:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/2320/sun-pharma-settles-gleevec-compound-litigation.html</guid>
		</item>	
				<item>
			<title>Biocon: A nesting ground for biotech spinoffs</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/5662/biocon-a-nesting-ground-for-biotech-spinoffs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/5662/biocon-a-nesting-ground-for-biotech-spinoffs.html</link>
			<pubDate>Fri, 16 May 2014 15:36:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biocon-launches-world-s-first-biosimilar-canmab-in-india.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/5662/biocon-a-nesting-ground-for-biotech-spinoffs.html</guid>
		</item>	
				<item>
			<title>Pfizer, GSK sign productivity pact with Singapore&#039;s A*Star</title>
			<atom:link href="https://biospectrumasia.com/news/33/1578/pfizer-gsk-sign-productivity-pact-with-singapores-astar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1578/pfizer-gsk-sign-productivity-pact-with-singapores-astar.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astar-s-genome-institute-of-singapore-gis-and-quantumdx-qmdx-join-hands-for-developing-asia-specific-point-of-care-genetic-tests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1578/pfizer-gsk-sign-productivity-pact-with-singapores-astar.html</guid>
		</item>	
				<item>
			<title>Dr Reddy&#039;s launches Eszopiclone tablets in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/3874/dr-reddys-launches-eszopiclone-tablets-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3874/dr-reddys-launches-eszopiclone-tablets-in-us.html</link>
			<pubDate>Wed, 16 Apr 2014 12:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-recalls-more-than-64-000-bottles-containing-tablets-of-lipitor-generic-atorvastatin-calcium.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3874/dr-reddys-launches-eszopiclone-tablets-in-us.html</guid>
		</item>	
				<item>
			<title>Taiwan firm gets ANDA approval for generics of Pfizer&#039;s Procardia</title>
			<atom:link href="https://biospectrumasia.com/news/33/962/taiwan-firm-gets-anda-approval-for-generics-of-pfizers-procardia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/962/taiwan-firm-gets-anda-approval-for-generics-of-pfizers-procardia.html</link>
			<pubDate>Wed, 09 Apr 2014 10:12:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/impending-free-trade-agreement-between-gcc-and-india-will-further-open-up-the-generics-market.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/962/taiwan-firm-gets-anda-approval-for-generics-of-pfizers-procardia.html</guid>
		</item>	
				<item>
			<title>Sun Pharma to acquire Ranbaxy</title>
			<atom:link href="https://biospectrumasia.com/news/33/3658/sun-pharma-to-acquire-ranbaxy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3658/sun-pharma-to-acquire-ranbaxy.html</link>
			<pubDate>Mon, 07 Apr 2014 10:31:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alector-johnson-johnson-explore-novel-alzheimer-s-target.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3658/sun-pharma-to-acquire-ranbaxy.html</guid>
		</item>	
				<item>
			<title>Actavis sets up APAC headquarter in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/33/4964/actavis-sets-up-apac-headquarter-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4964/actavis-sets-up-apac-headquarter-in-singapore.html</link>
			<pubDate>Fri, 04 Apr 2014 12:39:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thailand-science-park-tsp-will-lend-its-laboratory-and-office-space-to-austrianova-s-wholly-owned-thai-subsidiary.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4964/actavis-sets-up-apac-headquarter-in-singapore.html</guid>
		</item>	
				<item>
			<title>Lupin acquires Mexican firm Laboratorios Grin</title>
			<atom:link href="https://biospectrumasia.com/news/33/3641/lupin-acquires-mexican-firm-laboratorios-grin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3641/lupin-acquires-mexican-firm-laboratorios-grin.html</link>
			<pubDate>Mon, 31 Mar 2014 11:36:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3641/lupin-acquires-mexican-firm-laboratorios-grin.html</guid>
		</item>	
				<item>
			<title>Ranbaxy now recalls 64,000 bottles of generic heart drug </title>
			<atom:link href="https://biospectrumasia.com/news/33/4801/ranbaxy-now-recalls-64000-bottles-of-generic-heart-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4801/ranbaxy-now-recalls-64000-bottles-of-generic-heart-drug-.html</link>
			<pubDate>Tue, 11 Mar 2014 17:31:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-recalls-more-than-64-000-bottles-containing-tablets-of-lipitor-generic-atorvastatin-calcium.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4801/ranbaxy-now-recalls-64000-bottles-of-generic-heart-drug-.html</guid>
		</item>	
				<item>
			<title>Lilly to expand generics manufacturing facility in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/3197/lilly-to-expand-generics-manufacturing-facility-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3197/lilly-to-expand-generics-manufacturing-facility-in-china.html</link>
			<pubDate>Thu, 06 Mar 2014 10:58:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3197/lilly-to-expand-generics-manufacturing-facility-in-china.html</guid>
		</item>	
				<item>
			<title>Teva gets FDA nod for generics of Eli Lillys Evista </title>
			<atom:link href="https://biospectrumasia.com/news/33/3131/teva-gets-fda-nod-for-generics-of-eli-lillys-evista-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3131/teva-gets-fda-nod-for-generics-of-eli-lillys-evista-.html</link>
			<pubDate>Wed, 05 Mar 2014 10:20:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3131/teva-gets-fda-nod-for-generics-of-eli-lillys-evista-.html</guid>
		</item>	
				<item>
			<title>Natco wins patent dispute case against Teva</title>
			<atom:link href="https://biospectrumasia.com/news/33/3200/natco-wins-patent-dispute-case-against-teva.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3200/natco-wins-patent-dispute-case-against-teva.html</link>
			<pubDate>Tue, 04 Mar 2014 13:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10079556.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3200/natco-wins-patent-dispute-case-against-teva.html</guid>
		</item>	
				<item>
			<title>Bayer to acquire China&#039;s OTC firm</title>
			<atom:link href="https://biospectrumasia.com/news/33/3035/bayer-to-acquire-chinas-otc-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3035/bayer-to-acquire-chinas-otc-firm.html</link>
			<pubDate>Fri, 28 Feb 2014 11:12:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3035/bayer-to-acquire-chinas-otc-firm.html</guid>
		</item>	
				<item>
			<title>APAC Epilepsy Therapeutics market to touch $1.5 bn by 2019</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/4773/apac-epilepsy-therapeutics-market-to-touch-1-5-bn-by-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/4773/apac-epilepsy-therapeutics-market-to-touch-1-5-bn-by-2019.html</link>
			<pubDate>Fri, 28 Feb 2014 10:17:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100174164.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/4773/apac-epilepsy-therapeutics-market-to-touch-1-5-bn-by-2019.html</guid>
		</item>	
				<item>
			<title>Cipla&#039;s HIV drug gets tentative nod from FDA </title>
			<atom:link href="https://biospectrumasia.com/news/33/5464/ciplas-hiv-drug-gets-tentative-nod-from-fda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5464/ciplas-hiv-drug-gets-tentative-nod-from-fda-.html</link>
			<pubDate>Thu, 27 Feb 2014 10:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100233821.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5464/ciplas-hiv-drug-gets-tentative-nod-from-fda-.html</guid>
		</item>	
				<item>
			<title>Actavis clocks $8.7 bn revenue in 2013</title>
			<atom:link href="https://biospectrumasia.com/company-results/33/2972/actavis-clocks-8-7-bn-revenue-in-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/33/2972/actavis-clocks-8-7-bn-revenue-in-2013.html</link>
			<pubDate>Fri, 21 Feb 2014 11:50:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/actavis-net-revenue-increased-47-percent-in-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/33/2972/actavis-clocks-8-7-bn-revenue-in-2013.html</guid>
		</item>	
				<item>
			<title>Aurobindo diabetes generic gets US FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/4732/aurobindo-diabetes-generic-gets-us-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/4732/aurobindo-diabetes-generic-gets-us-fda-nod.html</link>
			<pubDate>Tue, 04 Feb 2014 14:36:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-diabetes-patients-aurobindo-generic-gets-us-fda-nod.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/4732/aurobindo-diabetes-generic-gets-us-fda-nod.html</guid>
		</item>	
				<item>
			<title>Aurobindo to acquire Actavis generics unit in EU</title>
			<atom:link href="https://biospectrumasia.com/news/33/5876/aurobindo-to-acquire-actavis-generics-unit-in-eu.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5876/aurobindo-to-acquire-actavis-generics-unit-in-eu.html</link>
			<pubDate>Mon, 20 Jan 2014 17:13:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aurobindo-pharma-will-acquire-actavis-generics-in-seven-markets-in-western-europe.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5876/aurobindo-to-acquire-actavis-generics-unit-in-eu.html</guid>
		</item>	
				<item>
			<title>Another Ranbaxy plant faces US FDA ire</title>
			<atom:link href="https://biospectrumasia.com/news/33/1114/another-ranbaxy-plant-faces-us-fda-ire.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1114/another-ranbaxy-plant-faces-us-fda-ire.html</link>
			<pubDate>Tue, 14 Jan 2014 12:04:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100207207.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1114/another-ranbaxy-plant-faces-us-fda-ire.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, BMS gets FDA nod for diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/729/astrazeneca-bms-gets-fda-nod-for-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/729/astrazeneca-bms-gets-fda-nod-for-diabetes-drug.html</link>
			<pubDate>Thu, 09 Jan 2014 13:01:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100211183.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/729/astrazeneca-bms-gets-fda-nod-for-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Ranbaxy to market infliximab biosimilar</title>
			<atom:link href="https://biospectrumasia.com/news/33/3145/ranbaxy-to-market-infliximab-biosimilar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3145/ranbaxy-to-market-infliximab-biosimilar.html</link>
			<pubDate>Thu, 09 Jan 2014 12:48:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100187529.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3145/ranbaxy-to-market-infliximab-biosimilar.html</guid>
		</item>	
				<item>
			<title>GSK seeks FIPB nod to hike stake in India</title>
			<atom:link href="https://biospectrumasia.com/news/33/4185/gsk-seeks-fipb-nod-to-hike-stake-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4185/gsk-seeks-fipb-nod-to-hike-stake-in-india.html</link>
			<pubDate>Mon, 06 Jan 2014 15:07:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10060620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4185/gsk-seeks-fipb-nod-to-hike-stake-in-india.html</guid>
		</item>	
				<item>
			<title>BioSpectrum announces the hits and misses of 2013</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7126/biospectrum-announces-the-hits-and-misses-of-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7126/biospectrum-announces-the-hits-and-misses-of-2013.html</link>
			<pubDate>Thu, 02 Jan 2014 17:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/what-were-the-biggest-hits-and-misses-of-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7126/biospectrum-announces-the-hits-and-misses-of-2013.html</guid>
		</item>	
				<item>
			<title>First generic versions of Cymbalta receive FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/8026/first-generic-versions-of-cymbalta-receive-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/8026/first-generic-versions-of-cymbalta-receive-fda-nod.html</link>
			<pubDate>Fri, 13 Dec 2013 11:33:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10060468.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/8026/first-generic-versions-of-cymbalta-receive-fda-nod.html</guid>
		</item>	
				<item>
			<title>Asia pharma industry to touch $386 bn:Report</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/3634/asia-pharma-industry-to-touch-386-bnreport.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/3634/asia-pharma-industry-to-touch-386-bnreport.html</link>
			<pubDate>Thu, 05 Dec 2013 14:25:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100176084.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/3634/asia-pharma-industry-to-touch-386-bnreport.html</guid>
		</item>	
				<item>
			<title>German firm buys $200 mn stake in Indian generic company</title>
			<atom:link href="https://biospectrumasia.com/news/33/5741/german-firm-buys-200-mn-stake-in-indian-generic-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5741/german-firm-buys-200-mn-stake-in-indian-generic-company.html</link>
			<pubDate>Thu, 28 Nov 2013 12:52:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/quest-diagnostics-acquires-converge-diagnostic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5741/german-firm-buys-200-mn-stake-in-indian-generic-company.html</guid>
		</item>	
				<item>
			<title>Mundipharma, Shionogi tie up for pain treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/33/617/mundipharma-shionogi-tie-up-for-pain-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/617/mundipharma-shionogi-tie-up-for-pain-treatment-in-japan.html</link>
			<pubDate>Fri, 22 Nov 2013 14:19:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pain-no-more-mundipharma-and-shionogi-sign-deal-for-oxycodone-oxycontin-neo-tablets-and-targin-tablets-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/617/mundipharma-shionogi-tie-up-for-pain-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Ranbaxy aiming to sell its generics in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/33/2238/ranbaxy-aiming-to-sell-its-generics-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2238/ranbaxy-aiming-to-sell-its-generics-in-japan.html</link>
			<pubDate>Mon, 18 Nov 2013 11:24:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10036213.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2238/ranbaxy-aiming-to-sell-its-generics-in-japan.html</guid>
		</item>	
				<item>
			<title>Teva patent request rejected by US Supreme Court</title>
			<atom:link href="https://biospectrumasia.com/news/33/5916/teva-patent-request-rejected-by-us-supreme-court.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5916/teva-patent-request-rejected-by-us-supreme-court.html</link>
			<pubDate>Mon, 18 Nov 2013 09:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/israel-based-d-pharm-recieved-patent-in-the-us-and-china-for-thr-18-a-synthetic-therapeutic-peptide-used-in-thromboembolic-diseases-and-pathological-conditions-associated-with-neurological-damage.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5916/teva-patent-request-rejected-by-us-supreme-court.html</guid>
		</item>	
				<item>
			<title>Pneumonia kills a 5-year-old child every 30 secs: UN</title>
			<atom:link href="https://biospectrumasia.com/news/33/6460/pneumonia-kills-a-5-year-old-child-every-30-secs-un.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6460/pneumonia-kills-a-5-year-old-child-every-30-secs-un.html</link>
			<pubDate>Thu, 14 Nov 2013 10:56:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pneumonia-kills-one-million-children-each-year-says-the-un.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6460/pneumonia-kills-a-5-year-old-child-every-30-secs-un.html</guid>
		</item>	
				<item>
			<title>Sanofi files first-of-a-kind suit against FDA </title>
			<atom:link href="https://biospectrumasia.com/news/33/6413/sanofi-files-first-of-a-kind-suit-against-fda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6413/sanofi-files-first-of-a-kind-suit-against-fda-.html</link>
			<pubDate>Wed, 13 Nov 2013 15:18:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sanofi-doesn-t-want-the-us-fda-to-release-packaging-information-of-its-newly-approved-over-the-counter-otc-allergy-spray-nasacort.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6413/sanofi-files-first-of-a-kind-suit-against-fda-.html</guid>
		</item>	
				<item>
			<title>Mundipharma, Horizon subsidiary sign arthritis deal</title>
			<atom:link href="https://biospectrumasia.com/news/33/4743/mundipharma-horizon-subsidiary-sign-arthritis-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4743/mundipharma-horizon-subsidiary-sign-arthritis-deal.html</link>
			<pubDate>Wed, 13 Nov 2013 08:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mundipharma-and-swiss-subsidiary-of-horizon-pharma-sign-exclusive-agreement-for-commercialization-and-distribution-of-rheumatoid-arthritis-ra-drug-lodotra-in-the-middle-east-and-african-region.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4743/mundipharma-horizon-subsidiary-sign-arthritis-deal.html</guid>
		</item>	
				<item>
			<title>Teva to pay $718 mn to apex tax body in Israel</title>
			<atom:link href="https://biospectrumasia.com/news/33/6748/teva-to-pay-718-mn-to-apex-tax-body-in-israel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6748/teva-to-pay-718-mn-to-apex-tax-body-in-israel.html</link>
			<pubDate>Wed, 13 Nov 2013 08:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teva-to-pay-usd718-million-to-israel-tax-authority-to-pay-for-the-release-of-trapped-profits-and-settling-tax-assessments.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6748/teva-to-pay-718-mn-to-apex-tax-body-in-israel.html</guid>
		</item>	
				<item>
			<title>Mundipharma appoints John Lee as GM for SEA</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/3952/mundipharma-appoints-john-lee-as-gm-for-sea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/3952/mundipharma-appoints-john-lee-as-gm-for-sea.html</link>
			<pubDate>Wed, 06 Nov 2013 12:45:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/johnlee-mundipharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/3952/mundipharma-appoints-john-lee-as-gm-for-sea.html</guid>
		</item>	
				<item>
			<title>Drug shortage forces FDA to approve cancer generic</title>
			<atom:link href="https://biospectrumasia.com/news/33/6629/drug-shortage-forces-fda-to-approve-cancer-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6629/drug-shortage-forces-fda-to-approve-cancer-generic.html</link>
			<pubDate>Wed, 06 Nov 2013 11:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10060133.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6629/drug-shortage-forces-fda-to-approve-cancer-generic.html</guid>
		</item>	
				<item>
			<title>Ranbaxy sues Actavis to stop acne generic sale</title>
			<atom:link href="https://biospectrumasia.com/news/33/5855/ranbaxy-sues-actavis-to-stop-acne-generic-sale.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5855/ranbaxy-sues-actavis-to-stop-acne-generic-sale.html</link>
			<pubDate>Mon, 04 Nov 2013 11:16:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10048215.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5855/ranbaxy-sues-actavis-to-stop-acne-generic-sale.html</guid>
		</item>	
				<item>
			<title>Sun Pharma&#039;s founder named India&#039;s 3rd richest</title>
			<atom:link href="https://biospectrumasia.com/news/33/5973/sun-pharmas-founder-named-indias-3rd-richest.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5973/sun-pharmas-founder-named-indias-3rd-richest.html</link>
			<pubDate>Fri, 25 Oct 2013 12:58:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dilip.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5973/sun-pharmas-founder-named-indias-3rd-richest.html</guid>
		</item>	
				<item>
			<title>US firms lobbying to protect patents in India: Report</title>
			<atom:link href="https://biospectrumasia.com/news/33/5197/us-firms-lobbying-to-protect-patents-in-india-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5197/us-firms-lobbying-to-protect-patents-in-india-report.html</link>
			<pubDate>Thu, 24 Oct 2013 14:01:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10022763.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5197/us-firms-lobbying-to-protect-patents-in-india-report.html</guid>
		</item>	
				<item>
			<title>Wockhardt&#039;s third Indian plant faces export ban</title>
			<atom:link href="https://biospectrumasia.com/news/33/5635/wockhardts-third-indian-plant-faces-export-ban.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5635/wockhardts-third-indian-plant-faces-export-ban.html</link>
			<pubDate>Wed, 23 Oct 2013 12:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10056420.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5635/wockhardts-third-indian-plant-faces-export-ban.html</guid>
		</item>	
				<item>
			<title>Another Indian pharma company rapped by FDA</title>
			<atom:link href="https://biospectrumasia.com/news/33/2488/another-indian-pharma-company-rapped-by-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2488/another-indian-pharma-company-rapped-by-fda.html</link>
			<pubDate>Tue, 22 Oct 2013 14:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100120131.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2488/another-indian-pharma-company-rapped-by-fda.html</guid>
		</item>	
				<item>
			<title>Jubilant smoking cessation aid gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/33/6023/jubilant-smoking-cessation-aid-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6023/jubilant-smoking-cessation-aid-gets-fda-nod.html</link>
			<pubDate>Mon, 21 Oct 2013 15:29:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-us-fda-approved-glaxosmithkline-gsk-flulaval-quadrivalent-influenza-virus-vaccine-for-the-active-immunization-of-persons-three-years-of-age-and-older.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6023/jubilant-smoking-cessation-aid-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>FDA approves Novo Nordisk haemophilia A drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/2344/fda-approves-novo-nordisk-haemophilia-a-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/2344/fda-approves-novo-nordisk-haemophilia-a-drug-.html</link>
			<pubDate>Thu, 17 Oct 2013 08:32:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-approves-bayer-healthcare-s-adempas-riociguat-for-chronic-thromboembolic-pulmonary-hypertension-cteph-and-pulmonary-arterial-hypertension-pah.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/2344/fda-approves-novo-nordisk-haemophilia-a-drug-.html</guid>
		</item>	
				<item>
			<title>US antidepressant market slides down by 4%: report</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7527/us-antidepressant-market-slides-down-by-4-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7527/us-antidepressant-market-slides-down-by-4-report.html</link>
			<pubDate>Mon, 14 Oct 2013 10:21:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7527/us-antidepressant-market-slides-down-by-4-report.html</guid>
		</item>	
				<item>
			<title>Actavis files ANDA for Reckitt generic with FDA</title>
			<atom:link href="https://biospectrumasia.com/news/33/2773/actavis-files-anda-for-reckitt-generic-with-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2773/actavis-files-anda-for-reckitt-generic-with-fda.html</link>
			<pubDate>Thu, 10 Oct 2013 12:08:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/actavis-seeks-approval-from-the-us-fda-to-market-buprenorphine-hydrochloride-and-naloxone-hydrochloride-sublingual-film.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2773/actavis-files-anda-for-reckitt-generic-with-fda.html</guid>
		</item>	
				<item>
			<title>US court lifts temporary injunction against Hanmi</title>
			<atom:link href="https://biospectrumasia.com/news/33/2833/us-court-lifts-temporary-injunction-against-hanmi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2833/us-court-lifts-temporary-injunction-against-hanmi.html</link>
			<pubDate>Thu, 03 Oct 2013 11:52:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-court-of-appeals-for-the-federal-circuit-cafc-lifts-temporary-injunction-against-the-us-launch-of-south-korea-based-hanmi-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2833/us-court-lifts-temporary-injunction-against-hanmi.html</guid>
		</item>	
				<item>
			<title>TB claims 74000 children each year: WHO</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7055/tb-claims-74000-children-each-year-who.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7055/tb-claims-74000-children-each-year-who.html</link>
			<pubDate>Wed, 02 Oct 2013 11:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/healthcare.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7055/tb-claims-74000-children-each-year-who.html</guid>
		</item>	
				<item>
			<title>Mylan launches generic of Pfizer&#039;s antifungal drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/5971/mylan-launches-generic-of-pfizers-antifungal-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5971/mylan-launches-generic-of-pfizers-antifungal-drug.html</link>
			<pubDate>Tue, 01 Oct 2013 09:31:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sinochem-will-market-generic-mecobalamin-tablets-that-are-made-by-suzhou-amerigen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5971/mylan-launches-generic-of-pfizers-antifungal-drug.html</guid>
		</item>	
				<item>
			<title>Rabies claims 100 lives annually in Vietnam: UN</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/697/rabies-claims-100-lives-annually-in-vietnam-un.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/697/rabies-claims-100-lives-annually-in-vietnam-un.html</link>
			<pubDate>Mon, 30 Sep 2013 11:52:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/in-vietnam-more-than-90-percent-of-the-human-rabies-cases-are-caused-by-unvaccinated-dogs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/697/rabies-claims-100-lives-annually-in-vietnam-un.html</guid>
		</item>	
				<item>
			<title>Huahai gets China FDA nod to make HIV/AIDS generic </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/5231/huahai-gets-china-fda-nod-to-make-hiv-aids-generic-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/5231/huahai-gets-china-fda-nod-to-make-hiv-aids-generic-.html</link>
			<pubDate>Wed, 25 Sep 2013 15:39:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-hiv-aids-patients-zhejiang-huahai-gets-nod-from-china-fda-to-produce-efavirenz.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/5231/huahai-gets-china-fda-nod-to-make-hiv-aids-generic-.html</guid>
		</item>	
				<item>
			<title>Daiichi  to work with US FDA to solve Ranbaxy quality issue</title>
			<atom:link href="https://biospectrumasia.com/news/33/2256/daiichi-to-work-with-us-fda-to-solve-ranbaxy-quality-issue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2256/daiichi-to-work-with-us-fda-to-solve-ranbaxy-quality-issue.html</link>
			<pubDate>Wed, 25 Sep 2013 14:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10095073.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2256/daiichi-to-work-with-us-fda-to-solve-ranbaxy-quality-issue.html</guid>
		</item>	
				<item>
			<title>Takeda gets Japanese NDA approval for obesity drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html</link>
			<pubDate>Mon, 23 Sep 2013 10:55:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oblean-is-a-lipase-inhibitor-discovered-by-uk-based-alizyme-therapeutics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html</guid>
		</item>	
				<item>
			<title>Unlike FDA, Indian regulators finds no violations at Ranbaxy</title>
			<atom:link href="https://biospectrumasia.com/news/33/6894/unlike-fda-indian-regulators-finds-no-violations-at-ranbaxy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6894/unlike-fda-indian-regulators-finds-no-violations-at-ranbaxy.html</link>
			<pubDate>Fri, 20 Sep 2013 13:27:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088325.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6894/unlike-fda-indian-regulators-finds-no-violations-at-ranbaxy.html</guid>
		</item>	
				<item>
			<title>Lupin gets FDA nod to make generic insomnia drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/4519/lupin-gets-fda-nod-to-make-generic-insomnia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4519/lupin-gets-fda-nod-to-make-generic-insomnia-drug.html</link>
			<pubDate>Fri, 20 Sep 2013 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100146537.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4519/lupin-gets-fda-nod-to-make-generic-insomnia-drug.html</guid>
		</item>	
				<item>
			<title>FDA finds hair from human arm in Ranbaxy drugs </title>
			<atom:link href="https://biospectrumasia.com/news/33/7712/fda-finds-hair-from-human-arm-in-ranbaxy-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7712/fda-finds-hair-from-human-arm-in-ranbaxy-drugs-.html</link>
			<pubDate>Thu, 19 Sep 2013 11:36:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100176552.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7712/fda-finds-hair-from-human-arm-in-ranbaxy-drugs-.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s Azacitidine for injection gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/33/5458/dr-reddys-azacitidine-for-injection-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5458/dr-reddys-azacitidine-for-injection-gets-fda-nod.html</link>
			<pubDate>Wed, 18 Sep 2013 11:41:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10060468.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5458/dr-reddys-azacitidine-for-injection-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>US FDA imposes import alert on Ranbaxy drugs</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6342/us-fda-imposes-import-alert-on-ranbaxy-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6342/us-fda-imposes-import-alert-on-ranbaxy-drugs.html</link>
			<pubDate>Tue, 17 Sep 2013 11:52:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-asks-ranbaxy-to-conduct-a-third-party-inspection-of-its-mohali-facility-and-certify-to-the-fda-that-the-processes-being-followed-are-in-compliance-with-cgmp.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6342/us-fda-imposes-import-alert-on-ranbaxy-drugs.html</guid>
		</item>	
				<item>
			<title>Sun&#039;s generic of Takeda ulcer drug gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6750/suns-generic-of-takeda-ulcer-drug-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6750/suns-generic-of-takeda-ulcer-drug-gets-fda-nod.html</link>
			<pubDate>Mon, 16 Sep 2013 15:11:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10066026.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6750/suns-generic-of-takeda-ulcer-drug-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>Indian firms get FDA approval for 110 generic drugs</title>
			<atom:link href="https://biospectrumasia.com/news/33/2820/indian-firms-get-fda-approval-for-110-generic-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2820/indian-firms-get-fda-approval-for-110-generic-drugs.html</link>
			<pubDate>Mon, 16 Sep 2013 13:44:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10087069-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2820/indian-firms-get-fda-approval-for-110-generic-drugs.html</guid>
		</item>	
				<item>
			<title>Chinese medicine firm Tianyin gets GMP certificate</title>
			<atom:link href="https://biospectrumasia.com/news/33/3284/chinese-medicine-firm-tianyin-gets-gmp-certificate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3284/chinese-medicine-firm-tianyin-gets-gmp-certificate.html</link>
			<pubDate>Mon, 16 Sep 2013 11:50:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tianyin-pharmaceutical-gets-gmp-certification-for-its-pre-extraction-plant-and-formulate-facilities.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3284/chinese-medicine-firm-tianyin-gets-gmp-certificate.html</guid>
		</item>	
				<item>
			<title>Eli Lilly files $500 mn suit against Canada govt</title>
			<atom:link href="https://biospectrumasia.com/news/33/4095/eli-lilly-files-500-mn-suit-against-canada-govt.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4095/eli-lilly-files-500-mn-suit-against-canada-govt.html</link>
			<pubDate>Mon, 16 Sep 2013 02:32:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eli-lilly-files-usd500-mn-suit-against-the-canadian-government-under-north-american-free-trade-agreement-nafta-rules.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4095/eli-lilly-files-500-mn-suit-against-canada-govt.html</guid>
		</item>	
				<item>
			<title>Wockhardt restructures quality control team</title>
			<atom:link href="https://biospectrumasia.com/news/33/6512/wockhardt-restructures-quality-control-team.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6512/wockhardt-restructures-quality-control-team.html</link>
			<pubDate>Thu, 12 Sep 2013 13:10:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/time-medical-device-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6512/wockhardt-restructures-quality-control-team.html</guid>
		</item>	
				<item>
			<title>Avanir Pharma settles patent litigation with Wockhardt </title>
			<atom:link href="https://biospectrumasia.com/news/33/432/avanir-pharma-settles-patent-litigation-with-wockhardt-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/432/avanir-pharma-settles-patent-litigation-with-wockhardt-.html</link>
			<pubDate>Mon, 09 Sep 2013 10:55:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/432/avanir-pharma-settles-patent-litigation-with-wockhardt-.html</guid>
		</item>	
				<item>
			<title>DCGI asks Wockhardt, Ranbaxy to explain lapses</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3355/dcgi-asks-wockhardt-ranbaxy-to-explain-lapses.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3355/dcgi-asks-wockhardt-ranbaxy-to-explain-lapses.html</link>
			<pubDate>Mon, 02 Sep 2013 12:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-drug-regulator-is-now-awaiting-responses-from-the-companies-to-take-further-action.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3355/dcgi-asks-wockhardt-ranbaxy-to-explain-lapses.html</guid>
		</item>	
				<item>
			<title>50% of all drug firms have counter-generics team </title>
			<atom:link href="https://biospectrumasia.com/news/33/1961/50-of-all-drug-firms-have-counter-generics-team-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1961/50-of-all-drug-firms-have-counter-generics-team-.html</link>
			<pubDate>Mon, 26 Aug 2013 15:25:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/post-patent-generic-and-biosimilar-defense-harnessing-competitive-tactics-to-mitigate-revenue-erosion-the-genie-is-out-of-the-bottle.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1961/50-of-all-drug-firms-have-counter-generics-team-.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches generic psychiatric drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/3339/dr-reddys-launches-generic-psychiatric-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3339/dr-reddys-launches-generic-psychiatric-drug.html</link>
			<pubDate>Fri, 23 Aug 2013 09:09:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3339/dr-reddys-launches-generic-psychiatric-drug.html</guid>
		</item>	
				<item>
			<title>Generics take center stage in South East Asia</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/2109/generics-take-center-stage-in-south-east-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/2109/generics-take-center-stage-in-south-east-asia.html</link>
			<pubDate>Wed, 21 Aug 2013 14:20:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-pharmaceutical-market-dominated-by-local-players-has-been-gearing-up-its-production-and-distribution-infrastructure-to-cope-with-the-expected-multiple-increases-in-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/2109/generics-take-center-stage-in-south-east-asia.html</guid>
		</item>	
				<item>
			<title>India: PSUs need to be  revived to boost generics</title>
			<atom:link href="https://biospectrumasia.com/news/33/3513/india-psus-need-to-be-revived-to-boost-generics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3513/india-psus-need-to-be-revived-to-boost-generics.html</link>
			<pubDate>Tue, 20 Aug 2013 17:22:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/investment-zenotec.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3513/india-psus-need-to-be-revived-to-boost-generics.html</guid>
		</item>	
				<item>
			<title>Teva launches generic of cancer drug Temodar in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/1015/teva-launches-generic-of-cancer-drug-temodar-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1015/teva-launches-generic-of-cancer-drug-temodar-in-us.html</link>
			<pubDate>Fri, 16 Aug 2013 10:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teva-launches-generic-of-cancer-drug-temodar-in-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1015/teva-launches-generic-of-cancer-drug-temodar-in-us.html</guid>
		</item>	
				<item>
			<title>Fosun Pharma listed in CCTV Financial 50 Index Sample Stock</title>
			<atom:link href="https://biospectrumasia.com/company-results/33/5386/fosun-pharma-listed-in-cctv-financial-50-index-sample-stock.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/33/5386/fosun-pharma-listed-in-cctv-financial-50-index-sample-stock.html</link>
			<pubDate>Wed, 14 Aug 2013 12:19:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-business.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/33/5386/fosun-pharma-listed-in-cctv-financial-50-index-sample-stock.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s hires its HR global head from IBM</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/5272/dr-reddys-hires-its-hr-global-head-from-ibm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/5272/dr-reddys-hires-its-hr-global-head-from-ibm.html</link>
			<pubDate>Tue, 13 Aug 2013 11:14:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-sripada-chandrasekhar-is-the-new-president-and-global-head-of-human-resources-of-dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/5272/dr-reddys-hires-its-hr-global-head-from-ibm.html</guid>
		</item>	
				<item>
			<title>Lupin begins trial runs at Nagpur&#039;s Mihan unit</title>
			<atom:link href="https://biospectrumasia.com/news/33/2632/lupin-begins-trial-runs-at-nagpurs-mihan-unit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2632/lupin-begins-trial-runs-at-nagpurs-mihan-unit.html</link>
			<pubDate>Mon, 12 Aug 2013 15:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thermo-fisher-scientific-s-30-800-square-feet-manufacturing-plant-in-tuas-singapore-is-the-first-ever-cell-culture-dry-powder-media-dpm-production-site-in-singapore.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2632/lupin-begins-trial-runs-at-nagpurs-mihan-unit.html</guid>
		</item>	
				<item>
			<title>Hong Kong to host international TCM exhibition, conference</title>
			<atom:link href="https://biospectrumasia.com/news/33/6592/hong-kong-to-host-international-tcm-exhibition-conference.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6592/hong-kong-to-host-international-tcm-exhibition-conference.html</link>
			<pubDate>Mon, 12 Aug 2013 10:43:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotec-nstda-took-part-in-an-exhibition-of-kelantan-international-bio-carnival-conference-and-exhibition-2013-bio-k-on-february-28-march-2-2013-in-kelantan-malaysia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6592/hong-kong-to-host-international-tcm-exhibition-conference.html</guid>
		</item>	
				<item>
			<title>Takeda diabetes drug gets China&#039;s import license</title>
			<atom:link href="https://biospectrumasia.com/news/33/1098/takeda-diabetes-drug-gets-chinas-import-license.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1098/takeda-diabetes-drug-gets-chinas-import-license.html</link>
			<pubDate>Tue, 06 Aug 2013 13:22:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lyxumia-gets-japanese-nod-for-diabetes-therapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1098/takeda-diabetes-drug-gets-chinas-import-license.html</guid>
		</item>	
				<item>
			<title>India revokes Roche&#039;s cancer drug Herceptin patent</title>
			<atom:link href="https://biospectrumasia.com/news/33/3379/india-revokes-roches-cancer-drug-herceptin-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3379/india-revokes-roches-cancer-drug-herceptin-patent.html</link>
			<pubDate>Mon, 05 Aug 2013 11:42:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/india-may-revoke-roche-s-breast-cancer-drug-s-patent-using-section-66-of-the-indian-patents-act.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3379/india-revokes-roches-cancer-drug-herceptin-patent.html</guid>
		</item>	
				<item>
			<title>FDA nod for Lupin&#039;s angina generic Ranolazine </title>
			<atom:link href="https://biospectrumasia.com/news/33/4141/fda-nod-for-lupins-angina-generic-ranolazine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4141/fda-nod-for-lupins-angina-generic-ranolazine-.html</link>
			<pubDate>Mon, 05 Aug 2013 11:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-hiv-aids-patients-fda-tentatively-approves-strides-arcolab-s-drug-emtricitabine-and-tenofovir-disoproxil-fumarate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4141/fda-nod-for-lupins-angina-generic-ranolazine-.html</guid>
		</item>	
				<item>
			<title>IPAB revokes patent for GSK&#039;s anti-cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/33/5843/ipab-revokes-patent-for-gsks-anti-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5843/ipab-revokes-patent-for-gsks-anti-cancer-drug-.html</link>
			<pubDate>Mon, 05 Aug 2013 10:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/is-gene-testing-for-breast-cancer-a-preventive-healthcare-option.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5843/ipab-revokes-patent-for-gsks-anti-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Indian drug dealers worried about $1.69 bn old stocks </title>
			<atom:link href="https://biospectrumasia.com/news/33/8052/indian-drug-dealers-worried-about-1-69-bn-old-stocks-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/8052/indian-drug-dealers-worried-about-1-69-bn-old-stocks-.html</link>
			<pubDate>Fri, 02 Aug 2013 13:45:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-price-revision.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/8052/indian-drug-dealers-worried-about-1-69-bn-old-stocks-.html</guid>
		</item>	
				<item>
			<title>Glenmark-MSD patent suit put on hold by Indian HC</title>
			<atom:link href="https://biospectrumasia.com/news/33/3466/glenmark-msd-patent-suit-put-on-hold-by-indian-hc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3466/glenmark-msd-patent-suit-put-on-hold-by-indian-hc.html</link>
			<pubDate>Fri, 02 Aug 2013 13:25:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3466/glenmark-msd-patent-suit-put-on-hold-by-indian-hc.html</guid>
		</item>	
				<item>
			<title>Strides gets tentative FDA nod for HIV generic</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3338/strides-gets-tentative-fda-nod-for-hiv-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3338/strides-gets-tentative-fda-nod-for-hiv-generic.html</link>
			<pubDate>Fri, 02 Aug 2013 11:52:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-hiv-aids-patients-fda-tentatively-approves-strides-arcolab-s-drug-emtricitabine-and-tenofovir-disoproxil-fumarate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3338/strides-gets-tentative-fda-nod-for-hiv-generic.html</guid>
		</item>	
				<item>
			<title>Indian market expected to grow 12% during 2011-15</title>
			<atom:link href="https://biospectrumasia.com/news/33/2885/indian-market-expected-to-grow-12-during-2011-15.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2885/indian-market-expected-to-grow-12-during-2011-15.html</link>
			<pubDate>Thu, 01 Aug 2013 18:16:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/concord-medical-q1-2013-results-report-gross-profit-of-usd11.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2885/indian-market-expected-to-grow-12-during-2011-15.html</guid>
		</item>	
				<item>
			<title>Cipla gets drug pricing breather from Delhi Court </title>
			<atom:link href="https://biospectrumasia.com/news/33/157/cipla-gets-drug-pricing-breather-from-delhi-court-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/157/cipla-gets-drug-pricing-breather-from-delhi-court-.html</link>
			<pubDate>Wed, 31 Jul 2013 15:11:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/assocham-pushes-for-market-based-drug-pricing-in-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/157/cipla-gets-drug-pricing-breather-from-delhi-court-.html</guid>
		</item>	
				<item>
			<title>Teva to uphold Copaxone patent until May 2015 </title>
			<atom:link href="https://biospectrumasia.com/news/33/7577/teva-to-uphold-copaxone-patent-until-may-2015-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7577/teva-to-uphold-copaxone-patent-until-may-2015-.html</link>
			<pubDate>Wed, 31 Jul 2013 09:42:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7577/teva-to-uphold-copaxone-patent-until-may-2015-.html</guid>
		</item>	
				<item>
			<title>Comply or face action: US FDA tells Indian drugmakers</title>
			<atom:link href="https://biospectrumasia.com/news/33/6263/comply-or-face-action-us-fda-tells-indian-drugmakers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6263/comply-or-face-action-us-fda-tells-indian-drugmakers.html</link>
			<pubDate>Mon, 29 Jul 2013 17:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-issues-warning-against-nizoral-tablets.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6263/comply-or-face-action-us-fda-tells-indian-drugmakers.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches Aricept generic Donepezil</title>
			<atom:link href="https://biospectrumasia.com/news/33/1078/dr-reddys-launches-aricept-generic-donepezil.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1078/dr-reddys-launches-aricept-generic-donepezil.html</link>
			<pubDate>Mon, 29 Jul 2013 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1078/dr-reddys-launches-aricept-generic-donepezil.html</guid>
		</item>	
				<item>
			<title>Sanofi, Carlyle to buy Elder Pharma for $450 mn</title>
			<atom:link href="https://biospectrumasia.com/news/33/8463/sanofi-carlyle-to-buy-elder-pharma-for-450-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/8463/sanofi-carlyle-to-buy-elder-pharma-for-450-mn.html</link>
			<pubDate>Thu, 25 Jul 2013 17:23:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bgi-shenzhen-s-subsidiary-beta-acquisition-extends-its-cash-tender-offer-to-acquire-complete-genomics-stocks-until-midnight-of-wednesday-february-6-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/8463/sanofi-carlyle-to-buy-elder-pharma-for-450-mn.html</guid>
		</item>	
				<item>
			<title>Mylan signs a settlement agreement with OSI Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/33/7277/mylan-signs-a-settlement-agreement-with-osi-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7277/mylan-signs-a-settlement-agreement-with-osi-pharma.html</link>
			<pubDate>Thu, 25 Jul 2013 15:48:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna-logix-and-co-diagnostics-form-joint-venture-named-co-diagnostics-hbdc-to-sell-testing-products-and-services-to-middle-and-low-income-countries.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7277/mylan-signs-a-settlement-agreement-with-osi-pharma.html</guid>
		</item>	
				<item>
			<title>GSK CEO: London HQ &#039;knew nothing&#039; of the fraud</title>
			<atom:link href="https://biospectrumasia.com/news/33/4153/gsk-ceo-london-hq-knew-nothing-of-the-fraud.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4153/gsk-ceo-london-hq-knew-nothing-of-the-fraud.html</link>
			<pubDate>Thu, 25 Jul 2013 13:24:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/andrew-witty.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4153/gsk-ceo-london-hq-knew-nothing-of-the-fraud.html</guid>
		</item>	
				<item>
			<title>IOF, Fonterra grants $43K to Indonesian for bone R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/33/1260/iof-fonterra-grants-43k-to-indonesian-for-bone-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1260/iof-fonterra-grants-43k-to-indonesian-for-bone-rd.html</link>
			<pubDate>Thu, 25 Jul 2013 10:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-suharti-suherman-of-the-faculty-of-medicine-university-of-indonesia-has-been-awarded-a-grant-of-approximately-usd43-000-for-bone-research-by-international-osteoporosis-foundation-iof-and-fonterra.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1260/iof-fonterra-grants-43k-to-indonesian-for-bone-rd.html</guid>
		</item>	
				<item>
			<title>UCB sues 15 firms for patent infringement</title>
			<atom:link href="https://biospectrumasia.com/news/33/1977/ucb-sues-15-firms-for-patent-infringement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1977/ucb-sues-15-firms-for-patent-infringement.html</link>
			<pubDate>Wed, 24 Jul 2013 16:17:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1977/ucb-sues-15-firms-for-patent-infringement.html</guid>
		</item>	
				<item>
			<title>Self monitoring diabetes market to reach $358 mn</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7453/self-monitoring-diabetes-market-to-reach-358-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7453/self-monitoring-diabetes-market-to-reach-358-mn.html</link>
			<pubDate>Tue, 23 Jul 2013 10:27:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/self-monitoring-diabetes-market-to-reach-usd358-mn.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7453/self-monitoring-diabetes-market-to-reach-358-mn.html</guid>
		</item>	
				<item>
			<title>Indian state to slash prices of 348 drugs</title>
			<atom:link href="https://biospectrumasia.com/news/33/2274/indian-state-to-slash-prices-of-348-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2274/indian-state-to-slash-prices-of-348-drugs.html</link>
			<pubDate>Tue, 23 Jul 2013 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-price-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2274/indian-state-to-slash-prices-of-348-drugs.html</guid>
		</item>	
				<item>
			<title>Trans-Pacific trade talks reach stalemate over IP rights</title>
			<atom:link href="https://biospectrumasia.com/news/33/7667/trans-pacific-trade-talks-reach-stalemate-over-ip-rights.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7667/trans-pacific-trade-talks-reach-stalemate-over-ip-rights.html</link>
			<pubDate>Tue, 23 Jul 2013 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7667/trans-pacific-trade-talks-reach-stalemate-over-ip-rights.html</guid>
		</item>	
				<item>
			<title>India to review its pharma FDI policies </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/1352/india-to-review-its-pharma-fdi-policies-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/1352/india-to-review-its-pharma-fdi-policies-.html</link>
			<pubDate>Mon, 22 Jul 2013 08:44:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/global-currencies-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/1352/india-to-review-its-pharma-fdi-policies-.html</guid>
		</item>	
				<item>
			<title>China bans GSK finance head from leaving country</title>
			<atom:link href="https://biospectrumasia.com/news/33/1984/china-bans-gsk-finance-head-from-leaving-country.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1984/china-bans-gsk-finance-head-from-leaving-country.html</link>
			<pubDate>Thu, 18 Jul 2013 10:04:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-china.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1984/china-bans-gsk-finance-head-from-leaving-country.html</guid>
		</item>	
				<item>
			<title>GSK China VP confesses in bribery scandal</title>
			<atom:link href="https://biospectrumasia.com/news/33/3384/gsk-china-vp-confesses-in-bribery-scandal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3384/gsk-china-vp-confesses-in-bribery-scandal.html</link>
			<pubDate>Thu, 18 Jul 2013 07:27:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-vp.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3384/gsk-china-vp-confesses-in-bribery-scandal.html</guid>
		</item>	
				<item>
			<title>Abbott Laboratories unveils strategy for India </title>
			<atom:link href="https://biospectrumasia.com/news/33/3986/abbott-laboratories-unveils-strategy-for-india-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3986/abbott-laboratories-unveils-strategy-for-india-.html</link>
			<pubDate>Wed, 17 Jul 2013 14:19:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/indian-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3986/abbott-laboratories-unveils-strategy-for-india-.html</guid>
		</item>	
				<item>
			<title>Cipla, Alembic contest Indian drug pricing in court</title>
			<atom:link href="https://biospectrumasia.com/news/33/8099/cipla-alembic-contest-indian-drug-pricing-in-court.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/8099/cipla-alembic-contest-indian-drug-pricing-in-court.html</link>
			<pubDate>Wed, 17 Jul 2013 13:14:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/this-will-be-the-first-time-that-generic-drugmakers-will-pay-damages-for-marketing-a-copy-of-an-existing-drug-for-which-patents-have-yet-to-expire.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/8099/cipla-alembic-contest-indian-drug-pricing-in-court.html</guid>
		</item>	
				<item>
			<title>Police: Sexual favours spurred GSK&#039;s $1.5 bn China sales</title>
			<atom:link href="https://biospectrumasia.com/news/33/1298/police-sexual-favours-spurred-gsks-1-5-bn-china-sales.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1298/police-sexual-favours-spurred-gsks-1-5-bn-china-sales.html</link>
			<pubDate>Tue, 16 Jul 2013 14:16:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sexual-favours-and-bribes.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1298/police-sexual-favours-spurred-gsks-1-5-bn-china-sales.html</guid>
		</item>	
				<item>
			<title>Bribery inquiries rising in China: SPP</title>
			<atom:link href="https://biospectrumasia.com/news/33/1989/bribery-inquiries-rising-in-china-spp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1989/bribery-inquiries-rising-in-china-spp.html</link>
			<pubDate>Mon, 15 Jul 2013 17:35:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/investigation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1989/bribery-inquiries-rising-in-china-spp.html</guid>
		</item>	
				<item>
			<title>China: GSK used sexual bribery to boost sales</title>
			<atom:link href="https://biospectrumasia.com/news/33/2062/china-gsk-used-sexual-bribery-to-boost-sales.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2062/china-gsk-used-sexual-bribery-to-boost-sales.html</link>
			<pubDate>Mon, 15 Jul 2013 17:24:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bribery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2062/china-gsk-used-sexual-bribery-to-boost-sales.html</guid>
		</item>	
				<item>
			<title>Britain&#039;s MHRA recalls 16 Wockhardt medicines</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6590/britains-mhra-recalls-16-wockhardt-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6590/britains-mhra-recalls-16-wockhardt-medicines.html</link>
			<pubDate>Fri, 12 Jul 2013 14:46:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/health-life-recalls-ez-breathe-atomizers-on-behalf-of-nephron-pharmaceuticals.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6590/britains-mhra-recalls-16-wockhardt-medicines.html</guid>
		</item>	
				<item>
			<title>FDA approves Sun Pharma&#039;s generic Prandin</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/8123/fda-approves-sun-pharmas-generic-prandin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/8123/fda-approves-sun-pharmas-generic-prandin.html</link>
			<pubDate>Fri, 12 Jul 2013 13:59:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approved.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/8123/fda-approves-sun-pharmas-generic-prandin.html</guid>
		</item>	
				<item>
			<title>GSK executives confessed to bribery charges: China</title>
			<atom:link href="https://biospectrumasia.com/news/33/1418/gsk-executives-confessed-to-bribery-charges-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1418/gsk-executives-confessed-to-bribery-charges-china.html</link>
			<pubDate>Fri, 12 Jul 2013 12:07:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/confession-to-bribery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1418/gsk-executives-confessed-to-bribery-charges-china.html</guid>
		</item>	
				<item>
			<title>Abbott rejigs strategy, realigns India business</title>
			<atom:link href="https://biospectrumasia.com/news/33/3321/abbott-rejigs-strategy-realigns-india-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3321/abbott-rejigs-strategy-realigns-india-business.html</link>
			<pubDate>Fri, 12 Jul 2013 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regeneron-acquires-rights-to-sanofi-s-ophthalmology-antibodies-targeting-the-pdgf-platelet-derived-growth-factor-and-ang2-angiopoietin2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3321/abbott-rejigs-strategy-realigns-india-business.html</guid>
		</item>	
				<item>
			<title>Japan pharma to grow at 2% CAGR from 2013-20</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/1066/japan-pharma-to-grow-at-2-cagr-from-2013-20.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/1066/japan-pharma-to-grow-at-2-cagr-from-2013-20.html</link>
			<pubDate>Thu, 11 Jul 2013 13:59:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jordan-s-pharma-market-witnessed-a-20-percent-growth-in-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/1066/japan-pharma-to-grow-at-2-cagr-from-2013-20.html</guid>
		</item>	
				<item>
			<title>US FDA issues API bulk &amp; tapped density guidance</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3139/us-fda-issues-api-bulk-tapped-density-guidance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3139/us-fda-issues-api-bulk-tapped-density-guidance.html</link>
			<pubDate>Thu, 11 Jul 2013 13:51:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orexo-received-us-fda-approval-for-opoid-zubsolv-buprenorphinenaloxone-sublingual-tablet.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3139/us-fda-issues-api-bulk-tapped-density-guidance.html</guid>
		</item>	
				<item>
			<title>GSK officials under criminal investigation in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/6486/gsk-officials-under-criminal-investigation-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6486/gsk-officials-under-criminal-investigation-in-china.html</link>
			<pubDate>Thu, 11 Jul 2013 13:43:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/investigation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6486/gsk-officials-under-criminal-investigation-in-china.html</guid>
		</item>	
				<item>
			<title>Big pharma to drive R&amp;D innovation with $4.4 bn</title>
			<atom:link href="https://biospectrumasia.com/news/33/240/big-pharma-to-drive-rd-innovation-with-4-4-bn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/240/big-pharma-to-drive-rd-innovation-with-4-4-bn.html</link>
			<pubDate>Thu, 11 Jul 2013 13:37:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/verde-the-latest-in-the-line-of-investment-funds-opens-shop-in-australia.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/240/big-pharma-to-drive-rd-innovation-with-4-4-bn.html</guid>
		</item>	
				<item>
			<title>GSK files for approval on melanoma drug combo </title>
			<atom:link href="https://biospectrumasia.com/news/33/443/gsk-files-for-approval-on-melanoma-drug-combo-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/443/gsk-files-for-approval-on-melanoma-drug-combo-.html</link>
			<pubDate>Wed, 10 Jul 2013 14:06:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-metastatic-melanoma-patients-abraxane-works-better-than-chemotherapy-agent-dacarbazine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/443/gsk-files-for-approval-on-melanoma-drug-combo-.html</guid>
		</item>	
				<item>
			<title>Diabetes drug Actos banned in India</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/1952/diabetes-drug-actos-banned-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/1952/diabetes-drug-actos-banned-in-india.html</link>
			<pubDate>Wed, 10 Jul 2013 14:03:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-habil-khorakiwala-chairman-wockhardt-fears-that-the-firm-may-lose-usd100-million-in-sales-due-to-the-ban-by-indian-authorities.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/1952/diabetes-drug-actos-banned-in-india.html</guid>
		</item>	
				<item>
			<title>MHRA issues import alert to Wockhardt&#039;s India plant</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/897/mhra-issues-import-alert-to-wockhardts-india-plant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/897/mhra-issues-import-alert-to-wockhardts-india-plant.html</link>
			<pubDate>Tue, 09 Jul 2013 14:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/who-serological-tb-diagnostics-tests-are-unreliable-and-must-be-banned.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/897/mhra-issues-import-alert-to-wockhardts-india-plant.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Mayne Pharma launches Doryx in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/2386/australias-mayne-pharma-launches-doryx-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2386/australias-mayne-pharma-launches-doryx-in-us.html</link>
			<pubDate>Tue, 09 Jul 2013 14:11:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/is-japan-changing-its-attitude-towards-generic-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2386/australias-mayne-pharma-launches-doryx-in-us.html</guid>
		</item>	
				<item>
			<title>Lupin scouts for acquisitions across the world</title>
			<atom:link href="https://biospectrumasia.com/news/33/7206/lupin-scouts-for-acquisitions-across-the-world.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7206/lupin-scouts-for-acquisitions-across-the-world.html</link>
			<pubDate>Tue, 09 Jul 2013 13:57:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiwan-expansion.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7206/lupin-scouts-for-acquisitions-across-the-world.html</guid>
		</item>	
				<item>
			<title>GSK hit by more bribery allegations in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/3334/gsk-hit-by-more-bribery-allegations-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3334/gsk-hit-by-more-bribery-allegations-in-china.html</link>
			<pubDate>Mon, 08 Jul 2013 17:23:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-which-has-a-strong-code-of-conduct-and-marketing-practices-guidelines-with-zero-tolerance-for-deviations-launched-a-investigation-into-unethical-practices.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3334/gsk-hit-by-more-bribery-allegations-in-china.html</guid>
		</item>	
				<item>
			<title>Indian drugmakers shifting R&amp;D to South East Asia</title>
			<atom:link href="https://biospectrumasia.com/news/33/6896/indian-drugmakers-shifting-rd-to-south-east-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6896/indian-drugmakers-shifting-rd-to-south-east-asia.html</link>
			<pubDate>Mon, 08 Jul 2013 16:12:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-based-avantor-performance-materials-set-up-current-good-manufacturing-practices-cgmp-production-facility-in-panoli-gujarat-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6896/indian-drugmakers-shifting-rd-to-south-east-asia.html</guid>
		</item>	
				<item>
			<title>Takeda close to releasing Norovirus vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/33/7958/takeda-close-to-releasing-norovirus-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7958/takeda-close-to-releasing-norovirus-vaccine.html</link>
			<pubDate>Mon, 08 Jul 2013 16:10:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/if-approved-takeda-s-norovirus-vaccine-would-be-the-first-to-protect-people-against-the-vomiting-germ.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7958/takeda-close-to-releasing-norovirus-vaccine.html</guid>
		</item>	
				<item>
			<title>Indian formulation industry to grow by 10-12%</title>
			<atom:link href="https://biospectrumasia.com/news/33/5308/indian-formulation-industry-to-grow-by-10-12.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5308/indian-formulation-industry-to-grow-by-10-12.html</link>
			<pubDate>Mon, 08 Jul 2013 16:06:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heartbeat-recorded-substantial-growth-in-china-in-its-user-base-for-its-stakeholder-management-software-data-analytics-solutions-and-stakeholder-data-offering.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5308/indian-formulation-industry-to-grow-by-10-12.html</guid>
		</item>	
				<item>
			<title>FIPB clears seven pharma proposals, defers three</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3053/fipb-clears-seven-pharma-proposals-defers-three.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3053/fipb-clears-seven-pharma-proposals-defers-three.html</link>
			<pubDate>Mon, 08 Jul 2013 15:59:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/moleac-s-neuroaid-develops-stroke-treatment-based-on-traditional-chinese-medicine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3053/fipb-clears-seven-pharma-proposals-defers-three.html</guid>
		</item>	
				<item>
			<title>Chinese planning agency to probe pharma prices</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6575/chinese-planning-agency-to-probe-pharma-prices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6575/chinese-planning-agency-to-probe-pharma-prices.html</link>
			<pubDate>Fri, 05 Jul 2013 11:53:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-pricing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6575/chinese-planning-agency-to-probe-pharma-prices.html</guid>
		</item>	
				<item>
			<title>British drug major GSK awaits Chinese probe details </title>
			<atom:link href="https://biospectrumasia.com/news/33/3467/british-drug-major-gsk-awaits-chinese-probe-details-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3467/british-drug-major-gsk-awaits-chinese-probe-details-.html</link>
			<pubDate>Fri, 05 Jul 2013 08:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3467/british-drug-major-gsk-awaits-chinese-probe-details-.html</guid>
		</item>	
				<item>
			<title>Mayne Pharma acquires generic drugmaker Libertas</title>
			<atom:link href="https://biospectrumasia.com/news/33/2020/mayne-pharma-acquires-generic-drugmaker-libertas.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2020/mayne-pharma-acquires-generic-drugmaker-libertas.html</link>
			<pubDate>Fri, 05 Jul 2013 08:28:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merger-acquisition-world.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2020/mayne-pharma-acquires-generic-drugmaker-libertas.html</guid>
		</item>	
				<item>
			<title>Patents rights in India unreasonably denied: US Pharma</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/6110/patents-rights-in-india-unreasonably-denied-us-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/6110/patents-rights-in-india-unreasonably-denied-us-pharma.html</link>
			<pubDate>Wed, 03 Jul 2013 17:52:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-plea-nexavar-natco.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/6110/patents-rights-in-india-unreasonably-denied-us-pharma.html</guid>
		</item>	
				<item>
			<title>Simcere Pharma sells Boda subsidiary for $65 mn</title>
			<atom:link href="https://biospectrumasia.com/news/33/2797/simcere-pharma-sells-boda-subsidiary-for-65-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2797/simcere-pharma-sells-boda-subsidiary-for-65-mn.html</link>
			<pubDate>Tue, 02 Jul 2013 08:38:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/simcere-pharma-sells-boda-subsidiary-for-usd65-mn.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2797/simcere-pharma-sells-boda-subsidiary-for-65-mn.html</guid>
		</item>	
				<item>
			<title>Reports: GSK staff detained in &#039;fraud data&#039; case in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/1916/reports-gsk-staff-detained-in-fraud-data-case-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1916/reports-gsk-staff-detained-in-fraud-data-case-in-china.html</link>
			<pubDate>Mon, 01 Jul 2013 16:38:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-which-has-a-strong-code-of-conduct-and-marketing-practices-guidelines-with-zero-tolerance-for-deviations-launched-a-investigation-into-unethical-practices.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1916/reports-gsk-staff-detained-in-fraud-data-case-in-china.html</guid>
		</item>	
				<item>
			<title>Interpol seized $41 mn fake drugs to be sold online</title>
			<atom:link href="https://biospectrumasia.com/news/33/5361/interpol-seized-41-mn-fake-drugs-to-be-sold-online.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5361/interpol-seized-41-mn-fake-drugs-to-be-sold-online.html</link>
			<pubDate>Mon, 01 Jul 2013 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/associate-professor-serge-rudaz-of-geneva-university-s-school-of-pharmaceutical-sciences-invented-a-low-cost-machine-that-can-detect-weakened-or-counterfeit-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5361/interpol-seized-41-mn-fake-drugs-to-be-sold-online.html</guid>
		</item>	
				<item>
			<title>India bans pain killer 36 years after the US did so</title>
			<atom:link href="https://biospectrumasia.com/news/33/7268/india-bans-pain-killer-36-years-after-the-us-did-so.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7268/india-bans-pain-killer-36-years-after-the-us-did-so.html</link>
			<pubDate>Fri, 28 Jun 2013 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/who-serological-tb-diagnostics-tests-are-unreliable-and-must-be-banned.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7268/india-bans-pain-killer-36-years-after-the-us-did-so.html</guid>
		</item>	
				<item>
			<title>Ranbaxy claims FDA form &#039;483&#039; not a show stopper</title>
			<atom:link href="https://biospectrumasia.com/news/33/2228/ranbaxy-claims-fda-form-483-not-a-show-stopper.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2228/ranbaxy-claims-fda-form-483-not-a-show-stopper.html</link>
			<pubDate>Fri, 28 Jun 2013 11:57:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxylab.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2228/ranbaxy-claims-fda-form-483-not-a-show-stopper.html</guid>
		</item>	
				<item>
			<title>Sandoz launches trial with Amgen biosimilar</title>
			<atom:link href="https://biospectrumasia.com/news/33/391/sandoz-launches-trial-with-amgen-biosimilar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/391/sandoz-launches-trial-with-amgen-biosimilar.html</link>
			<pubDate>Wed, 26 Jun 2013 15:11:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-brasil-farmaceutica-and-ranbaxy-farmaceutica-use-hybrid-business-model-to-promote-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/391/sandoz-launches-trial-with-amgen-biosimilar.html</guid>
		</item>	
				<item>
			<title>Simcere, Zhuhai enter share transfer agreement</title>
			<atom:link href="https://biospectrumasia.com/news/33/111/simcere-zhuhai-enter-share-transfer-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/111/simcere-zhuhai-enter-share-transfer-agreement.html</link>
			<pubDate>Wed, 26 Jun 2013 15:02:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gi-dynamics-and-cms-medical-enter-agreement-to-distribute-endobarrier-in-brazil.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/111/simcere-zhuhai-enter-share-transfer-agreement.html</guid>
		</item>	
				<item>
			<title>Arvind sets up $42.37 mn plant top tap US market</title>
			<atom:link href="https://biospectrumasia.com/news/33/207/arvind-sets-up-42-37-mn-plant-top-tap-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/207/arvind-sets-up-42-37-mn-plant-top-tap-us-market.html</link>
			<pubDate>Wed, 26 Jun 2013 14:00:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arvind-remedies-lab.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/207/arvind-sets-up-42-37-mn-plant-top-tap-us-market.html</guid>
		</item>	
				<item>
			<title>Astellas prostrate cancer drug gets EU nod</title>
			<atom:link href="https://biospectrumasia.com/news/33/8499/astellas-prostrate-cancer-drug-gets-eu-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/8499/astellas-prostrate-cancer-drug-gets-eu-nod.html</link>
			<pubDate>Tue, 25 Jun 2013 14:49:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prostrate-cancer-zytiga.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/8499/astellas-prostrate-cancer-drug-gets-eu-nod.html</guid>
		</item>	
				<item>
			<title>Pricing revision to cost Indian pharma $160 mn</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7539/pricing-revision-to-cost-indian-pharma-160-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7539/pricing-revision-to-cost-indian-pharma-160-mn.html</link>
			<pubDate>Tue, 25 Jun 2013 11:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/indian-drug-price-control-order-dpco-2013-pharma-firms-need-to-issue-public-notice-six-months-in-advance-if-they-plan-to-stop-manufacturing-of-any-essential-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7539/pricing-revision-to-cost-indian-pharma-160-mn.html</guid>
		</item>	
				<item>
			<title>Boehringer, Lilly diabetes drug shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/33/7017/boehringer-lilly-diabetes-drug-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7017/boehringer-lilly-diabetes-drug-shows-ve-results.html</link>
			<pubDate>Tue, 25 Jun 2013 10:59:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-type-2-diabetes-patients-janssen-gets-us-fda-nod-for-invokana-canagliflozin-a-sodium-glucose-co-transporter-2-sglt2-inhibitor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7017/boehringer-lilly-diabetes-drug-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>RPG issued warning letter by US FDA</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3688/rpg-issued-warning-letter-by-us-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3688/rpg-issued-warning-letter-by-us-fda.html</link>
			<pubDate>Mon, 24 Jun 2013 18:24:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-to-probe-into-whether-medicines-such-as-incretin-mimetics-for-type-2-diabetes-could-cause-pancreatic-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3688/rpg-issued-warning-letter-by-us-fda.html</guid>
		</item>	
				<item>
			<title>Now Ranbaxy&#039;s Mohali unit under FDA scanner</title>
			<atom:link href="https://biospectrumasia.com/news/33/684/now-ranbaxys-mohali-unit-under-fda-scanner.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/684/now-ranbaxys-mohali-unit-under-fda-scanner.html</link>
			<pubDate>Mon, 24 Jun 2013 15:13:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxylab.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/684/now-ranbaxys-mohali-unit-under-fda-scanner.html</guid>
		</item>	
				<item>
			<title>Australia temporarily bans 19 synthetic drugs</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3052/australia-temporarily-bans-19-synthetic-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3052/australia-temporarily-bans-19-synthetic-drugs.html</link>
			<pubDate>Fri, 21 Jun 2013 12:42:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/indian-drug-price-control-order-dpco-2013-pharma-firms-need-to-issue-public-notice-six-months-in-advance-if-they-plan-to-stop-manufacturing-of-any-essential-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3052/australia-temporarily-bans-19-synthetic-drugs.html</guid>
		</item>	
				<item>
			<title>Irish firm&#039;s track-&amp;-trace system to curb fake drugs</title>
			<atom:link href="https://biospectrumasia.com/news/33/867/irish-firms-track-trace-system-to-curb-fake-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/867/irish-firms-track-trace-system-to-curb-fake-drugs.html</link>
			<pubDate>Wed, 19 Jun 2013 12:32:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/horizon-managing-director-aiden-corcoran.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/867/irish-firms-track-trace-system-to-curb-fake-drugs.html</guid>
		</item>	
				<item>
			<title>Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suit </title>
			<atom:link href="https://biospectrumasia.com/news/33/7587/teva-sun-to-pay-2-15-bn-to-pfizer-takeda-to-settle-patent-suit-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7587/teva-sun-to-pay-2-15-bn-to-pfizer-takeda-to-settle-patent-suit-.html</link>
			<pubDate>Thu, 13 Jun 2013 09:08:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/this-will-be-the-first-time-that-generic-drugmakers-will-pay-damages-for-marketing-a-copy-of-an-existing-drug-for-which-patents-have-yet-to-expire.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7587/teva-sun-to-pay-2-15-bn-to-pfizer-takeda-to-settle-patent-suit-.html</guid>
		</item>	
				<item>
			<title>New tech promises revenue boost for drug makers</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/1180/new-tech-promises-revenue-boost-for-drug-makers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/1180/new-tech-promises-revenue-boost-for-drug-makers.html</link>
			<pubDate>Wed, 12 Jun 2013 17:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-nick-ede-executive-director-imugene-australia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/1180/new-tech-promises-revenue-boost-for-drug-makers.html</guid>
		</item>	
				<item>
			<title>Apollo Pharmacy cautions against Ranbaxy drugs&#039; use</title>
			<atom:link href="https://biospectrumasia.com/news/33/6333/apollo-pharmacy-cautions-against-ranbaxy-drugs-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6333/apollo-pharmacy-cautions-against-ranbaxy-drugs-use.html</link>
			<pubDate>Mon, 10 Jun 2013 14:37:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apollo-pharmacy-india-s-biggest-branded-drug-retail-network-issues-a-cautionary-advisory-against-drugs-manufactured-by-ranbaxy.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6333/apollo-pharmacy-cautions-against-ranbaxy-drugs-use.html</guid>
		</item>	
				<item>
			<title>DCGI nod for Zydus Cadila diabetic dyslipidemeia drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/1303/dcgi-nod-for-zydus-cadila-diabetic-dyslipidemeia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1303/dcgi-nod-for-zydus-cadila-diabetic-dyslipidemeia-drug.html</link>
			<pubDate>Mon, 10 Jun 2013 14:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/zydus-cadila.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1303/dcgi-nod-for-zydus-cadila-diabetic-dyslipidemeia-drug.html</guid>
		</item>	
				<item>
			<title>Astellas joins hands with Tecnofarma International</title>
			<atom:link href="https://biospectrumasia.com/news/33/2197/astellas-joins-hands-with-tecnofarma-international.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2197/astellas-joins-hands-with-tecnofarma-international.html</link>
			<pubDate>Fri, 07 Jun 2013 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sodium-tablets-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2197/astellas-joins-hands-with-tecnofarma-international.html</guid>
		</item>	
				<item>
			<title>Sun Pharma generic testosterone injection gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/1793/sun-pharma-generic-testosterone-injection-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/1793/sun-pharma-generic-testosterone-injection-gets-fda-nod.html</link>
			<pubDate>Thu, 06 Jun 2013 17:17:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sun-pharma-s-generic-of-pfizer-s-depo-testosterone-injection-gets-approval-form-the-us-fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/1793/sun-pharma-generic-testosterone-injection-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>Ranbaxy, Lundbeck face EU fury for blocking generics </title>
			<atom:link href="https://biospectrumasia.com/news/33/4576/ranbaxy-lundbeck-face-eu-fury-for-blocking-generics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4576/ranbaxy-lundbeck-face-eu-fury-for-blocking-generics-.html</link>
			<pubDate>Tue, 04 Jun 2013 13:42:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/european-commission-to-fine-firms-that-have-been-part-of-pay-for-delay-deals-where-brand-name-drug-firms-pay-generic-manufacturers-for-not-delivering-cheaper-versions-of-their-drugs-to-the-market.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4576/ranbaxy-lundbeck-face-eu-fury-for-blocking-generics-.html</guid>
		</item>	
				<item>
			<title>Deregulation will boost Japanese pharma sector</title>
			<atom:link href="https://biospectrumasia.com/news/33/1968/deregulation-will-boost-japanese-pharma-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1968/deregulation-will-boost-japanese-pharma-sector.html</link>
			<pubDate>Tue, 04 Jun 2013 11:23:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-japanese-government-astellas-eisai-daiichi-sankyo-shionogi-takeda-and-bill-melinda-gates-foundation-will-initiate-an-effort-worth-usd100-million-to-tackle-hiv-malaria-tuberculosis-and-tropical-diseas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1968/deregulation-will-boost-japanese-pharma-sector.html</guid>
		</item>	
				<item>
			<title>Fujifilm, Dr Reddy&#039;s terminate generics JV</title>
			<atom:link href="https://biospectrumasia.com/news/33/1504/fujifilm-dr-reddys-terminate-generics-jv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1504/fujifilm-dr-reddys-terminate-generics-jv.html</link>
			<pubDate>Tue, 04 Jun 2013 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1504/fujifilm-dr-reddys-terminate-generics-jv.html</guid>
		</item>	
				<item>
			<title>Ranbaxy advisory: All our products are safe and efficacious</title>
			<atom:link href="https://biospectrumasia.com/news/33/701/ranbaxy-advisory-all-our-products-are-safe-and-efficacious.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/701/ranbaxy-advisory-all-our-products-are-safe-and-efficacious.html</link>
			<pubDate>Mon, 03 Jun 2013 15:14:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxylab.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/701/ranbaxy-advisory-all-our-products-are-safe-and-efficacious.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe files NDA for Canagliflozin</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/2487/mitsubishi-tanabe-files-nda-for-canagliflozin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/2487/mitsubishi-tanabe-files-nda-for-canagliflozin.html</link>
			<pubDate>Thu, 30 May 2013 11:43:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-diabetes-patients-mitsubishi-tanabe-pharma-seeks-approval-of-ta-7284-canagliflozin-a-sodium-glucose-co-transporter-2-sglt2-inhibitor-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/2487/mitsubishi-tanabe-files-nda-for-canagliflozin.html</guid>
		</item>	
				<item>
			<title>Will Japan be able to reduce its generic drug prices?</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/7356/will-japan-be-able-to-reduce-its-generic-drug-prices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/7356/will-japan-be-able-to-reduce-its-generic-drug-prices.html</link>
			<pubDate>Tue, 21 May 2013 08:59:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/is-japan-changing-its-attitude-towards-generic-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/7356/will-japan-be-able-to-reduce-its-generic-drug-prices.html</guid>
		</item>	
				<item>
			<title>TWi Pharma gets FDA nod for ADHD drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/421/twi-pharma-gets-fda-nod-for-adhd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/421/twi-pharma-gets-fda-nod-for-adhd-drug.html</link>
			<pubDate>Wed, 15 May 2013 12:22:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/twi-guanfacine-hydrochloride-abbreviated-new-drug-application-anda-gets-fda-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/421/twi-pharma-gets-fda-nod-for-adhd-drug.html</guid>
		</item>	
				<item>
			<title>TB prevention faces gap of $1.6bn: WHO estimates</title>
			<atom:link href="https://biospectrumasia.com/news/33/434/tb-prevention-faces-gap-of-1-6bn-who-estimates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/434/tb-prevention-faces-gap-of-1-6bn-who-estimates.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/434/tb-prevention-faces-gap-of-1-6bn-who-estimates.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand</title>
			<atom:link href="https://biospectrumasia.com/news/33/760/daiichi-sankyo-ranbaxy-to-leverage-synergies-in-thailand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/760/daiichi-sankyo-ranbaxy-to-leverage-synergies-in-thailand.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/760/daiichi-sankyo-ranbaxy-to-leverage-synergies-in-thailand.html</guid>
		</item>	
				<item>
			<title>Gulf nations woo Indian generic firms</title>
			<atom:link href="https://biospectrumasia.com/news/33/1675/gulf-nations-woo-indian-generic-firms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1675/gulf-nations-woo-indian-generic-firms.html</link>
			<pubDate>Thu, 04 Apr 2013 14:11:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/impending-free-trade-agreement-between-gcc-and-india-will-further-open-up-the-generics-market.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1675/gulf-nations-woo-indian-generic-firms.html</guid>
		</item>	
				<item>
			<title>DRL launches Alchemia thrombosis generic in India</title>
			<atom:link href="https://biospectrumasia.com/news/33/4078/drl-launches-alchemia-thrombosis-generic-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4078/drl-launches-alchemia-thrombosis-generic-in-india.html</link>
			<pubDate>Thu, 04 Apr 2013 13:30:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4078/drl-launches-alchemia-thrombosis-generic-in-india.html</guid>
		</item>	
				<item>
			<title>Actavis to sell generic AstraZeneca&#039;s Crestor </title>
			<atom:link href="https://biospectrumasia.com/news/33/1579/actavis-to-sell-generic-astrazenecas-crestor-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1579/actavis-to-sell-generic-astrazenecas-crestor-.html</link>
			<pubDate>Tue, 26 Mar 2013 16:16:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/actavis-to-sell-generic-astrazeneca-s-crestor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1579/actavis-to-sell-generic-astrazenecas-crestor-.html</guid>
		</item>	
				<item>
			<title>Beximco Pharma enters EU market</title>
			<atom:link href="https://biospectrumasia.com/news/33/7267/beximco-pharma-enters-eu-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7267/beximco-pharma-enters-eu-market.html</link>
			<pubDate>Thu, 14 Mar 2013 12:30:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/beximco-pharma-exporter-eu.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7267/beximco-pharma-enters-eu-market.html</guid>
		</item>	
				<item>
			<title>Dr Reddy&#039;s launches generic fracture drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/1494/dr-reddys-launches-generic-fracture-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1494/dr-reddys-launches-generic-fracture-drug.html</link>
			<pubDate>Thu, 07 Mar 2013 11:05:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-cancer-patients-who-suffer-fractures-dr-reddy-s-laboratories-launches-generic-version-of-novartis-zometa-injection.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1494/dr-reddys-launches-generic-fracture-drug.html</guid>
		</item>	
				<item>
			<title>Ranbaxy to market Desvenlafaxine in the US</title>
			<atom:link href="https://biospectrumasia.com/news/33/1407/ranbaxy-to-market-desvenlafaxine-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1407/ranbaxy-to-market-desvenlafaxine-in-the-us.html</link>
			<pubDate>Wed, 06 Mar 2013 11:35:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-drug-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1407/ranbaxy-to-market-desvenlafaxine-in-the-us.html</guid>
		</item>	
				<item>
			<title>GlobalData: New Zealand focuses on generics </title>
			<atom:link href="https://biospectrumasia.com/news/33/1745/globaldata-new-zealand-focuses-on-generics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1745/globaldata-new-zealand-focuses-on-generics-.html</link>
			<pubDate>Wed, 27 Feb 2013 13:59:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globaldata-new-zealand-pharmaceutical-management-agency-pharmac-is-emphasising-on-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1745/globaldata-new-zealand-focuses-on-generics-.html</guid>
		</item>	
				<item>
			<title>Gilead, Teva to settle patent case of HIV drug </title>
			<atom:link href="https://biospectrumasia.com/news/33/1300/gilead-teva-to-settle-patent-case-of-hiv-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1300/gilead-teva-to-settle-patent-case-of-hiv-drug-.html</link>
			<pubDate>Thu, 21 Feb 2013 12:45:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-teva-to-settle-patent-case-of-hiv-drug-viread.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1300/gilead-teva-to-settle-patent-case-of-hiv-drug-.html</guid>
		</item>	
				<item>
			<title>Mylan to develop, market Biocon generic insulin</title>
			<atom:link href="https://biospectrumasia.com/news/33/2425/mylan-to-develop-market-biocon-generic-insulin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2425/mylan-to-develop-market-biocon-generic-insulin.html</link>
			<pubDate>Thu, 14 Feb 2013 11:04:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mylan-will-develop-and-market-insulin-generics-including-biocon-s-glargine-lispro-and-aspart.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2425/mylan-to-develop-market-biocon-generic-insulin.html</guid>
		</item>	
				<item>
			<title>Sun Pharma cancer drug to address shortage</title>
			<atom:link href="https://biospectrumasia.com/news/33/6100/sun-pharma-cancer-drug-to-address-shortage.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6100/sun-pharma-cancer-drug-to-address-shortage.html</link>
			<pubDate>Tue, 05 Feb 2013 09:54:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-drug-shortage-fda-list.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6100/sun-pharma-cancer-drug-to-address-shortage.html</guid>
		</item>	
				<item>
			<title>Generics will lead to $7 bn loss for statins market </title>
			<atom:link href="https://biospectrumasia.com/news/33/5986/generics-will-lead-to-7-bn-loss-for-statins-market-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5986/generics-will-lead-to-7-bn-loss-for-statins-market-.html</link>
			<pubDate>Thu, 31 Jan 2013 11:02:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gbi-research-worldwide-statins-market-will-drop-usd19.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5986/generics-will-lead-to-7-bn-loss-for-statins-market-.html</guid>
		</item>	
				<item>
			<title>Glenmark generics business grows by 34%</title>
			<atom:link href="https://biospectrumasia.com/news/33/3591/glenmark-generics-business-grows-by-34.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3591/glenmark-generics-business-grows-by-34.html</link>
			<pubDate>Wed, 30 Jan 2013 13:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/option-agreement-with-forest-laboratories-for-the-development-of-novel-mpges-1-inhibitors-and-the-us-fda-approval-for-in-licensed-molecule-crofelemer-provides-a-big-boost-to-glenmark-s-business.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3591/glenmark-generics-business-grows-by-34.html</guid>
		</item>	
				<item>
			<title>Indian regulator cracks down on banned drugs</title>
			<atom:link href="https://biospectrumasia.com/news/33/4926/indian-regulator-cracks-down-on-banned-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4926/indian-regulator-cracks-down-on-banned-drugs.html</link>
			<pubDate>Mon, 21 Jan 2013 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-controller-general-of-india-dgci-all-generic-drug-makers-need-to-conduct-trials-and-seek-approval-within-18-months.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4926/indian-regulator-cracks-down-on-banned-drugs.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches generic Finasteride</title>
			<atom:link href="https://biospectrumasia.com/news/33/6180/dr-reddys-launches-generic-finasteride.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6180/dr-reddys-launches-generic-finasteride.html</link>
			<pubDate>Fri, 04 Jan 2013 10:31:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-reddys-laboratories-drl-launched-finasteride-tablets-generic-version-of-propecia-in-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6180/dr-reddys-launches-generic-finasteride.html</guid>
		</item>	
				<item>
			<title>Canadian generic maker enters Korea with JV</title>
			<atom:link href="https://biospectrumasia.com/news/33/4437/canadian-generic-maker-enters-korea-with-jv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4437/canadian-generic-maker-enters-korea-with-jv.html</link>
			<pubDate>Thu, 03 Jan 2013 13:48:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmascience-korea-a-korean-canadian-generics-joint-venture-is-born.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4437/canadian-generic-maker-enters-korea-with-jv.html</guid>
		</item>	
				<item>
			<title>Japan approves generic drug for osteoporosis</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/1047/japan-approves-generic-drug-for-osteoporosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/1047/japan-approves-generic-drug-for-osteoporosis.html</link>
			<pubDate>Fri, 28 Dec 2012 12:03:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-osteoporosis-patients-generics-of-risedronate-sodium-hydrate-by-ajinomoto-and-takeda-get-japanese-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/1047/japan-approves-generic-drug-for-osteoporosis.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo generics&#039; unit to launch 5 drugs</title>
			<atom:link href="https://biospectrumasia.com/news/33/2524/daiichi-sankyo-generics-unit-to-launch-5-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2524/daiichi-sankyo-generics-unit-to-launch-5-drugs.html</link>
			<pubDate>Mon, 17 Dec 2012 13:36:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-espha-to-launch-five-generic-products-including-quetiapine-and-mosapride-citrate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2524/daiichi-sankyo-generics-unit-to-launch-5-drugs.html</guid>
		</item>	
				<item>
			<title>Cipla appoints Subhanu Saxena as CEO</title>
			<atom:link href="https://biospectrumasia.com/news/33/5611/cipla-appoints-subhanu-saxena-as-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5611/cipla-appoints-subhanu-saxena-as-ceo.html</link>
			<pubDate>Fri, 23 Nov 2012 10:30:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/subhanu-saxena-cipla.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5611/cipla-appoints-subhanu-saxena-as-ceo.html</guid>
		</item>	
				<item>
			<title>US FDA extends timeline for generic drug approval</title>
			<atom:link href="https://biospectrumasia.com/news/33/7788/us-fda-extends-timeline-for-generic-drug-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/7788/us-fda-extends-timeline-for-generic-drug-approval.html</link>
			<pubDate>Mon, 29 Oct 2012 17:51:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/7788/us-fda-extends-timeline-for-generic-drug-approval.html</guid>
		</item>	
				<item>
			<title>Why Mylan sued US FDA over Diovan generic?</title>
			<atom:link href="https://biospectrumasia.com/news/33/4806/why-mylan-sued-us-fda-over-diovan-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4806/why-mylan-sued-us-fda-over-diovan-generic.html</link>
			<pubDate>Thu, 04 Oct 2012 14:44:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mylan-sues-fda-for-novartis-diovan-generic.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4806/why-mylan-sued-us-fda-over-diovan-generic.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches generic of Singulair oral granules</title>
			<atom:link href="https://biospectrumasia.com/news/33/2552/dr-reddys-launches-generic-of-singulair-oral-granules.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2552/dr-reddys-launches-generic-of-singulair-oral-granules.html</link>
			<pubDate>Fri, 28 Sep 2012 10:24:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approved-singulair-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2552/dr-reddys-launches-generic-of-singulair-oral-granules.html</guid>
		</item>	
				<item>
			<title>Bayer plea for stay on compulsory license dismissed</title>
			<atom:link href="https://biospectrumasia.com/news/33/4626/bayer-plea-for-stay-on-compulsory-license-dismissed.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4626/bayer-plea-for-stay-on-compulsory-license-dismissed.html</link>
			<pubDate>Mon, 17 Sep 2012 10:28:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-plea-nexavar-natco.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4626/bayer-plea-for-stay-on-compulsory-license-dismissed.html</guid>
		</item>	
				<item>
			<title>Aurobindo gets FDA nod for anti-depression generic</title>
			<atom:link href="https://biospectrumasia.com/news/33/5411/aurobindo-gets-fda-nod-for-anti-depression-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5411/aurobindo-gets-fda-nod-for-anti-depression-generic.html</link>
			<pubDate>Thu, 13 Sep 2012 12:15:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aurobindo-pharma-gets-fda-approval-for-anti-depression-generic-drug-escitalopram-oxalate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5411/aurobindo-gets-fda-nod-for-anti-depression-generic.html</guid>
		</item>	
				<item>
			<title>Pfizer, Hisun launch generics joint venture in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/6807/pfizer-hisun-launch-generics-joint-venture-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/6807/pfizer-hisun-launch-generics-joint-venture-in-china.html</link>
			<pubDate>Thu, 13 Sep 2012 10:04:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-and-zhejiang-hisun-pharmaceuticals-jv-to-develop-off-patent-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/6807/pfizer-hisun-launch-generics-joint-venture-in-china.html</guid>
		</item>	
				<item>
			<title>Blogger sued by pharma firm for the first time in India </title>
			<atom:link href="https://biospectrumasia.com/news/33/4977/blogger-sued-by-pharma-firm-for-the-first-time-in-india-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4977/blogger-sued-by-pharma-firm-for-the-first-time-in-india-.html</link>
			<pubDate>Mon, 10 Sep 2012 15:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blogger-natco-s-lawsuit-is-attack-on-the-right-to-free-speech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4977/blogger-sued-by-pharma-firm-for-the-first-time-in-india-.html</guid>
		</item>	
				<item>
			<title>Cipla wins patent case against Roche</title>
			<atom:link href="https://biospectrumasia.com/news/33/5959/cipla-wins-patent-case-against-roche.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5959/cipla-wins-patent-case-against-roche.html</link>
			<pubDate>Mon, 10 Sep 2012 13:02:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cipla-wins-patent-case.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5959/cipla-wins-patent-case-against-roche.html</guid>
		</item>	
				<item>
			<title>Pfizer, Mylan settle litigation over Detrol LA generic</title>
			<atom:link href="https://biospectrumasia.com/news/33/4770/pfizer-mylan-settle-litigation-over-detrol-la-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4770/pfizer-mylan-settle-litigation-over-detrol-la-generic.html</link>
			<pubDate>Mon, 10 Sep 2012 10:50:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-mylan-litigation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4770/pfizer-mylan-settle-litigation-over-detrol-la-generic.html</guid>
		</item>	
				<item>
			<title>US FDA seeks inputs on its generic drug amendments </title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/8189/us-fda-seeks-inputs-on-its-generic-drug-amendments-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/8189/us-fda-seeks-inputs-on-its-generic-drug-amendments-.html</link>
			<pubDate>Tue, 04 Sep 2012 17:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-wants-to-discuss-its-generic-drug-user-fee-amendments.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/8189/us-fda-seeks-inputs-on-its-generic-drug-amendments-.html</guid>
		</item>	
				<item>
			<title>Novartis case hearing against Indian patent office on Sept 11</title>
			<atom:link href="https://biospectrumasia.com/news/33/5992/novartis-case-hearing-against-indian-patent-office-on-sept-11.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5992/novartis-case-hearing-against-indian-patent-office-on-sept-11.html</link>
			<pubDate>Tue, 21 Aug 2012 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/glivec-patent-case-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5992/novartis-case-hearing-against-indian-patent-office-on-sept-11.html</guid>
		</item>	
				<item>
			<title>Ranbaxy launches generic of Pioglitazone in US</title>
			<atom:link href="https://biospectrumasia.com/news/33/3333/ranbaxy-launches-generic-of-pioglitazone-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3333/ranbaxy-launches-generic-of-pioglitazone-in-us.html</link>
			<pubDate>Mon, 20 Aug 2012 09:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-launches-generic-of-pioglitazone.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3333/ranbaxy-launches-generic-of-pioglitazone-in-us.html</guid>
		</item>	
				<item>
			<title>First generic of diabetes drug Actos approved</title>
			<atom:link href="https://biospectrumasia.com/news/33/5384/first-generic-of-diabetes-drug-actos-approved.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/5384/first-generic-of-diabetes-drug-actos-approved.html</link>
			<pubDate>Mon, 20 Aug 2012 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes-check.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/5384/first-generic-of-diabetes-drug-actos-approved.html</guid>
		</item>	
				<item>
			<title>Wockhardt gets FDA nod for generic treatment of enlarged prostate</title>
			<atom:link href="https://biospectrumasia.com/news/33/3729/wockhardt-gets-fda-nod-for-generic-treatment-of-enlarged-prostate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3729/wockhardt-gets-fda-nod-for-generic-treatment-of-enlarged-prostate.html</link>
			<pubDate>Wed, 15 Aug 2012 08:16:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-wockhardt.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3729/wockhardt-gets-fda-nod-for-generic-treatment-of-enlarged-prostate.html</guid>
		</item>	
				<item>
			<title>Sun Pharma revenue touches $480 million in Q2 2012</title>
			<atom:link href="https://biospectrumasia.com/company-results/33/3088/sun-pharma-revenue-touches-480-million-in-q2-2012.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/33/3088/sun-pharma-revenue-touches-480-million-in-q2-2012.html</link>
			<pubDate>Fri, 10 Aug 2012 16:48:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/33/3088/sun-pharma-revenue-touches-480-million-in-q2-2012.html</guid>
		</item>	
				<item>
			<title>Pharmaniaga report 51% jump in net profit</title>
			<atom:link href="https://biospectrumasia.com/company-results/33/3607/pharmaniaga-report-51-jump-in-net-profit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/33/3607/pharmaniaga-report-51-jump-in-net-profit.html</link>
			<pubDate>Thu, 09 Aug 2012 11:07:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/revenue-growth-pharmaniaga.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/33/3607/pharmaniaga-report-51-jump-in-net-profit.html</guid>
		</item>	
				<item>
			<title>Mylan launches operations in India with 18 ARV products</title>
			<atom:link href="https://biospectrumasia.com/news/33/3957/mylan-launches-operations-in-india-with-18-arv-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3957/mylan-launches-operations-in-india-with-18-arv-products.html</link>
			<pubDate>Thu, 09 Aug 2012 10:07:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3957/mylan-launches-operations-in-india-with-18-arv-products.html</guid>
		</item>	
				<item>
			<title>Generic sodium tablets from Dr. Reddy&#039;s, Mylan hit US market</title>
			<atom:link href="https://biospectrumasia.com/news/33/2194/generic-sodium-tablets-from-dr-reddys-mylan-hit-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2194/generic-sodium-tablets-from-dr-reddys-mylan-hit-us-market.html</link>
			<pubDate>Wed, 08 Aug 2012 12:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sodium-tablets-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2194/generic-sodium-tablets-from-dr-reddys-mylan-hit-us-market.html</guid>
		</item>	
				<item>
			<title>Mylan to produce generic of Gilead&#039;s HIV drug </title>
			<atom:link href="https://biospectrumasia.com/news/33/1594/mylan-to-produce-generic-of-gileads-hiv-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1594/mylan-to-produce-generic-of-gileads-hiv-drug-.html</link>
			<pubDate>Fri, 03 Aug 2012 10:55:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mylan-will-produce-generic-version-of-gilead-s-arv-emtriva.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1594/mylan-to-produce-generic-of-gileads-hiv-drug-.html</guid>
		</item>	
				<item>
			<title>Pharma FDI cap, right move for India</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/4157/pharma-fdi-cap-right-move-for-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/4157/pharma-fdi-cap-right-move-for-india.html</link>
			<pubDate>Tue, 31 Jul 2012 10:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/foreign-firms-will-need-fipb-approval-for-acquiring-more-than-49-stakes-in-indian-pharma-companies.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/4157/pharma-fdi-cap-right-move-for-india.html</guid>
		</item>	
				<item>
			<title>Mylan launches generic version of Sporanox</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/859/mylan-launches-generic-version-of-sporanox.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/859/mylan-launches-generic-version-of-sporanox.html</link>
			<pubDate>Mon, 30 Jul 2012 11:41:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/generic-version-of-sporanox-launched.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/859/mylan-launches-generic-version-of-sporanox.html</guid>
		</item>	
				<item>
			<title>FDA clears 152 antiretroviral drugs for HIV/AIDS program</title>
			<atom:link href="https://biospectrumasia.com/news/33/3820/fda-clears-152-antiretroviral-drugs-for-hiv-aids-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3820/fda-clears-152-antiretroviral-drugs-for-hiv-aids-program.html</link>
			<pubDate>Tue, 24 Jul 2012 10:19:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-hiv-aids-drugs.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3820/fda-clears-152-antiretroviral-drugs-for-hiv-aids-program.html</guid>
		</item>	
				<item>
			<title>Lupin gets FDA approval for Lyrica generic</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/2291/lupin-gets-fda-approval-for-lyrica-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/2291/lupin-gets-fda-approval-for-lyrica-generic.html</link>
			<pubDate>Fri, 06 Jul 2012 10:44:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-lyrica-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/2291/lupin-gets-fda-approval-for-lyrica-generic.html</guid>
		</item>	
				<item>
			<title>Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/8156/lupin-gets-fda-nod-for-generic-ortho-tri-cyclen-lo-tablets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/8156/lupin-gets-fda-nod-for-generic-ortho-tri-cyclen-lo-tablets.html</link>
			<pubDate>Thu, 05 Jul 2012 11:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lupin-fda-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/8156/lupin-gets-fda-nod-for-generic-ortho-tri-cyclen-lo-tablets.html</guid>
		</item>	
				<item>
			<title>Generics challenge pharma drug pricing regime</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/3558/generics-challenge-pharma-drug-pricing-regime.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/3558/generics-challenge-pharma-drug-pricing-regime.html</link>
			<pubDate>Wed, 04 Jul 2012 10:48:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/3558/generics-challenge-pharma-drug-pricing-regime.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches generic of Boniva</title>
			<atom:link href="https://biospectrumasia.com/news/33/3654/dr-reddys-launches-generic-of-boniva.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/3654/dr-reddys-launches-generic-of-boniva.html</link>
			<pubDate>Mon, 02 Jul 2012 13:32:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-dr-reddys.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/3654/dr-reddys-launches-generic-of-boniva.html</guid>
		</item>	
				<item>
			<title>Mylan gets FDA nod for Thiamine Hydrochloride Injection</title>
			<atom:link href="https://biospectrumasia.com/news/33/264/mylan-gets-fda-nod-for-thiamine-hydrochloride-injection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/264/mylan-gets-fda-nod-for-thiamine-hydrochloride-injection.html</link>
			<pubDate>Mon, 02 Jul 2012 12:51:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-mylan-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/264/mylan-gets-fda-nod-for-thiamine-hydrochloride-injection.html</guid>
		</item>	
				<item>
			<title>HIV generics to take over antivirals market</title>
			<atom:link href="https://biospectrumasia.com/news/33/1538/hiv-generics-to-take-over-antivirals-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1538/hiv-generics-to-take-over-antivirals-market.html</link>
			<pubDate>Mon, 02 Jul 2012 10:50:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiv-antiviral-drugs-market.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1538/hiv-generics-to-take-over-antivirals-market.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s rides on biosimilar product line</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/3678/dr-reddys-rides-on-biosimilar-product-line.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/3678/dr-reddys-rides-on-biosimilar-product-line.html</link>
			<pubDate>Fri, 15 Jun 2012 13:13:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-reddy-s-laboratories-graph.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/3678/dr-reddys-rides-on-biosimilar-product-line.html</guid>
		</item>	
				<item>
			<title>Lilly expands partnership with Novast</title>
			<atom:link href="https://biospectrumasia.com/news/33/1705/lilly-expands-partnership-with-novast.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/1705/lilly-expands-partnership-with-novast.html</link>
			<pubDate>Wed, 13 Jun 2012 10:48:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-generics-eli-lilly-novast.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/1705/lilly-expands-partnership-with-novast.html</guid>
		</item>	
				<item>
			<title>Cipla nurtures global vision for affordable drugs</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/4667/cipla-nurtures-global-vision-for-affordable-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/4667/cipla-nurtures-global-vision-for-affordable-drugs.html</link>
			<pubDate>Wed, 13 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cipla-graph-8.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/4667/cipla-nurtures-global-vision-for-affordable-drugs.html</guid>
		</item>	
				<item>
			<title>Ranbaxy redesigns strategy to meet regulations</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/5380/ranbaxy-redesigns-strategy-to-meet-regulations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/5380/ranbaxy-redesigns-strategy-to-meet-regulations.html</link>
			<pubDate>Tue, 12 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-laboratories-graph-7.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/5380/ranbaxy-redesigns-strategy-to-meet-regulations.html</guid>
		</item>	
				<item>
			<title>India to realign regulatory with pharma industry</title>
			<atom:link href="https://biospectrumasia.com/opinion/33/1872/india-to-realign-regulatory-with-pharma-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/33/1872/india-to-realign-regulatory-with-pharma-industry.html</link>
			<pubDate>Wed, 06 Jun 2012 12:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dose-of-regulation-for-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/33/1872/india-to-realign-regulatory-with-pharma-industry.html</guid>
		</item>	
				<item>
			<title>US FDA approves Suprax 400 mg by Lupin</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/120/us-fda-approves-suprax-400-mg-by-lupin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/120/us-fda-approves-suprax-400-mg-by-lupin.html</link>
			<pubDate>Wed, 06 Jun 2012 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lupin-fda-suprax.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/120/us-fda-approves-suprax-400-mg-by-lupin.html</guid>
		</item>	
				<item>
			<title>Generics market to touch $231 bn by 2017: Report</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/3048/generics-market-to-touch-231-bn-by-2017-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/3048/generics-market-to-touch-231-bn-by-2017-report.html</link>
			<pubDate>Mon, 04 Jun 2012 10:02:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/generics-pharma-market-growth.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/3048/generics-market-to-touch-231-bn-by-2017-report.html</guid>
		</item>	
				<item>
			<title>Aurobindo receives FDA approval for Nevirapine</title>
			<atom:link href="https://biospectrumasia.com/news/33/2508/aurobindo-receives-fda-approval-for-nevirapine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/2508/aurobindo-receives-fda-approval-for-nevirapine.html</link>
			<pubDate>Fri, 01 Jun 2012 10:15:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-aurobindo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/2508/aurobindo-receives-fda-approval-for-nevirapine.html</guid>
		</item>	
				<item>
			<title>Aged society fuels growth of generics</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/3450/aged-society-fuels-growth-of-generics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/3450/aged-society-fuels-growth-of-generics.html</link>
			<pubDate>Fri, 01 Jun 2012 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/old-age.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/3450/aged-society-fuels-growth-of-generics.html</guid>
		</item>	
				<item>
			<title>Bioscience firms queue up for Japan market</title>
			<atom:link href="https://biospectrumasia.com/analysis/33/3855/bioscience-firms-queue-up-for-japan-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/33/3855/bioscience-firms-queue-up-for-japan-market.html</link>
			<pubDate>Fri, 01 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/33/3855/bioscience-firms-queue-up-for-japan-market.html</guid>
		</item>	
				<item>
			<title>FDA approves generic versions of Plavix</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/7776/fda-approves-generic-versions-of-plavix.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/7776/fda-approves-generic-versions-of-plavix.html</link>
			<pubDate>Fri, 18 May 2012 14:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-generic-versions-of-plavix.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/7776/fda-approves-generic-versions-of-plavix.html</guid>
		</item>	
				<item>
			<title>Debate over compulsory licensing of Bayer&#039;s Nexavar</title>
			<atom:link href="https://biospectrumasia.com/regulatory/33/3470/debate-over-compulsory-licensing-of-bayers-nexavar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/33/3470/debate-over-compulsory-licensing-of-bayers-nexavar.html</link>
			<pubDate>Mon, 30 Apr 2012 15:09:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nexavar.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/33/3470/debate-over-compulsory-licensing-of-bayers-nexavar.html</guid>
		</item>	
				<item>
			<title>Lilly strengthens its foothold in China</title>
			<atom:link href="https://biospectrumasia.com/news/33/164/lilly-strengthens-its-foothold-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/164/lilly-strengthens-its-foothold-in-china.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/164/lilly-strengthens-its-foothold-in-china.html</guid>
		</item>	
				<item>
			<title> Multiple organzations join hands to curb fake drug business</title>
			<atom:link href="https://biospectrumasia.com/news/33/234/-multiple-organzations-join-hands-to-curb-fake-drug-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/234/-multiple-organzations-join-hands-to-curb-fake-drug-business.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fake-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/234/-multiple-organzations-join-hands-to-curb-fake-drug-business.html</guid>
		</item>	
				<item>
			<title>US company leverages on generics</title>
			<atom:link href="https://biospectrumasia.com/news/33/337/us-company-leverages-on-generics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/337/us-company-leverages-on-generics.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/337/us-company-leverages-on-generics.html</guid>
		</item>	
				<item>
			<title>Industry body expresses concern over Nexavar decision</title>
			<atom:link href="https://biospectrumasia.com/news/33/151/industry-body-expresses-concern-over-nexavar-decision.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/151/industry-body-expresses-concern-over-nexavar-decision.html</link>
			<pubDate>Fri, 16 Mar 2012 16:04:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/151/industry-body-expresses-concern-over-nexavar-decision.html</guid>
		</item>	
				<item>
			<title>NATCO wins compulsory license for anti-cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/33/269/natco-wins-compulsory-license-for-anti-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/269/natco-wins-compulsory-license-for-anti-cancer-drug.html</link>
			<pubDate>Fri, 16 Mar 2012 15:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nexavar.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/269/natco-wins-compulsory-license-for-anti-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Dr Yusuf K Hamied: India&#039;s generics king</title>
			<atom:link href="https://biospectrumasia.com/influencers/33/1915/dr-yusuf-k-hamied-indias-generics-king.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/33/1915/dr-yusuf-k-hamied-indias-generics-king.html</link>
			<pubDate>Thu, 15 Mar 2012 17:41:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yusuf-hamied-cipla.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/33/1915/dr-yusuf-k-hamied-indias-generics-king.html</guid>
		</item>	
				<item>
			<title>Patents worth $60 billion set to expire by 2019</title>
			<atom:link href="https://biospectrumasia.com/news/33/4724/patents-worth-60-billion-set-to-expire-by-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/33/4724/patents-worth-60-billion-set-to-expire-by-2019.html</link>
			<pubDate>Wed, 07 Mar 2012 21:23:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/33/4724/patents-worth-60-billion-set-to-expire-by-2019.html</guid>
		</item>	
				</channel>
</rss>
